

<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.21.0 -->
<!-- Round: 3 -->
<!-- Creation date: 2014-03-21T20:38:12Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:galt="http://www.galectintherapeutics.com/20131231" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="galt-20131231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20030131_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8AEA34F8-F963-48B2-AC3C-9ED53F96BF39_1002_0">6.00</us-gaap:SharePrice>
  <galt:CommonStockAdditionalSharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20030131_0" unitRef="shares" decimals="INF" id="id_4142217_8AEA34F8-F963-48B2-AC3C-9ED53F96BF39_1002_2">2042</galt:CommonStockAdditionalSharesIssued>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x731237" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_3001_7">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x731237" unitRef="iso4217_USD" decimals="0" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_3001_9">239000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x780010" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_4001_6">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x780010" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_4001_1">18.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_4001_8">4786000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080204_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_5003_7">9.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20080204_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_5003_11">3.54</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20080204_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_5003_8">984000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1310-K0015_STD_0_20080204_0_711196x713505" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_6001_8">P20D</galt:NumberOfConsecutiveTradingDays>
  <us-gaap:DividendsPayableAmountPerShare contextRef="eol_PE87402---1310-K0015_STD_0_20080204_0_711196x713505_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_7001_6">6.00</us-gaap:DividendsPayableAmountPerShare>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_3001_5">2.40</us-gaap:SharePrice>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_4001_1">3.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_3001_4">2281000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_711952x731237_716763x821234" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_5001_8">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x725855" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_6001_6">3.78</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x805643" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_4001_11">3.78</us-gaap:FairValueAssumptionsExercisePrice>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x813918" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_5001_7">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x821234" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_7001_4">3.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x821234" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_7001_2">2013-08-25</galt:WarrantExpirationDate>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090212_0_711196x710990" unitRef="shares" decimals="INF" id="id_4142217_05CB19C5-FA7A-4449-89D7-ED12100BFE68_2001_2">2000000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090212_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_5001_1">600000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:MinimumCompanyMarketCapitalization contextRef="eol_PE87402---1310-K0015_STD_0_20090228_0" unitRef="iso4217_USD" decimals="-6" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_2001_6">100000000</galt:MinimumCompanyMarketCapitalization>
  <galt:AccruedSeparationAgreement contextRef="eol_PE87402---1310-K0015_STD_0_20090228_0" unitRef="iso4217_USD" decimals="-5" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_2001_0">1000000</galt:AccruedSeparationAgreement>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE87402---1310-K0015_STD_0_20090228_0_711502x711169" unitRef="shares" decimals="INF" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_3001_5">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:EquityMethodInvestments contextRef="eol_PE87402---1310-K0015_STD_0_20090228_0_711502x711169" unitRef="iso4217_USD" decimals="-5" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_3001_3">10000000</us-gaap:EquityMethodInvestments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20090228_0_713879x781654" unitRef="shares" decimals="INF" id="id_4142217_47A47EB1-503A-4965-87BA-7925DB1531E1_1001_0">3333334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090513_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_5001_1">300000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090812_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_5001_1">100000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20091104_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_5001_1">103333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20100510_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_5001_1">190000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20130131_0_713115x715581" unitRef="shares" decimals="0" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_2001_0">5000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20130131_0_713115x715581" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_2001_1">2.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantToPurchaseCommonStock contextRef="eol_PE87402---1310-K0015_STD_0_20130506_0_711196x742455" unitRef="shares" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_9001_1">1000000</galt:WarrantToPurchaseCommonStock>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20130506_0_711196x752557" unitRef="shares" decimals="INF" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_10001_0">4000000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20140131_0_710720x714667_711196x742455" unitRef="shares" decimals="INF" id="id_4142217_23708C2F-6AFB-46D5-96BB-0BED38799AFF_2001_0">500000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x731237" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_3001_7">31.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x731237" unitRef="iso4217_USD" decimals="0" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_3001_9">154000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x780010" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_4001_6">31.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x780010" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_4001_1">21.60</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_4001_8">1931000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20090430_0_716763x740658" unitRef="shares" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_5001_0">55000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20090430_0_716763x740658" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_5001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20090430_0_716763x740658" unitRef="shares" decimals="INF" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_5001_3">41666</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20100308_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_5001_1">111667</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20100430_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_5001_1">103334</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20120322_0_714750x796043" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_2001_7">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20120322_0_714750x796043" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_2001_6">9.00</us-gaap:SharePrice>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20120322_0_714750x796043" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_2001_8">2017-03-28</galt:WarrantExpirationDate>
  <galt:ClassOfWarrantOrRightIssuableWithEachNewShareOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_0_20120322_0_714750x796043" unitRef="shares" decimals="INF" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_2001_3">1</galt:ClassOfWarrantOrRightIssuableWithEachNewShareOfCommonStock>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20120322_0_716763x740658" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_3002_4">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20120328_0" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_2001_1">2016-05-02</galt:WarrantExpirationDate>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20120328_0_716763x740658" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_2001_6">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20140319_0" unitRef="shares" decimals="INF" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_2_500008">21932775</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20030531_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1001_6">32.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1001_7">261000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:PurchasePricePerUnitUnderPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_0_20030531_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1001_1">12.00</galt:PurchasePricePerUnitUnderPrivatePlacement>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080531_0_705999x767774" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_8DBE07CE-BF33-4EE3-B911-3492D0C6D4B8_2001_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20080702_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_D106A945-E638-48EF-9581-1A4E69A1356F_1001_2">6.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ClassOfWarrantOrRightTerm contextRef="eol_PE87402---1310-K0015_STD_0_20080702_0" id="id_4142217_D106A945-E638-48EF-9581-1A4E69A1356F_1001_3">P3Y</galt:ClassOfWarrantOrRightTerm>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20090531_0_716763x749992" unitRef="shares" decimals="0" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_2001_0">95834</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20090531_0_716763x749992" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_2001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090630_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_5001_1">166666</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x756917" unitRef="shares" decimals="0" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_4001_0">12000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x756917" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_4001_1">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ClassOfWarrantOrRightNumberOfSharesVestingInEqualInstallments contextRef="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x756917" unitRef="shares" decimals="0" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_4001_7">500</galt:ClassOfWarrantOrRightNumberOfSharesVestingInEqualInstallments>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x804137" unitRef="shares" decimals="0" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_3001_0">35001</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x804137" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_3001_1">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100630_0_716763x810377" unitRef="shares" decimals="0" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_2001_0">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20100630_0_716763x810377" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_2001_1">4.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNextYear contextRef="eol_PE87402---1310-K0015_STD_0_20100630_0_716763x810377" unitRef="shares" decimals="0" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_2001_3">25000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNextYear>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20100630_0_716763x810377" unitRef="shares" decimals="INF" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_2001_4">50000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <galt:OperatingLeasesMonthlyBaseRentExpense contextRef="eol_PE87402---1310-K0015_STD_0_20110731_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1001_2">235000</galt:OperatingLeasesMonthlyBaseRentExpense>
  <galt:MinimumCompanyMarketCapitalization contextRef="eol_PE87402---1310-K0015_STD_0_20130801_0" unitRef="iso4217_USD" decimals="-6" id="id_4142217_1DDB3080-C633-4273-94B0-EB33E3E93833_1001_0">100000000</galt:MinimumCompanyMarketCapitalization>
  <galt:ExpectedFuturePayments contextRef="eol_PE87402---1310-K0015_STD_0_20130801_0" unitRef="iso4217_USD" decimals="-6" id="id_4142217_1DDB3080-C633-4273-94B0-EB33E3E93833_1001_1">1000000</galt:ExpectedFuturePayments>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20010831_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1001_1">12.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20010831_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1001_4">39.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20010831_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1001_6">13.68</us-gaap:SharePrice>
  <us-gaap:ConvertibleDebt contextRef="eol_PE87402---1310-K0015_STD_0_20010831_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1001_0">1126000</us-gaap:ConvertibleDebt>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20010831_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1001_5">503000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20011031_0_713879x842739" unitRef="shares" decimals="INF" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_3001_0">833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:PurchasePricePerUnitUnderPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_0_20020930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_1001_1">6.00</galt:PurchasePricePerUnitUnderPrivatePlacement>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x731237" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_3001_8">41.16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x731237" unitRef="iso4217_USD" decimals="0" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_3001_10">191000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x780010" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_4001_6">31.74</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x780010" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_4001_2">21.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_4001_9">2531000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20090930_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_5001_1">108333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:LeaseDeposits contextRef="eol_PE87402---1310-K0015_STD_0_20120930_0_790000x792996" unitRef="iso4217_USD" decimals="0" id="id_4142217_291B1DDB-54DE-4557-837F-396197D4B42E_2001_3">6000</galt:LeaseDeposits>
  <galt:OperatingLeasesMonthlyBaseRentExpense contextRef="eol_PE87402---1310-K0015_STD_0_20120930_0_790000x792996" unitRef="iso4217_USD" decimals="0" id="id_4142217_291B1DDB-54DE-4557-837F-396197D4B42E_2001_2">3000</galt:OperatingLeasesMonthlyBaseRentExpense>
  <galt:OperatingLeasesAnnualRent contextRef="eol_PE87402---1310-K0015_STD_0_20121031_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_F73ED31B-11FF-466C-B130-9AEAF3A89732_1001_1">15000</galt:OperatingLeasesAnnualRent>
  <dei:EntityPublicFloat contextRef="eol_PE87402---1310-K0015_STD_0_20130630_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_3_600009">55400000</dei:EntityPublicFloat>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20130930_0_713115x708980" unitRef="shares" decimals="INF" id="id_4142217_8FE39EB3-3677-4B3E-9883-414E9C58EBA3_2001_0">103158</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:AggregateOfferingPrice contextRef="eol_PE87402---1310-K0015_STD_0_20131025_0_712375x743626" unitRef="iso4217_USD" decimals="-5" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1001_0">30000000</galt:AggregateOfferingPrice>
  <galt:CommissionsAsPercentageOfGrossOfferingProceeds contextRef="eol_PE87402---1310-K0015_STD_0_20131025_0_712375x743626" unitRef="pure" decimals="3" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1001_1">0.030</galt:CommissionsAsPercentageOfGrossOfferingProceeds>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20011213_0_714777x827982" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_0AD314C8-D84E-44BD-80DD-BF66D995CEBC_1001_0">21.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20011231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_3001_8">13.68</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_3001_7">886000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20011231_0_716763x797754" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_4001_6">30.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20011231_0_716763x815051" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_5001_5">39.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_B1A50791-A4D0-4101-98DF-7B490D528541_1001_1">21.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_B1A50791-A4D0-4101-98DF-7B490D528541_1001_4">21.00</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B1A50791-A4D0-4101-98DF-7B490D528541_1001_3">236000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_1002_5">150000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" unitRef="shares" decimals="INF" id="id_4142217_8AEA34F8-F963-48B2-AC3C-9ED53F96BF39_1001_1">29042</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockWarrantsTerm contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0" id="id_4142217_B1A50791-A4D0-4101-98DF-7B490D528541_1001_2">P10Y</galt:CommonStockWarrantsTerm>
  <us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0_707179x743063_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_3002_8">11000</us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x768389" unitRef="shares" decimals="INF" id="id_4142217_912A9360-0EA1-4F56-ADD8-14307BEA87A4_2001_0">350</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x770884" unitRef="shares" decimals="INF" id="id_4142217_4725DC2E-EB93-4DBF-AD27-C70AB74B20CF_2001_0">4226</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x771670" unitRef="shares" decimals="INF" id="id_4142217_4F70D6CF-BD9D-4B9C-B05A-F92C172FFD5E_2001_0">28917</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x781829" unitRef="shares" decimals="INF" id="id_4142217_4F70D6CF-BD9D-4B9C-B05A-F92C172FFD5E_3001_1">125</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x768389" unitRef="shares" decimals="INF" id="id_4142217_912A9360-0EA1-4F56-ADD8-14307BEA87A4_2003_0">1167</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x771670" unitRef="shares" decimals="INF" id="id_4142217_4F70D6CF-BD9D-4B9C-B05A-F92C172FFD5E_2002_0">417</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x781829" unitRef="shares" decimals="INF" id="id_4142217_4F70D6CF-BD9D-4B9C-B05A-F92C172FFD5E_3002_1">1625</galt:CommonStockIssuableSharesIssuable>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20031231_0_713879x778478" unitRef="shares" decimals="INF" id="id_4142217_2997156D-A968-4465-A15B-B0FC10F52DAE_1001_0">166667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:ExercisePriceOfWarrantsExpiredWithoutExercise contextRef="eol_PE87402---1310-K0015_STD_0_20081226_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_3_17">3.78</galt:ExercisePriceOfWarrantsExpiredWithoutExercise>
  <galt:WarrantsExpiredWithoutExercise contextRef="eol_PE87402---1310-K0015_STD_0_20081226_0" unitRef="shares" decimals="0" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_3_16">500000</galt:WarrantsExpiredWithoutExercise>
  <galt:ClassOfWarrantOrRightIssued contextRef="eol_PE87402---1310-K0015_STD_0_20081231_0_716389x770436" unitRef="shares" decimals="INF" id="id_4142217_7441BB64-933C-4231-A4DB-60237D99B681_2001_0">1164929</galt:ClassOfWarrantOrRightIssued>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20091208_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_5001_1">108333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20091231_0_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_5002_0">5333000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20100129_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_5001_1">108334</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20101229_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_8DE39B69-5E07-47FA-AE7D-970D09F18740_1001_1">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20101229_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_8DE39B69-5E07-47FA-AE7D-970D09F18740_1001_0">1000</us-gaap:PreferredStockSharesAuthorized>
  <galt:PreferredStockStatedValuePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20101229_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_8DE39B69-5E07-47FA-AE7D-970D09F18740_1001_2">10000</galt:PreferredStockStatedValuePerShare>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20101230_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_2001_6">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantLiabilitiesFairValueDisclosure contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4327487E-4711-4AE2-A211-8922E6EA9B01_1001_1">861000</galt:WarrantLiabilitiesFairValueDisclosure>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_708873x835592_716763x740658" unitRef="shares" decimals="INF" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_4002_15">33332</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_5001_0">4148000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_713115x716908" unitRef="shares" decimals="INF" id="id_4142217_2B67466C-0C71-4760-BAE9-844A51E6CB9E_1001_2">26042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_713115x716908" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BA022639-FF8A-419E-BE07-2E2410FBD1D7_1001_2">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x756917" unitRef="shares" decimals="0" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_2001_0">500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x756917" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_2001_1">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x804137" unitRef="shares" decimals="0" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_2001_0">33334</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x804137" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_2001_1">3.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:RedemptionTermNumberOfDaysOfConsecutiveTradingDays contextRef="eol_PE87402---1310-K0015_STD_0_20110126_0_711196x710990_711502x711169" id="id_4142217_0C21826A-35BF-405E-8F83-31FC195BADD0_2001_0">P30D</galt:RedemptionTermNumberOfDaysOfConsecutiveTradingDays>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_1001_400002">6673405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="pure" decimals="2" id="id_4142217_10FF9FFD-D5E0-4CD6-A6DF-73B4E091CA80_1001_0">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_1001_2">6.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_1001_2">3091474</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1013_1600001">-2125000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_2DD5CBA5-FC72-4D49-A6AC-726951E66D46_1_0">200000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_7001_32">6397000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_4001_0">166668</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <galt:ClassOfWarrantOrRightIntrinsicValueOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_4327487E-4711-4AE2-A211-8922E6EA9B01_3001_3">1385</galt:ClassOfWarrantOrRightIntrinsicValueOfWarrantsOrRights>
  <galt:BankDeposit contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1002_3">59000</galt:BankDeposit>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_708873x784846" unitRef="shares" decimals="INF" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_5001_1">83334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_708873x825279" unitRef="shares" decimals="INF" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_6001_3">83334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1012_1500001">-69137000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1011_1400001">66367000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713470" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1005_800001">220</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1005_900001">2154000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713505" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1007_1000001">1562500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713505" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1007_1100001">632000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1009_1200001">12919538</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1009_1300001">13000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x810388" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1003_600001">2100000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1003_700001">2687000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x827065" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1001_400001">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_1001_500001">1681000</us-gaap:StockholdersEquity>
  <galt:ConversionOfStockConversionPrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x710990" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_6994DEB9-5E45-4C6E-8949-243CD1E56EAB_2001_1">3.00</galt:ConversionOfStockConversionPrice>
  <us-gaap:PreferredStockLiquidationPreference contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_A49521E0-3BD2-4D25-9CAB-891F27B377FE_2001_0">10000</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_4F099D12-D2CF-43DE-BC81-31A7AA450964_3001_2">3.00</us-gaap:SharePrice>
  <us-gaap:PreferredStockRedemptionPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_1A932961-AFA1-467C-B9BF-BAA873724658_3001_2">3.00</us-gaap:PreferredStockRedemptionPricePerShare>
  <galt:ConversionOfStockConversionPrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_216F82CE-78FD-4B8A-A110-005D6C0F8415_2001_0">6.00</galt:ConversionOfStockConversionPrice>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_216F82CE-78FD-4B8A-A110-005D6C0F8415_2001_1">1667</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470" id="id_4142217_4F099D12-D2CF-43DE-BC81-31A7AA450964_3001_3">P10D</galt:NumberOfConsecutiveTradingDays>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_6994DEB9-5E45-4C6E-8949-243CD1E56EAB_3001_3">9.00</us-gaap:SharePrice>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x716112" unitRef="shares" decimals="INF" id="id_4142217_C3CDF4CF-B2CF-410B-AB94-3EFA7A379F38_1001_0">250000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseNumberOfSharesAvailableForGrant>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x716112_715329x726338" unitRef="Person" decimals="0" id="id_4142217_63D666F8-229B-49A0-9CE6-2A3ADCBC590C_1001_2">3</galt:NumberOfNewDirectorsElected>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_715329x726338" unitRef="Person" decimals="0" id="id_4142217_63D666F8-229B-49A0-9CE6-2A3ADCBC590C_2001_1">2</galt:NumberOfNewDirectorsElected>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_715329x760081" unitRef="Person" decimals="0" id="id_4142217_63D666F8-229B-49A0-9CE6-2A3ADCBC590C_3001_0">2</galt:NumberOfNewDirectorsElected>
  <galt:TerminationNoticePeriod contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x715581" id="id_4142217_0301AAB2-7726-418A-8213-3F81A2E9AE42_1001_0">P30D</galt:TerminationNoticePeriod>
  <galt:CommonStockMarketPrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x736056" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_0301AAB2-7726-418A-8213-3F81A2E9AE42_2001_3">7.50</galt:CommonStockMarketPrice>
  <galt:NumberOfTradingDays contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x736056" id="id_4142217_0301AAB2-7726-418A-8213-3F81A2E9AE42_2001_2">P15D</galt:NumberOfTradingDays>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x805518" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_4142217_0301AAB2-7726-418A-8213-3F81A2E9AE42_3001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:CommonStockMarketPrice contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x819924" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_0301AAB2-7726-418A-8213-3F81A2E9AE42_4001_4">10.50</galt:CommonStockMarketPrice>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE87402---1310-K0015_STD_0_20111231_0_842646x773308" unitRef="iso4217_USD" decimals="0" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_7001_5">1006000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_49">16060853</us-gaap:CommonStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_3001_400006">7424241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_44">1562500</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_3001_6">5.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_3001_6">3539961</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_1002_1">1472051</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_43">1562500</us-gaap:PreferredStockSharesIssued>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_48">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_47">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_42">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_50">16060853</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_17" />
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_14">1638000</us-gaap:LiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_2_1">42000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:DividendsPayableCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_13">80000</us-gaap:DividendsPayableCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_2_4">66000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_2_3">10000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_51">80535000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_11">397000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_2_0">109000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_4">24991000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_15">6000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_53">1165000</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_41">632000</us-gaap:PreferredStockValue>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_12">1161000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:Liabilities contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_16">1644000</us-gaap:Liabilities>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1002_3">48000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:CommonStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_46">16000</us-gaap:CommonStockValue>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_54">9561000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_0">21753000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_3">24991000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_6">6000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_7">30000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_5" />
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_2_3">74000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_2">2921000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_5">8000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_8">9561000</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_2">9364000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_52">80018000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:SecurityDeposit contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0617207D-A3C7-41C8-B766-706C5CD353E3_2_0">6000</us-gaap:SecurityDeposit>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1002_2">78000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_3">153000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_2_1">317000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:AssetsCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_4">9517000</us-gaap:AssetsCurrent>
  <galt:UndesignatedCapitalStockSharesAuthorizedButUnissued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_F67A1D46-8756-4162-8C2E-6DC855CE62BD_2_500006">11999000</galt:UndesignatedCapitalStockSharesAuthorizedButUnissued>
  <galt:UndesignatedCapitalStockNoParValue contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_38">0.01</galt:UndesignatedCapitalStockNoParValue>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_40">8001000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:AccruedSeparationAgreement contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_2_2">1000000</galt:AccruedSeparationAgreement>
  <galt:UndesignatedCapitalStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_39">20000000</galt:UndesignatedCapitalStockSharesAuthorized>
  <galt:UndesignatedCapitalStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2_37" />
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3012_1500020">-80018000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3011_1400020">80535000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713470" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3005_800020">220</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3005_900020">2154000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713505" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3007_1000020">1562500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713505" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3007_1100020">632000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3009_1200020">16060853</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3009_1300020">16000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x810388" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3003_600020">2100000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3003_700020">2900000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x827065" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3001_400020">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_3001_500020">1698000</us-gaap:StockholdersEquity>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1002_33">220</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1002_32">220</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1002_31">1000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1002_30">2154000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_F67A1D46-8756-4162-8C2E-6DC855CE62BD_1002_500005">1000</galt:UndesignatedCapitalStockSharesOutstanding>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2002_27">2100000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2002_26">2100000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2002_25">2100000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2002_24">2900000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_F67A1D46-8756-4162-8C2E-6DC855CE62BD_2002_500004">2100000</galt:UndesignatedCapitalStockSharesOutstanding>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3002_21">900000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3002_20">900000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3002_19">900000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3002_18">1698000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_F67A1D46-8756-4162-8C2E-6DC855CE62BD_3002_500003">900000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x842935" unitRef="shares" decimals="INF" id="id_4142217_F67A1D46-8756-4162-8C2E-6DC855CE62BD_4002_500002">5000000</galt:UndesignatedCapitalStockSharesOutstanding>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_712021x710575_715757x707855" unitRef="iso4217_USD" decimals="0" id="id_4142217_14D3AA78-CB5D-4E3C-A04C-66780DCF6AB3_1002_0">583000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_713879x820386" unitRef="shares" decimals="INF" id="id_4142217_5936315B-3124-45A2-9177-AE40E9213E6C_2001_1">1416669</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x710442" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_1002_2">59000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x716297" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_2002_0">2000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x725975" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_3002_1">13000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20121231_0_716763x781749" unitRef="iso4217_USD_per_Right" decimals="0" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_2003_8">6667</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_49">18386900</us-gaap:CommonStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_5001_400010">6035229</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_44">1452500</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_5001_11">2084463</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1006_3">3348705</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_5001_10">4.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_5001_10">3348705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_1001_1">1256735</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_43">1452500</us-gaap:PreferredStockSharesIssued>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1006_7">4.43</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharePrice contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_6A4E627D-EAFF-41BA-AA51-7AD1C9C147FC_1001_0">8.08</us-gaap:SharePrice>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1006_5">4.70</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_5001_11">4.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1006_6">2084463</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_48">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_47">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1029_1">6035229</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_42">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_50">18386900</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_17" />
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_6BDAB0F7-2769-4D95-81B2-7361E676E14A_1_0">36000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_14">2486000</us-gaap:LiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_1_1">526000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:DividendsPayableCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_13">73000</us-gaap:DividendsPayableCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_1_4">71000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_1_3">22000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_51">102841000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_11">762000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_1_0">103000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_4">30583000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_53">1481000</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_45">1496000</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:PreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_41">587000</us-gaap:PreferredStockValue>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_12">1651000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:Liabilities contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_16">2486000</us-gaap:Liabilities>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1001_3">55000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:CommonStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_46">18000</us-gaap:CommonStockValue>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_54">10713000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_0">25881000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_3">30583000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_7">23000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_5" />
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_1_3">74000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_2">4302000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_5">3000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_8">10713000</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_2">10489000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_D8E76D1A-631A-4600-A1D0-BBF5A17077FD_1001_3">7721000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_52">101965000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:SecurityDeposit contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0617207D-A3C7-41C8-B766-706C5CD353E3_1_0">6000</us-gaap:SecurityDeposit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_D8E76D1A-631A-4600-A1D0-BBF5A17077FD_1001_2">11420000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_1001_2">4522000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1001_2">78000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_3">198000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_4BD6776D-9600-40C8-A7F5-BB019A41BCBC_1_1">400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:AssetsCurrent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_4">10687000</us-gaap:AssetsCurrent>
  <galt:UndesignatedCapitalStockNoParValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_38">0.01</galt:UndesignatedCapitalStockNoParValue>
  <galt:DeferredTaxAssetsValuationAllowancePercentage contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="pure" decimals="2" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_3001_9">1.00</galt:DeferredTaxAssetsValuationAllowancePercentage>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_40">8001000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:NumberOfCompensationPlans contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="CompensationPlan" decimals="INF" id="id_4142217_460FEF39-3B1F-4502-8604-C21BA71985EA_1_0">3</galt:NumberOfCompensationPlans>
  <galt:AccruedSeparationAgreement contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9AACBC56-4570-454B-A8D0-05339BDDE59C_1_2">1000000</galt:AccruedSeparationAgreement>
  <galt:UndesignatedCapitalStockSharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_39">20000000</galt:UndesignatedCapitalStockSharesAuthorized>
  <galt:UndesignatedCapitalStockValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1_37" />
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x747231" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1004_3">1551626</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x747231" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1004_7">6.97</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x747231" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1004_5">6.97</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x747231" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1004_6">884958</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x753422" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1005_3">71945</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x753422" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1005_7">9.36</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x753422" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1005_5">9.36</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x753422" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1005_6">71945</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x760806" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1002_3">835001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x760806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1002_7">2.38</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x760806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1002_5">2.30</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x760806" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1002_6">496001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x765708" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1003_3">358294</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x765708" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1003_7">3.90</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x765708" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1003_5">4.07</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x765708" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1003_6">99720</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x803399" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1001_3">531839</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x803399" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1001_7">1.60</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x803399" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1001_5">1.60</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x803399" unitRef="shares" decimals="INF" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_1001_6">531839</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1012_1500075">-101965000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1011_1400075">102841000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713470" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1005_800075">196</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1005_900075">1919000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713505" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1007_1000075">1452500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713505" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1007_1100075">587000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1009_1200075">18386900</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1009_1300075">18000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x810388" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1003_600075">2100000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1003_700075">3112000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x827065" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1001_400075">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_1001_500075">1715000</us-gaap:StockholdersEquity>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_710844x707398" unitRef="iso4217_USD" decimals="0" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_4001_0">69888000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_710844x711886" unitRef="iso4217_USD" decimals="0" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_5001_1">29881000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:PreferredStockLiquidationPreference contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x710990" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_910723A3-88EA-40E7-B5DB-B6FA683CCDDE_1001_0">2</us-gaap:PreferredStockLiquidationPreference>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x710990" id="id_4142217_8AF0633B-76B2-4837-9AD6-37BD2DE7F3F4_2001_2">P20D</galt:NumberOfConsecutiveTradingDays>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_33">196</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_32">196</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_31">1000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_30">1919000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="iso4217_USD" decimals="0" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_34">5547000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470" unitRef="iso4217_USD" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_1001_35">1989400</us-gaap:TemporaryEquityLiquidationPreference>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_27">2100000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_26">2100000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_25">2100000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_24">3112000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_28">4200000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388" unitRef="iso4217_USD" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_2001_29">4200000</us-gaap:TemporaryEquityLiquidationPreference>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_21">900000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_20">900000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_19">900000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_18">1715000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="iso4217_USD" decimals="0" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_3001_0">1296000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="iso4217_USD" decimals="0" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_22">1800000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065" unitRef="iso4217_USD" decimals="INF" id="id_4142217_9532C7A8-40BF-4A38-A896-41DBA7129E20_3001_23">1800000</us-gaap:TemporaryEquityLiquidationPreference>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_21001_10">2009-08-12</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1008_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1008_1">200000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1008_4">2014-08-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1007_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1007_1">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1007_4">2014-08-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x730156" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1026_2">3.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x730156" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1026_1">33334</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x730156" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1026_4">2015-12-09</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x730156" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_22001_37">2010-12-09</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x735983" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1001_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x735983" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1001_1">1200000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x735983" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1001_4">2014-02-12</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x735983" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_23001_1">2009-02-12</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_24001_31">2010-05-10</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1022_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1022_1">380000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1022_4">2015-05-10</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1021_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1021_1">95000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1021_4">2015-05-10</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_25001_19">2009-12-08</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1014_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1014_1">216667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1014_4">2014-12-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1013_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1013_1">54167</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1013_4">2014-12-08</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_26001_22">2010-01-29</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1016_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1016_1">216667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1016_4">2015-01-29</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1015_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1015_1">54167</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1015_4">2015-01-29</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x773941" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1002_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x773941" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1002_1">600000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x773941" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1002_4">2014-05-13</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x773941" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_27001_3">2009-05-13</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x786055" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1025_2">4.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x786055" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1025_1">100000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x786055" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1025_4">2015-06-15</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x786055" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_28001_36">2010-06-15</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x796706" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1006_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x796706" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1006_1">40000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x796706" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1006_4">2014-06-30</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x796706" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_29001_9">2009-06-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x803310" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1028_2">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x803310" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1028_1">1333061</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x803310" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1028_4">2017-03-28</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_30001_25">2010-03-08</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1018_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1018_1">223334</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1018_4">2015-03-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1017_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1017_1">55834</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1017_4">2015-03-08</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_31001_16">2009-11-04</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1012_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1012_1">206666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1012_4">2014-11-04</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1011_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1011_1">51666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1011_4">2014-11-04</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x811277" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1027_2">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x811277" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1027_1">500</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x811277" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1027_4">2015-12-30</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x811277" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_32001_38">2010-12-30</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_33001_28">2010-04-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1020_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1020_1">206667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1020_4">2015-04-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1019_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1019_1">51667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1019_4">2015-04-30</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_716763x756917" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_34001_35">2010-05-25</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_716763x804137" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_35001_34">2010-05-25</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x756917" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1024_2">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x756917" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1024_1">7500</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x756917" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1024_4">2014-05-25</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x804137" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1023_2">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x804137" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1023_1">14584</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x804137" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1023_4">2014-05-25</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_36001_13">2009-09-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1010_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1010_1">216666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1010_4">2014-09-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1009_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1009_1">54166</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1009_4">2014-09-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x834904" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1005_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x834904" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1005_1">6250</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x834904" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1005_4">2014-05-01</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x834904" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_37001_8">2009-05-01</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_38001_5">2009-06-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x805643" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1004_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x805643" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1004_1">333333</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1004_4">2014-06-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x813918" unitRef="iso4217_USD_per_Right" decimals="2" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1003_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x813918" unitRef="shares" decimals="INF" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1003_1">33333</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_1003_4">2014-06-30</galt:WarrantExpirationDate>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_712021x710575_715757x707855" unitRef="iso4217_USD" decimals="0" id="id_4142217_14D3AA78-CB5D-4E3C-A04C-66780DCF6AB3_1001_0">0</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_712375x743626" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_2002_3">9.02</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x778478" unitRef="shares" decimals="INF" id="id_4142217_2997156D-A968-4465-A15B-B0FC10F52DAE_1002_3">5168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x781654" unitRef="shares" decimals="INF" id="id_4142217_47A47EB1-503A-4965-87BA-7925DB1531E1_1002_1">709638</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x842739" unitRef="shares" decimals="INF" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_4003_4">194167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x710442" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_1001_2">59000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x716297" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_2001_0">2000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x725975" unitRef="iso4217_USD" decimals="-3" id="id_4142217_28A24896-019F-4EDC-9B83-022EFFE06A73_3001_1">13000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x749992" unitRef="shares" decimals="INF" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_2003_13">6250</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x781749" unitRef="iso4217_USD_per_Right" decimals="0" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_2004_8">13750</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x781749" unitRef="shares" decimals="INF" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_2004_9">14584</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x781749_741278x756917" unitRef="shares" decimals="INF" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3004_18">7500</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x810377" unitRef="shares" decimals="INF" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1004_10">100000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <galt:WarrantExpense contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_2_4">8763000</galt:WarrantExpense>
  <galt:NumberOfWarrantsExercise contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0" unitRef="Warrants" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_2_5">5000000</galt:NumberOfWarrantsExercise>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1002_15">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1002_18">0.0119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1002_17">0.0074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1002_16">1.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1002_19">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867_711502x711169" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_2002_13">P5Y9M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867_711502x716112" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_3002_14">P7Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4002_8">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4002_11">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4002_10">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4002_9">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4002_12">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072_711502x711169" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_5002_6">P9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072_711502x716112" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_6002_7">P2Y4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x731237" unitRef="shares" decimals="INF" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_1001_5">16667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_2001_0">333334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_2001_3">485000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_2001_2">5515000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_CCAA6C78-A5D8-4483-AAEA-1C951286312A_2001_4">333334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0" unitRef="pure" decimals="2" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3_10">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0" unitRef="pure" decimals="4" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3_9">0.0251</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0" unitRef="shares" decimals="INF" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3_6">1400</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x744092_711196x713505" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_1001_10">--09-30</galt:DividendPaymentDateDayAndMonth>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x784846_711196x713505" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_2001_4">9.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x825279_711196x713505" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_3001_5">12.00</us-gaap:EquityIssuancePerShareAmount>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x840823_711196x713505" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_4001_9">--03-30</galt:DividendPaymentDateDayAndMonth>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="pure" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_5001_0">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_5001_1">6.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="iso4217_USD" decimals="0" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3003_3">52000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="iso4217_USD" decimals="0" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3003_4">1691000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:NumberOfSharesInEachUnit contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="shares" decimals="0" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_5001_2">1</galt:NumberOfSharesInEachUnit>
  <galt:ShareConversionRatio contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="pure" decimals="4" id="id_4142217_56C84F99-1F94-4650-9557-083DCFF70797_1001_0">0.1667</galt:ShareConversionRatio>
  <galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="pure" decimals="2" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_5001_7">1.00</galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate>
  <galt:NumberOfWarrantsInEachUnit contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" unitRef="shares" decimals="0" id="id_4142217_8711AE18-F985-4C7C-9E36-61AA3B97E476_5001_3">1</galt:NumberOfWarrantsInEachUnit>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505" id="id_4142217_56C84F99-1F94-4650-9557-083DCFF70797_1001_2">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <galt:ClosingStockPriceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_56C84F99-1F94-4650-9557-083DCFF70797_2001_1">18.00</galt:ClosingStockPriceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20080204_0_716763x715581" unitRef="iso4217_USD" decimals="0" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_4003_5">3000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0" unitRef="shares" decimals="INF" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_1_0">1250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1_3">1044000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1_1">369000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1_0">3381000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:StockIssuedIssuanceCostsWarrantsIssuedForAgentsFairValue contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0" unitRef="iso4217_USD" decimals="INF" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1_2">56000</galt:StockIssuedIssuanceCostsWarrantsIssuedForAgentsFairValue>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_711952x731237_716763x821234" unitRef="shares" decimals="INF" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_1001_7">34375</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x725855" unitRef="shares" decimals="INF" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_2001_5">500000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x805643" unitRef="pure" decimals="2" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1001_13">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x805643" unitRef="pure" decimals="4" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1001_12">0.0213</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x805643" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_1001_10">P4M</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x813918" unitRef="pure" decimals="2" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_2001_9">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x813918" unitRef="pure" decimals="4" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_2001_8">0.0294</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x813918" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_2001_6">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x821234" unitRef="shares" decimals="INF" id="id_4142217_6C89CB02-63FD-4AA4-A50F-2EB90D28506E_3001_3">1250000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_2_20080521_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_4_13">502000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:FairValueAdjustmentOfWarrants contextRef="eol_PE87402---1310-K0015_STD_2_20080521_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_4_12">100000</us-gaap:FairValueAdjustmentOfWarrants>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_1_5">1548000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuable contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0" unitRef="shares" decimals="INF" id="id_4142217_05CB19C5-FA7A-4449-89D7-ED12100BFE68_1_3">6000000</galt:ClassOfWarrantOrRightIssuable>
  <galt:StockIssuableValue contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x710990" unitRef="iso4217_USD" decimals="-5" id="id_4142217_05CB19C5-FA7A-4449-89D7-ED12100BFE68_1001_1">6000000</galt:StockIssuableValue>
  <galt:StockIssuableShares contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x710990" unitRef="shares" decimals="0" id="id_4142217_05CB19C5-FA7A-4449-89D7-ED12100BFE68_1001_0">3000000</galt:StockIssuableShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_1001_0">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_2001_3">300000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_3001_4">1200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_25E3A20C-6F6A-4D43-8E53-BCCBFD67850B_4001_2">300000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20090812_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_1_5">287000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_1001_0">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_2001_3">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_3001_4">200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_40520F69-8336-4A66-B1A0-8583BAD7BF35_4001_2">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20091104_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_1_5">296000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_1001_0">155000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_2001_3">51666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_3001_4">206666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_51F2DD82-08EC-4969-B48D-5246B29D60B7_4001_2">51666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20100510_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_1_5">536000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_1001_0">285000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_2001_3">95000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_3001_4">380000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_8CCCD5F6-7BA5-4D64-B0E4-7922FCDA519E_4001_2">95000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightExpirationDateExtensionPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20130506_0_711196x742455" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_7001_2">P5Y</galt:ClassOfWarrantOrRightExpirationDateExtensionPeriod>
  <galt:ClassOfWarrantOrRightExpirationDateExtensionPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20130506_0_711196x752557" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_8001_3">P5Y</galt:ClassOfWarrantOrRightExpirationDateExtensionPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20130816_0" unitRef="shares" decimals="INF" id="id_4142217_C379F535-B499-4BD1-AC82-B05BB0AF6A88_1_0">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20130816_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_C379F535-B499-4BD1-AC82-B05BB0AF6A88_1_3">0</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_2_20130816_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_C379F535-B499-4BD1-AC82-B05BB0AF6A88_1_1">3000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20130816_0" unitRef="shares" decimals="INF" id="id_4142217_C379F535-B499-4BD1-AC82-B05BB0AF6A88_1_2">0</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="eol_PE87402---1310-K0015_STD_2_20140131_0_710720x714667_716763x819924" unitRef="shares" decimals="INF" id="id_4142217_2FDB975C-7CBC-4EFD-9A62-2D199DE60890_1003_4">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_2_20140131_0_710720x714667_716763x819924" unitRef="iso4217_USD" decimals="INF" id="id_4142217_2FDB975C-7CBC-4EFD-9A62-2D199DE60890_1003_2">1500000</us-gaap:ProceedsFromWarrantExercises>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x731237" unitRef="shares" decimals="INF" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_1001_5">10301</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_2001_0">206019</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_2001_3">466000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_2001_2">3983000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_E2C5FCA0-82E3-4BF7-B99F-2283D1CB84F9_2001_4">103010</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20100308_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_1_5">322000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_1001_0">167500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_2001_3">55834</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_3001_4">223334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_46BB4936-0550-4838-A55E-D1B2B8FB6588_4001_2">55834</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20100430_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_1_5">297000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_1001_0">155000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_2001_3">51667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_3001_4">206667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_1ECC2233-178B-4302-8A98-41AAC70C8017_4001_2">51667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_2_3">143000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:UnitsIssuedDuringPeriodUnitsNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043" unitRef="shares" decimals="INF" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_1001_0">1159445</galt:UnitsIssuedDuringPeriodUnitsNewIssues>
  <galt:NumberOfWarrantSharesInEachUnit contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043" unitRef="shares" decimals="INF" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_1001_2">1</galt:NumberOfWarrantSharesInEachUnit>
  <galt:NumberOfSharesOfCommonStockInEachUnit contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043" unitRef="shares" decimals="INF" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_1001_1">2</galt:NumberOfSharesOfCommonStockInEachUnit>
  <galt:SaleOfStockPursuantToExerciseOfUnderwritersOverAllotmentOption contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043" unitRef="shares" decimals="0" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_1001_5">173916</galt:SaleOfStockPursuantToExerciseOfUnderwritersOverAllotmentOption>
  <galt:OpenOptionContractsSharePurchaseMaximumPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043" id="id_4142217_48F54B82-25DE-4CE3-A344-F016A6131A2F_1001_4">P45D</galt:OpenOptionContractsSharePurchaseMaximumPeriod>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_1002_6">1.17</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_716763x740658" unitRef="pure" decimals="4" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_1002_7">0.0078</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_2_20120322_0_716763x740658" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_1002_5">P4Y1M6D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="shares" decimals="INF" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_1">2666722</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_4">10403000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:UnitsIssuedDuringPeriodUnitsNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="shares" decimals="INF" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_0">1333361</galt:UnitsIssuedDuringPeriodUnitsNewIssues>
  <galt:CommonStockWarrantsIssued contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="shares" decimals="INF" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_2">1333361</galt:CommonStockWarrantsIssued>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="shares" decimals="INF" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_1_0">46378</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="iso4217_USD" decimals="2" id="id_4142217_3C0003A2-988D-4F88-8D39-ACE4DF5AA5BA_1_2">5.63</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:ProceedsFromIssuanceOrSaleOfEquityGross contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="iso4217_USD" decimals="-5" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_3">12000000</galt:ProceedsFromIssuanceOrSaleOfEquityGross>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1_5">4445000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1001_8">1.19</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0_716763x740658" unitRef="pure" decimals="4" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1001_9">0.0105</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_2_20120328_0_716763x740658" id="id_4142217_58131B01-FF61-4332-9429-6A8FA067CBA4_1001_7">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <galt:OrganizationalAndSeparationRelatedCharges contextRef="eol_PE87402---1310-K0015_STD_2_20120502_0" unitRef="iso4217_USD" decimals="-6" id="id_4142217_168B6A3C-798D-4B45-85EC-0EBBF8AB80FE_1_0">1000000</galt:OrganizationalAndSeparationRelatedCharges>
  <galt:MilestonePayments contextRef="eol_PE87402---1310-K0015_STD_2_20130329_0" unitRef="iso4217_USD" decimals="-5" id="id_4142217_2C017B70-827B-4F6F-87E0-EBEDAD9FD9EA_1_0">1000000</galt:MilestonePayments>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_2_20080702_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_D106A945-E638-48EF-9581-1A4E69A1356F_1_4">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="eol_PE87402---1310-K0015_STD_2_20080702_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_D106A945-E638-48EF-9581-1A4E69A1356F_1_1">20000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20080702_0" unitRef="shares" decimals="INF" id="id_4142217_D106A945-E638-48EF-9581-1A4E69A1356F_1_0">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20090630_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_1_5">473000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_1001_0">250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_2001_3">83333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_3001_4">333333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_93954871-79C8-4BB5-A96D-2FBA64ED4800_4001_2">83333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x731237" unitRef="shares" decimals="INF" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_1001_7">10955</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_2001_1">219096</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_2001_4">559000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010" unitRef="iso4217_USD" decimals="0" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_2001_3">4041000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_2001_0">238096</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010" unitRef="shares" decimals="INF" id="id_4142217_6946D152-9748-4EBE-A316-E0B5A7D16CF3_2001_5">109549</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20090930_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_1_5">305000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_1001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_2001_3">54166</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_3001_4">216666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_B83CAA93-B85F-4BAC-A7E1-A93A39A2E19A_4001_2">54166</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:LawsuitDamageClaim contextRef="eol_PE87402---1310-K0015_STD_2_20121012_0" unitRef="iso4217_USD" decimals="-5" id="id_4142217_3ADFE0A8-1A5B-417F-898E-EB84782A2F28_1_0">1000000</galt:LawsuitDamageClaim>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20030114_0" unitRef="shares" decimals="INF" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_3_2">181334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20030114_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_3_4">18000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_2_20030114_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_3_3">1070000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="eol_PE87402---1310-K0015_STD_2_20030114_0_715329x768389" unitRef="iso4217_USD" decimals="INF" id="id_4142217_912A9360-0EA1-4F56-ADD8-14307BEA87A4_1003_2">27000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_2_20030114_0_715329x781829" unitRef="iso4217_USD" decimals="0" id="id_4142217_4F70D6CF-BD9D-4B9C-B05A-F92C172FFD5E_1002_2">3000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20091208_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_1_5">310000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_1001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_2001_3">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_3001_4">216667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_3F42413C-0211-496E-807F-67B022313B42_4001_2">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_2_20100129_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_1_5">308000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_1001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_2001_3">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_3001_4">216667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_6356309F-2BDC-4CDE-8AAF-4CF62F6C8999_4001_2">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:PreferredStockRedemptionDate contextRef="eol_PE87402---1310-K0015_STD_2_20110126_0_711196x710990" id="id_4142217_0C21826A-35BF-405E-8F83-31FC195BADD0_1001_1">2019-02-12</us-gaap:PreferredStockRedemptionDate>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1310-K0015_STD_22_20120323_0" unitRef="shares" decimals="INF" id="id_4142217_49AA9324-9CCC-4B60-A104-E20C2552F337_1_1">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="eol_PE87402---1310-K0015_STD_22_20120323_0" unitRef="pure" decimals="INF" id="id_4142217_49AA9324-9CCC-4B60-A104-E20C2552F337_1_0">1.6667</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="eol_PE87402---1310-K0015_STD_22_20120323_0_707046x785450" unitRef="pure" decimals="INF" id="id_4142217_206D7368-0BF5-4DF9-B21E-04BFB89EE77A_1001_0">1.6667</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0" unitRef="shares" decimals="INF" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_1_2">83334</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:RoyaltyRevenue contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0" unitRef="iso4217_USD" decimals="-6" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_1_4">50000000</us-gaap:RoyaltyRevenue>
  <galt:SeverancePaymentPeriod contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_1_7">P6M</galt:SeverancePaymentPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_A38DE3E9-0FDF-4251-978D-2E268A26206C_1001_0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_A38DE3E9-0FDF-4251-978D-2E268A26206C_1001_1">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_A38DE3E9-0FDF-4251-978D-2E268A26206C_1001_2">0.72</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE87402---1310-K0015_STD_28_20090228_0_711502x711169" id="id_4142217_2A5C0384-75D0-4082-B579-6F84FA73604D_1001_1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_28_20111115_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_DB880073-AC5B-49B7-B528-22BC8E5C82E5_1002_2">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_28_20111115_0_707179x753998" unitRef="iso4217_USD" decimals="0" id="id_4142217_DB880073-AC5B-49B7-B528-22BC8E5C82E5_1002_1">113000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue>
  <galt:FairMarketValueOfShares contextRef="eol_PE87402---1310-K0015_STD_29_20120531_0_707179x753998" unitRef="iso4217_USD" decimals="0" id="id_4142217_0DFF215E-3155-4349-9B9B-589DCEE20059_1001_1">16000</galt:FairMarketValueOfShares>
  <galt:CommonStockOptionsGrantedShares contextRef="eol_PE87402---1310-K0015_STD_29_20120531_0_707179x753998" unitRef="shares" decimals="0" id="id_4142217_0DFF215E-3155-4349-9B9B-589DCEE20059_1001_0">7000</galt:CommonStockOptionsGrantedShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20051130_0_707179x764378" unitRef="shares" decimals="INF" id="id_4142217_BFE7885D-DC0F-416E-B4D0-6152FC9D443E_1001_0">834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20051130_0_707179x764378" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BFE7885D-DC0F-416E-B4D0-6152FC9D443E_1001_1">15.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20051130_0_707179x764378" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BFE7885D-DC0F-416E-B4D0-6152FC9D443E_1001_2">8.10</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_30_20090513_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_1_5">801000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_1001_0">450000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x742455" unitRef="shares" decimals="INF" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_2001_3">150000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x752557" unitRef="shares" decimals="INF" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_3001_4">600000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x807713" unitRef="shares" decimals="INF" id="id_4142217_BEB5E64E-365A-4EAD-8EA9-E09767D7F8DD_4001_2">150000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20040430_0_707179x745885" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1001_2">30.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuablePerMonth contextRef="eol_PE87402---1310-K0015_STD_30_20040430_0_707179x745885" unitRef="shares" decimals="0" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1001_0">834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuablePerMonth>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20040430_0_707179x745885_711502x716112" unitRef="shares" decimals="0" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_2001_1">10000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20080430_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_840382EA-3EFC-406F-8656-2B9A27E967F0_1001_0">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20080430_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_840382EA-3EFC-406F-8656-2B9A27E967F0_1001_1">2.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20080430_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_840382EA-3EFC-406F-8656-2B9A27E967F0_1001_2">2.34</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" unitRef="pure" decimals="4" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_7">0.0176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_6">1.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" unitRef="shares" decimals="INF" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_2">13334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_5">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3001_4">32000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20030630_0_707179x743063_708873x775931" unitRef="shares" decimals="INF" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1003_0">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20030630_0_707179x743063_708873x775931" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1003_3">21.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_30_20030630_0_707179x743063_708873x775931" unitRef="shares" decimals="INF" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1003_1">334</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_30_20030630_0_707179x743063_708873x775931" unitRef="iso4217_USD" decimals="0" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1003_2">33000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377" unitRef="pure" decimals="5" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1001_7">0.01705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377" unitRef="pure" decimals="2" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1001_6">1.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377" unitRef="shares" decimals="INF" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1001_2">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1001_5">P4Y3M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377" unitRef="pure" decimals="2" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1310-K0015_STD_30_20020930_0" unitRef="shares" decimals="INF" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_1_0">1666667</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x789346" unitRef="shares" decimals="INF" id="id_4142217_8DEE873D-6026-453A-A571-2F0FA56F3E1A_1002_0">4167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x789346" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8DEE873D-6026-453A-A571-2F0FA56F3E1A_1002_1">24.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x789346" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_8DEE873D-6026-453A-A571-2F0FA56F3E1A_1002_2">14.64</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x830547" unitRef="shares" decimals="INF" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1002_0">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x830547" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1002_1">24.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <galt:OperatingLeaseExpirationPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20120930_0_790000x792996" id="id_4142217_291B1DDB-54DE-4557-837F-396197D4B42E_1001_0">P26M</galt:OperatingLeaseExpirationPeriod>
  <galt:LongTermOperatingLeaseExpirationDate contextRef="eol_PE87402---1310-K0015_STD_30_20120930_0_790000x792996" id="id_4142217_291B1DDB-54DE-4557-837F-396197D4B42E_1001_1">2014-11-30</galt:LongTermOperatingLeaseExpirationDate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_1001_0">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_1001_2">3.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998" unitRef="iso4217_USD" decimals="0" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_1001_5">173000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardVestingDateMonthAndYear contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_1001_1">2013-08</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardVestingDateMonthAndYear>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_2001_3">3.97</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998_711502x716112" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CFEE868D-0059-414D-A30A-6ED2F6850F2E_3001_4">7.25</us-gaap:EquityIssuancePerShareAmount>
  <galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions contextRef="eol_PE87402---1310-K0015_STD_30_20130930_0_711528x781739_713115x708980" unitRef="iso4217_USD" decimals="0" id="id_4142217_8FE39EB3-3677-4B3E-9883-414E9C58EBA3_1001_2">930000</galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTermInCertainCases contextRef="eol_PE87402---1310-K0015_STD_30_20130930_0_711528x781739_713115x708980" id="id_4142217_8FE39EB3-3677-4B3E-9883-414E9C58EBA3_1001_1">P3M</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTermInCertainCases>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0" unitRef="shares" decimals="INF" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1_5">500</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1001_0">212</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1001_1">10000</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470" unitRef="iso4217_USD" decimals="0" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1001_3">47000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470" unitRef="iso4217_USD" decimals="0" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1001_2">2120000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <galt:ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470" unitRef="iso4217_USD" decimals="0" id="id_4142217_00F8E640-15B6-4EA3-B3D0-9A0AEB392EA1_1001_4">2073000</galt:ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts>
  <galt:OfferingCostsPayable contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_8AEA34F8-F963-48B2-AC3C-9ED53F96BF39_2_3">18000</galt:OfferingCostsPayable>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475" unitRef="shares" decimals="INF" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1003_0">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1003_4">16.80</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475" unitRef="iso4217_USD" decimals="0" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1003_3">156000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage contextRef="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475" unitRef="pure" decimals="4" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1003_2">0.3333</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_31_20110131_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_B4F55177-B6F1-4EFE-A5CA-6215BE3036F4_1001_0">13</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20110131_0_711196x713470" unitRef="iso4217_USD_per_shares" decimals="0" id="id_4142217_B4F55177-B6F1-4EFE-A5CA-6215BE3036F4_1001_1">10000</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE87402---1310-K0015_STD_31_20110131_0_711196x713470" unitRef="iso4217_USD" decimals="0" id="id_4142217_B4F55177-B6F1-4EFE-A5CA-6215BE3036F4_1001_2">130000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581" unitRef="pure" decimals="4" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_1001_4">0.0042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581" unitRef="pure" decimals="2" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_1001_3">0.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_1001_2">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581" unitRef="pure" decimals="2" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_1001_5">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581" unitRef="iso4217_USD" decimals="0" id="id_4142217_B4D47E3D-0359-47F5-9354-D4AA4EA786B2_1001_6">7000</us-gaap:ShareBasedCompensation>
  <galt:InitialCapitalContribution contextRef="eol_PE87402---1310-K0015_STD_31_20140131_0_710256x714598_710720x714667" unitRef="iso4217_USD" decimals="0" id="id_4142217_A2348454-E70A-4B0F-8186-E17184433AC9_1001_0">400000</galt:InitialCapitalContribution>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20140131_0_710720x714667_711196x742455" unitRef="iso4217_USD" decimals="0" id="id_4142217_23708C2F-6AFB-46D5-96BB-0BED38799AFF_1001_1">1500000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="shares" decimals="INF" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_2">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_5">12.96</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="shares" decimals="INF" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_3">334</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="iso4217_USD" decimals="0" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_4">11000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantPerMonth contextRef="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612" unitRef="shares" decimals="0" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1001_0">334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantPerMonth>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_1003_3">34.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885" unitRef="shares" decimals="INF" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_1003_1">834</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885_711502x716112" unitRef="shares" decimals="0" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_4003_2">16667</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885_713115x711585" unitRef="shares" decimals="INF" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_5003_0">4167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1001_0">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1001_2">22.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1001_3">13.20</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1001_1">834</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_2001_4">33000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_31_20090331_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1003_1">833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1_2">399917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1_4">128000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1_3">4671000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1_0">416667</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_4142217_D9431079-271B-4EDC-983F-A4487B887C20_1_5">18269</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378" unitRef="shares" decimals="INF" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1003_0">1667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1003_4">16.80</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378" unitRef="iso4217_USD" decimals="0" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1003_3">16000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage contextRef="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378" unitRef="pure" decimals="2" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1003_2">0.50</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage>
  <galt:ClassOfWarrantOrRightExercisePeriod contextRef="eol_PE87402---1310-K0015_STD_31_20080531_0_705999x767774" id="id_4142217_8DBE07CE-BF33-4EE3-B911-3492D0C6D4B8_1001_3">P3Y</galt:ClassOfWarrantOrRightExercisePeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20080531_0_705999x767774" unitRef="shares" decimals="INF" id="id_4142217_8DBE07CE-BF33-4EE3-B911-3492D0C6D4B8_1001_0">6500</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightsExpirationYear contextRef="eol_PE87402---1310-K0015_STD_31_20080531_0_705999x767774" id="id_4142217_8DBE07CE-BF33-4EE3-B911-3492D0C6D4B8_1001_4">2011</galt:ClassOfWarrantOrRightsExpirationYear>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20080531_0_705999x767774" unitRef="iso4217_USD" decimals="0" id="id_4142217_8DBE07CE-BF33-4EE3-B911-3492D0C6D4B8_1001_1">3000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="pure" decimals="4" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_7">0.0216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="pure" decimals="2" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_6">1.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="shares" decimals="INF" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_2">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_5">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="pure" decimals="2" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="shares" decimals="INF" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_3">21834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992" unitRef="iso4217_USD" decimals="0" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1001_4">232000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917" unitRef="pure" decimals="5" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3001_5">0.01610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3001_4">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3001_3">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917" unitRef="iso4217_USD" decimals="0" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3001_2">40000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137" unitRef="pure" decimals="5" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1001_5">0.01610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137" unitRef="pure" decimals="2" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1001_4">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1001_3">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137" unitRef="pure" decimals="2" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137" unitRef="iso4217_USD" decimals="0" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1001_2">134000</galt:IssuanceOfWarrantsValue>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1_4">44000</us-gaap:LeaseAndRentalExpense>
  <galt:OperatingLeaseMaturityPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1_5">P1Y</galt:OperatingLeaseMaturityPeriod>
  <galt:LeaseExtensionPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1_1">P1Y</galt:LeaseExtensionPeriod>
  <galt:LeaseAgreementExpirationDate contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0" id="id_4142217_E87FC928-8E3F-4248-9797-567EC531D117_1_0">2012-09-30</galt:LeaseAgreementExpirationDate>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1001_0">5</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1001_1">8334</us-gaap:ConversionOfStockSharesIssued1>
  <galt:PostConversionDividendRightsIssued contextRef="eol_PE87402---1310-K0015_STD_31_20110731_0_711196x713470" unitRef="shares" decimals="0" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1001_2">5</galt:PostConversionDividendRightsIssued>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_31_20010831_0" unitRef="shares" decimals="INF" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1_2">99705</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 contextRef="eol_PE87402---1310-K0015_STD_31_20010831_0" unitRef="shares" decimals="INF" id="id_4142217_BBDF1A9B-412D-43CC-925D-9919C9D1D720_1_3">93801</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20011031_0_711502x711169_713879x842739" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_1002_2">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20011031_0_711502x716112_713879x842739" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_2002_3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE87402---1310-K0015_STD_31_20011031_0_713879x842739" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_3002_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1003_5">17.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547" unitRef="shares" decimals="INF" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1003_6">2772</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547" unitRef="iso4217_USD" decimals="0" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1003_3">40000</us-gaap:ShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547_708873x796972" unitRef="shares" decimals="INF" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_2003_4">8334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547_713115x711585" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_3003_2">26.70</us-gaap:EquityIssuancePerShareAmount>
  <galt:FairMarketValueOfShares contextRef="eol_PE87402---1310-K0015_STD_31_20120831_0_707179x753998" unitRef="iso4217_USD" decimals="0" id="id_4142217_17D11F49-DCB4-4F44-9982-7D1F1FE69B77_1001_1">10000</galt:FairMarketValueOfShares>
  <galt:CommonStockOptionsGrantedShares contextRef="eol_PE87402---1310-K0015_STD_31_20120831_0_707179x753998" unitRef="shares" decimals="0" id="id_4142217_17D11F49-DCB4-4F44-9982-7D1F1FE69B77_1001_0">4348</galt:CommonStockOptionsGrantedShares>
  <galt:OperatingLeaseExpirationPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20121031_0" id="id_4142217_F73ED31B-11FF-466C-B130-9AEAF3A89732_1_0">P1Y</galt:OperatingLeaseExpirationPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_31_20071231_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_75D43369-6E9A-46EE-8A76-BE3A1E4C06C2_1001_0">834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_31_20071231_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_75D43369-6E9A-46EE-8A76-BE3A1E4C06C2_1001_1">3.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_31_20071231_0_707179x753998" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_75D43369-6E9A-46EE-8A76-BE3A1E4C06C2_1001_2">2.76</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917" unitRef="pure" decimals="4" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_1001_5">0.0206</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917" unitRef="pure" decimals="2" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_1001_4">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_1001_3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917" unitRef="pure" decimals="2" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917" unitRef="iso4217_USD" decimals="0" id="id_4142217_50813A81-F83C-4DE6-A845-86798C36226F_1001_2">2000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137" unitRef="pure" decimals="3" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1001_5">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137" unitRef="pure" decimals="2" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1001_4">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1001_3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137" unitRef="pure" decimals="2" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137" unitRef="iso4217_USD" decimals="0" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1001_2">112000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1310-K0015_STD_31_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1002_0">24</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_31_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1002_1">40193</us-gaap:ConversionOfStockSharesIssued1>
  <galt:PostConversionDividendRightsIssued contextRef="eol_PE87402---1310-K0015_STD_31_20131231_0_711196x713470" unitRef="shares" decimals="0" id="id_4142217_E1369A05-D1E6-49A3-A230-F779881EE2C6_1002_2">24</galt:PostConversionDividendRightsIssued>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_35_20080331_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_08CAAB02-A6A6-4B24-BE84-FC5DEDBFEFDE_1002_1">833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0" unitRef="shares" decimals="INF" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_1_0">114884</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_1_2">17000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_1_1">2221000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_713115x711585_809041x757891" unitRef="iso4217_USD" decimals="0" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_1003_4">147000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_809041x757891" unitRef="shares" decimals="INF" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_2003_0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_809041x757891" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_2003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_809041x757891" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_2003_3">13.68</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_809041x757891" unitRef="iso4217_USD" decimals="0" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_2003_2">239000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_716763x797754" unitRef="shares" decimals="INF" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_1001_4">58350</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20011231_0_716763x815051" unitRef="shares" decimals="INF" id="id_4142217_1E146267-4689-47EB-B817-37F725250A05_2001_3">56534</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0" unitRef="shares" decimals="INF" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_2_2">537227</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_2_4">212000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_0E51C1EC-173B-47C5-B428-017E8BC5C211_2_3">2861000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0" unitRef="shares" decimals="INF" id="id_4142217_B1A50791-A4D0-4101-98DF-7B490D528541_1_0">18334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_708873x733612" unitRef="shares" decimals="INF" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_1002_7">3334</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_708873x733612_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_375044B5-57F8-4D18-AC89-F4BA47C794F0_2002_6">41000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_713115x711585_809041x757891" unitRef="iso4217_USD" decimals="0" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_1002_4">64000</us-gaap:ShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_714777x827982" unitRef="shares" decimals="INF" id="id_4142217_0AD314C8-D84E-44BD-80DD-BF66D995CEBC_1002_1">31000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_714777x827982" unitRef="iso4217_USD" decimals="0" id="id_4142217_0AD314C8-D84E-44BD-80DD-BF66D995CEBC_1002_3">49000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_365_20021231_0_714777x827982" unitRef="iso4217_USD" decimals="0" id="id_4142217_0AD314C8-D84E-44BD-80DD-BF66D995CEBC_1002_2">602000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x735475" unitRef="iso4217_USD" decimals="0" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1002_5">82000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x735475_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_2002_6">193000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_708873x775931" unitRef="iso4217_USD" decimals="0" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1002_4">21000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_708873x775931_713115x708980" unitRef="iso4217_USD" decimals="0" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_2002_5">40000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_713115x711585_809041x757891" unitRef="iso4217_USD" decimals="0" id="id_4142217_CB342DDB-47B6-457B-A848-C7720D62756B_1001_4">71000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x745885_708873x756332_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_2002_4">29000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x764378" unitRef="iso4217_USD" decimals="0" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1002_5">6000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x764378_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_2002_6">13000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x789346_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_8DEE873D-6026-453A-A571-2F0FA56F3E1A_2001_3">122000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x830547" unitRef="iso4217_USD" decimals="0" id="id_4142217_5878601F-9AD6-4582-AD7C-EB37C102E96A_1001_3">74000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_713115x711585" unitRef="shares" decimals="INF" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_6002_6">2500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_715329x768389" unitRef="shares" decimals="INF" id="id_4142217_912A9360-0EA1-4F56-ADD8-14307BEA87A4_1002_1">350</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_715329x768389" unitRef="iso4217_USD" decimals="INF" id="id_4142217_912A9360-0EA1-4F56-ADD8-14307BEA87A4_1002_2">6000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="eol_PE87402---1310-K0015_STD_365_20031231_0_715329x770884" unitRef="shares" decimals="INF" id="id_4142217_4725DC2E-EB93-4DBF-AD27-C70AB74B20CF_1002_1">4226</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x745885" unitRef="shares" decimals="INF" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1003_4">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x745885" unitRef="shares" decimals="INF" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1003_3">2500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x745885" unitRef="iso4217_USD" decimals="0" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1003_5">14000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x764378_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_BFE7885D-DC0F-416E-B4D0-6152FC9D443E_2002_3">7000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20071231_0_707179x753998_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_75D43369-6E9A-46EE-8A76-BE3A1E4C06C2_2002_3">2000</us-gaap:ShareBasedCompensation>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1310-K0015_STD_365_20071231_0_708873x829211_711196x713505" unitRef="iso4217_USD" decimals="INF" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_2001_0">1667500</galt:ProceedsFromSubscriptionAdvances>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x735475" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_1001_3">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x735475" unitRef="shares" decimals="INF" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_1001_0">416670</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x735475" unitRef="iso4217_USD" decimals="0" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_1001_2">450000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x753998_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_A38DE3E9-0FDF-4251-978D-2E268A26206C_2002_3">24000</us-gaap:ShareBasedCompensation>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_709650x710802_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_1002_7">1732000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_709650x806044_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_80BC2167-42C6-4A27-8879-14EF2442C606_1002_0">628000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_2002_6">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1003_5">1330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_2002_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1003_4">2472000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x711169" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_3002_2">1.24</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x711169" unitRef="pure" decimals="4" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_3002_4">0.0198</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x716112" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_4002_3">1.27</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x716112" unitRef="pure" decimals="4" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_4002_5">0.0270</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_2003_7">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x827065" unitRef="iso4217_USD" decimals="0" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_2003_6">1548000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_61CE54B9-C6C7-4EA6-B305-5EAF11DE2B91_1_0">489000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:ProceedsFromGrantors contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_61CE54B9-C6C7-4EA6-B305-5EAF11DE2B91_1_1">255000</us-gaap:ProceedsFromGrantors>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_707179x735475" unitRef="shares" decimals="INF" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_1002_1">26042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" unitRef="pure" decimals="4" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_13">0.0169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_12">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" unitRef="shares" decimals="INF" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_9">8334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_11">P3Y22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_14">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_1002_10">16000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658" unitRef="pure" decimals="4" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_2002_19">0.0061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_2002_18">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_2002_17">P2Y3M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_2002_20">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_2002_16">124000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_709650x710802_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_1001_7">1028000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_709650x806044_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_80BC2167-42C6-4A27-8879-14EF2442C606_1001_0">388000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_2001_6">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1002_5">770000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_2001_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388" unitRef="iso4217_USD" decimals="0" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1002_4">1463000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x711169" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_3001_2">1.26</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x711169" unitRef="pure" decimals="4" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_3001_4">0.0227</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x716112" unitRef="pure" decimals="2" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_4001_3">1.29</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x716112" unitRef="pure" decimals="4" id="id_4142217_F8770CF8-DACD-46A7-9FF7-B021539DF1E1_4001_5">0.0243</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x711169_716763x781749_741278x756917" unitRef="pure" decimals="4" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1003_14">0.0051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x711169_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1003_12">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x711169_716763x781749_741278x756917" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1003_10">P3Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x716112_716763x781749_741278x756917" unitRef="pure" decimals="4" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2003_15">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x716112_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2003_13">1.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x716112_716763x781749_741278x756917" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2003_11">P3Y11M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3002_26">111000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x749992" unitRef="shares" decimals="INF" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1002_10">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x749992" unitRef="shares" decimals="INF" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1002_11">21834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x749992" unitRef="iso4217_USD" decimals="0" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1002_9">53000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3003_16">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x781749_741278x756917" unitRef="iso4217_USD" decimals="0" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3003_17">15000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x781749_741278x804137" unitRef="iso4217_USD" decimals="0" id="id_4142217_20D070B4-10D4-4DBD-B4FD-BBE1AC96FC57_1002_7">134000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x789620_741278x804137" unitRef="iso4217_USD" decimals="0" id="id_4142217_16D5C72D-9C7F-4227-ABF0-E1CD8746BD33_1002_7">112000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x810377" unitRef="iso4217_USD" decimals="0" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1003_9">219000</us-gaap:ShareBasedCompensation>
  <us-gaap:ProceedsFromGrantors contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_61CE54B9-C6C7-4EA6-B305-5EAF11DE2B91_2_1">234000</us-gaap:ProceedsFromGrantors>
  <us-gaap:FairValueAdjustmentOfWarrants contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_DBAA808B-0AE0-4B7F-AA98-FC9AF8CBB360_1_0">524000</us-gaap:FairValueAdjustmentOfWarrants>
  <galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_A69517FE-82EF-42F5-ACBB-D498BE82A28B_2_2">63000</galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x735475" unitRef="shares" decimals="INF" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_1003_1">390628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x735475_713115x716908" unitRef="iso4217_USD" decimals="0" id="id_4142217_A85E370D-C2B9-4D2C-8DF7-FFEE4566743D_2003_4">18000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x753998" unitRef="shares" decimals="INF" id="id_4142217_DB880073-AC5B-49B7-B528-22BC8E5C82E5_1001_0">20834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x753998_708873x825279_713115x716908" unitRef="iso4217_USD" decimals="0" id="id_4142217_DB880073-AC5B-49B7-B528-22BC8E5C82E5_2001_3">110000</us-gaap:ShareBasedCompensation>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x744092_711196x713470" id="id_4142217_4F099D12-D2CF-43DE-BC81-31A7AA450964_1001_1">--09-30</galt:DividendPaymentDateDayAndMonth>
  <galt:DividendAsPercentageOfNetSales contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x770326_711196x713470" unitRef="pure" decimals="3" id="id_4142217_C6A932D8-AF3B-40E4-BFA9-D2CACD19EDCA_1001_1">0.025</galt:DividendAsPercentageOfNetSales>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x784846" unitRef="iso4217_USD" decimals="-9" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_1001_2">5000000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x825279" unitRef="iso4217_USD" decimals="-9" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_2001_4">10000000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <galt:DividendAsPercentageOfNetSales contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x840719_711196x713470" unitRef="pure" decimals="4" id="id_4142217_C6A932D8-AF3B-40E4-BFA9-D2CACD19EDCA_2001_2">0.0125</galt:DividendAsPercentageOfNetSales>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x840823_711196x713470" id="id_4142217_4F099D12-D2CF-43DE-BC81-31A7AA450964_2001_0">--03-31</galt:DividendPaymentDateDayAndMonth>
  <galt:ShareConversionRatio contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x710990" unitRef="pure" decimals="3" id="id_4142217_6994DEB9-5E45-4C6E-8949-243CD1E56EAB_1001_0">0.667</galt:ShareConversionRatio>
  <galt:NoticePeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x710990" id="id_4142217_6994DEB9-5E45-4C6E-8949-243CD1E56EAB_1001_2">P10D</galt:NoticePeriod>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x710990" id="id_4142217_6994DEB9-5E45-4C6E-8949-243CD1E56EAB_1001_4">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470" unitRef="pure" decimals="2" id="id_4142217_C6A932D8-AF3B-40E4-BFA9-D2CACD19EDCA_3001_0">0.06</us-gaap:PreferredStockDividendRatePercentage>
  <galt:PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470" unitRef="shares" decimals="0" id="id_4142217_1A932961-AFA1-467C-B9BF-BAA873724658_1001_1">10000</galt:PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount>
  <galt:NumberOfDaysForRedemptions contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470" id="id_4142217_1A932961-AFA1-467C-B9BF-BAA873724658_1001_3">P10D</galt:NumberOfDaysForRedemptions>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470" id="id_4142217_00E99758-2137-4906-A46C-05375E91EF6E_1001_1">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <galt:ClosingStockPriceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_711502x711169" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_00E99758-2137-4906-A46C-05375E91EF6E_2001_0">18.00</galt:ClosingStockPriceOfCommonStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_711502x716112" unitRef="iso4217_USD" decimals="0" id="id_4142217_C6A932D8-AF3B-40E4-BFA9-D2CACD19EDCA_4001_3">100000</us-gaap:DividendsPreferredStock>
  <galt:RedemptionPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_711502x716112" id="id_4142217_1A932961-AFA1-467C-B9BF-BAA873724658_2001_0">P30D</galt:RedemptionPeriod>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x730903" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1008_2">on or after the eighth anniversary of the date of issuance, but before the ninth anniversary of the date of issuance.</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x730903" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1008_1">5.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x735492" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1002_2">on or after the second anniversary of the date of issuance, but before the third anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x735492" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1002_1">2.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x770088" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1003_2">on or after the third anniversary of the date of issuance, but before the fourth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x770088" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1003_1">3.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x796385" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1005_2">on or after the fifth anniversary of the date of issuance, but before the sixth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x796385" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1005_1">4.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x814598" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1006_2">on or after the sixth anniversary of the date of issuance, but before the seventh anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x814598" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1006_1">4.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x824056" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1004_2">on or after the fourth anniversary of the date of issuance, but before the fifth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x824056" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1004_1">3.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x828584" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1007_2">on or after the seventh anniversary of the date of issuance, but before the eighth anniversary of the date of issuance; and</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x828584" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1007_1">5.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x829211" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1001_2">before the second anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x829211" unitRef="pure" decimals="2" id="id_4142217_4C9B23B3-3DA0-49E4-9A84-7764B50F2B39_1001_1">2.00</galt:PercentageOfReturnOnInvestment>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713505" unitRef="pure" decimals="2" id="id_4142217_A49521E0-3BD2-4D25-9CAB-891F27B377FE_1001_1">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x711169_716763x781749_741278x756917" unitRef="pure" decimals="4" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1002_14">0.0079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x711169_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1002_12">1.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x711169_716763x781749_741278x756917" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_1002_10">P2Y11M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x716112_716763x781749_741278x756917" unitRef="pure" decimals="4" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2002_15">0.0129</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x716112_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2002_13">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x716112_716763x781749_741278x756917" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_2002_11">P3Y3M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <galt:ExtensionOfExercisePeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x711585" id="id_4142217_A69517FE-82EF-42F5-ACBB-D498BE82A28B_1002_0">P90D</galt:ExtensionOfExercisePeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x716908" unitRef="shares" decimals="INF" id="id_4142217_2B67466C-0C71-4760-BAE9-844A51E6CB9E_5001_4">46876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x716908" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BA022639-FF8A-419E-BE07-2E2410FBD1D7_5001_4">4.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x716908" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BA022639-FF8A-419E-BE07-2E2410FBD1D7_5001_3">8.04</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x716908" unitRef="shares" decimals="INF" id="id_4142217_2B67466C-0C71-4760-BAE9-844A51E6CB9E_5001_3">20834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x736056" unitRef="iso4217_USD" decimals="INF" id="id_4142217_2FDB975C-7CBC-4EFD-9A62-2D199DE60890_2002_0">3000000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" unitRef="pure" decimals="4" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_24">0.0012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_23">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_22">P1Y3M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" unitRef="pure" decimals="2" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_25">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_21">104000</galt:IssuanceOfWarrantsValue>
  <galt:ReversalOfSharebasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3003_27">13000</galt:ReversalOfSharebasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x781749_741278x756917" unitRef="shares" decimals="INF" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3002_8">7500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x781749_741278x756917" unitRef="pure" decimals="2" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3002_16">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x781749_741278x756917" unitRef="shares" decimals="INF" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3002_9">4500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x781749_741278x756917" unitRef="iso4217_USD" decimals="0" id="id_4142217_1C82BD6F-5B68-4D56-9F0D-2A2C0BD39AC3_3002_17">12000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x810377" unitRef="iso4217_USD" decimals="0" id="id_4142217_B46968EC-A163-4261-A0C3-22529775EE3F_1002_9">340000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_842646x773308" unitRef="pure" decimals="3" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_3001_8">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_842646x773308" unitRef="pure" decimals="2" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_3001_7">1.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_842646x773308" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_3001_9">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE87402---1310-K0015_STD_365_20111231_0_842646x773308" id="id_4142217_7477302F-21ED-45D1-A863-550E32189AD7_3001_6">P5Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <dei:TradingSymbol contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400000">GALT</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400001">GALECTIN THERAPEUTICS INC</dei:EntityRegistrantName>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <dei:AmendmentFlag contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6C9EBBB1-21A1-4357-B344-25644E30B557_1_1">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400007">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6C9EBBB1-21A1-4357-B344-25644E30B557_1_3">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6C9EBBB1-21A1-4357-B344-25644E30B557_1_0">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6C9EBBB1-21A1-4357-B344-25644E30B557_1_2">2013-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400002">0001133416</dei:EntityCentralIndexKey>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400004">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6C9EBBB1-21A1-4357-B344-25644E30B557_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityVoluntaryFilers contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4ACB2B21-D7B4-446D-805C-E2D11C49DB8A_1_400006">No</dei:EntityVoluntaryFilers>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_7001_8">14.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_FB1C83FE-5407-4800-8007-1E419DFCF4DC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes additional information regarding outstanding and
 exercisable options under our stock based compensation plans at
 December&amp;#xA0;31, 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="45%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Options
 Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Options&amp;#xA0;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1px; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px; WIDTH: 46pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price
 (Range)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number
 of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number
 of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.72 &amp;#x2013;
 1.83&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;531,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.33&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.60&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;531,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.60&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$2.08 &amp;#x2013;
 2.88&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;835,001&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;496,001&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.38&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$3.59 &amp;#x2013;
 4.41&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;358,294&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.07&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;99,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$5.82 &amp;#x2013;
 7.56&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,551,626&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.11&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;884,958&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$8.10 &amp;#x2013;
 11.40&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;71,945&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.96&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;71,945&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,084,463&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.43&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:BasisOfAccounting contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_F43E4EF7-C729-4E6F-8F80-25E347A2ACFC_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Nature of Business and
 Basis of Presentation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Galectin
 Therapeutics Inc. (the &amp;#x201C;Company&amp;#x201D;) is a
 development-stage company that is applying its leadership in
 galectin science and drug development to create new therapies for
 fibrotic disease and cancer. These candidates are based on the
 Company&amp;#x2019;s targeting of galectin proteins which are key
 mediators of biologic and pathologic function. These compounds also
 may have application for drugs to treat other diseases and chronic
 health conditions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 March&amp;#xA0;23, 2012, the Company effected a one-for-six reverse
 stock split. All common share and per share amounts in these
 financial statements have been adjusted to reflect the effect of
 the reverse split.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company has
 operated at a loss since its inception and has had no revenues. The
 Company anticipates that losses will continue for the foreseeable
 future. At December&amp;#xA0;31, 2013, the Company had $10,489,000 of
 unrestricted cash and cash equivalents available to fund future
 operations. Additionally, in January and February 2014, the Company
 received $28,178,000 in net proceeds from the issuance of common
 stock at market through its at the market (&amp;#x201C;ATM&amp;#x201D;)
 financing arrangement and $1,500,000 from the exercise of stock
 purchase warrants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As shown in the
 consolidated financial statements, the Company incurred cumulative
 net losses applicable to common stockholders of $102.2 million for
 the period from inception (July 10, 2000) through December&amp;#xA0;31,
 2013. The Company&amp;#x2019;s net losses have resulted principally from
 costs associated with (i)&amp;#xA0;research and development expenses,
 including clinical trial costs, (ii)&amp;#xA0;general and
 administrative activities and (iii)&amp;#xA0;the Company&amp;#x2019;s
 financing transactions including interest, dividend payments, and
 the costs related to fair value accounting for the Company&amp;#x2019;s
 convertible debt instruments. As a result of planned expenditures
 for future research, discovery, development and commercialization
 activities and potential legal cost to protect its intellectual
 property, the Company expects to incur additional losses and use
 additional cash in its operations for the foreseeable future.
 Through December&amp;#xA0;31, 2013, the Company had raised a net total
 of $77.4 million in capital through sale and issuance of common
 stock, common stock purchase warrants, convertible preferred stock
 and debt securities in public and private offerings. From inception
 (July 10, 2000) through December&amp;#xA0;31, 2013, the Company used
 cash of $66.0 million in its operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company was
 founded in July 2000, was incorporated in the State of Nevada in
 January 2001 under the name &amp;#x201C;Pro-Pharmaceuticals,
 Inc.,&amp;#x201D; and changed its name to &amp;#x201C;Galectin Therapeutics
 Inc.&amp;#x201D; on May&amp;#xA0;26, 2011.&amp;#xA0;On&amp;#xA0;March&amp;#xA0;23, 2012,
 the Company began trading on The NASDAQ Capital Market under the
 symbol GALT. Prior to March&amp;#xA0;23, 2012, the Company was traded
 on the Over-the Counter Bulletin Board (&amp;#x201C;OTCBB&amp;#x201D;) under
 the symbol GALT.OB (previously PRWP.OB) from January&amp;#xA0;21, 2009
 to March&amp;#xA0;22, 2012 after the Company was delisted from the NYSE
 Alternext US (&amp;#x201C;Exchange&amp;#x201D;), formerly the American Stock
 Exchange, due to non-compliance with the Exchange minimum
 shareholders&amp;#x2019; equity requirements on January&amp;#xA0;9,
 2009.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company is
 subject to a number of risks similar to those of other
 development-stage companies, including dependence on key
 individuals, uncertainty of product development and generation of
 revenues, dependence on outside sources of capital, risks
 associated with clinical trials of products, dependence on
 third-party collaborators for research operations, need for
 regulatory approval of products, risks associated with protection
 of intellectual property, and competition with larger,
 better-capitalized companies. Successful completion of the
 Company&amp;#x2019;s development program and, ultimately, the attainment
 of profitable operations is dependent upon future events, including
 obtaining adequate financing to fulfill its development activities
 and achieving a level of revenues adequate to support the
 Company&amp;#x2019;s cost structure. There are no assurances that the
 Company will be able to obtain additional financing on favorable
 terms, or at all, or successfully market its products.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_ACE1F389-AA1A-491F-B92B-F1FB2AE67190_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consists of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer and office
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture and
 fixtures&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(71&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment&amp;#x2014;net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_5C210C2F-50A0-44ED-B0D9-42E78B21DE4C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dilutive shares
 which could exist pursuant to the exercise of outstanding stock
 instruments and which were not included in the calculation because
 their affect would have been anti-dilutive are as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="74%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year
 Ended&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants to purchase shares
 of common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Options to purchase shares
 of common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares of common stock
 issuable upon conversion preferred stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,568,771&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,952,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,591,312&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_7913022A-7788-47D5-A8FB-F9959FF315C0_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Property and
 Equipment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consists of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer and office
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture and
 fixtures&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(71&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment&amp;#x2014;net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation
 and amortization expense for the years ended December&amp;#xA0;31, 2013
 and 2012 was $5,000 and $3,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_1_0">0.0117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_A073E701-A6BE-4904-8F27-938F95C94667_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Revenue
 Recognition&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company records revenue
 provided that there is persuasive evidence that an arrangement
 exists, the price is fixed and determinable, services were rendered
 and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_045396DD-3154-4199-B22B-E757B8AFEEFB_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Agreement with PROCAPS
 S.A. and Research Grants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Agreement
 with PROCAPS S.A.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%;padding-bottom:0px;"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 March&amp;#xA0;25, 2010, the Company granted PROCAPS S.A.
 (&amp;#x201C;PROCAPS&amp;#x201D;) (in the form of a definitive term sheet)
 exclusive rights to market and sell GM-CT-01 (formerly
 DAVANAT&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;sup style="vertical-align:baseline; position:relative; bottom:.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;)
 to treat cancer in Colombia, South America. PROCAPS is an
 international, privately held pharmaceutical company based in
 Barranquilla, Colombia. In October 2010, the Company received a
 payment of $200,000 and shipped GM-CT-01 to PROCAPS to be used by
 PROCAPS to qualify its vial filling process and to replicate the
 Company&amp;#x2019;s stability study. The $200,000 payment from PROCAPS
 was included as deferred income on the condensed consolidated
 balance sheets as of December&amp;#xA0;31, 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 October&amp;#xA0;18, 2011, the Company entered into a Collaboration,
 Supply, Marketing and Distribution Agreement (the
 &amp;#x201C;Agreement&amp;#x201D;) with PROCAPS. The Agreement granted
 PROCAPS first negotiation rights to enter into similar agreements
 in other Central and South American countries. The Company was to
 be the sole manufacturer and supplier of GM-CT-01 to PROCAPS. The
 Agreement obligated PROCAPS to procure regulatory approvals
 necessary for the marketing and sale of GM-CT-01 naming the Company
 as the owner of such approvals to the extent permitted by law, or
 alternatively hold the approvals for the Company&amp;#x2019;s benefit.
 PROCAPS was to pay the Company a stated fee for each dose it
 purchased and royalties at an incremental rate determined by annual
 net sales of GM-CT-01. The Company retains all intellectual
 property rights to GM-CT-01 and related products and PROCAPS may
 not produce, modify, reverse engineer, or otherwise interfere with
 the GM-CT-01 compound. PROCAPS was not able to manufacture or sell
 products that compete with GM-CT-01 during the term of the
 Agreement and for five years thereafter.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;PROCAPS had not
 obtained approval to sell GM-CT-01 in Columbia as required by the
 Agreement and, as they were in material breach of the Agreement,
 the Company terminated the Agreement, effective September&amp;#xA0;29,
 2012. With no further obligations, the Company recognized the
 $200,000 payment as Other Income in the Statements of Operations
 during the year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Qualifying
 Therapeutic Discovery Project&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In October 2010,
 the Company was notified that it was awarded $489,000 total in two
 federal grants under the Qualifying Therapeutic Discovery Project
 (&amp;#x201C;QTDP&amp;#x201D;) Program for its GM-CT-01 anti-cancer compound
 and for its GR/GM-Series of anti-fibrotic, cirrhosis compounds for
 work performed during 2010 and 2009. The Company recognized this
 grant in other income in the statement of operations for the year
 ended December&amp;#xA0;31, 2010. The Company received $255,000 of the
 grant in 2010 and the remaining $234,000 was received in
 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_00A47A38-8BFB-402D-AF5A-91AA2A40D2B3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes the stock option activity in the stock based
 compensation plans:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Remaining&lt;br /&gt;
 Contractual&lt;br /&gt;
 Life&lt;br /&gt;
 (in years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&amp;#xA0;Value&lt;br /&gt;
 (in thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.83&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;800,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(299,683&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,830&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.31&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;425,426&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.89&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(403,674&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(213,008&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,420&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable,
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,084,463&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.43&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,721&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_75540B32-94A8-4921-986B-B698497CD189_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrant
 activity is summarized as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,379,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(616,726&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,177&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,344,012&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information with regard to outstanding warrants
 issued in connection with equity and debt financings and
 consultants as of December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 90pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Issued in
 Connection With&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 Issued&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercisable&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Expiration&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February&amp;#xA0;12, 2009
 Series B-1 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,200,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February 12,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;13, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;600,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,333&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;333,333&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;1, 2009 Consultant
 Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,250&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 1, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 1, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;40,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August&amp;#xA0;12, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;50,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;200,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,166&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September 30,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September 30,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November&amp;#xA0;4, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;206,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;8, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January&amp;#xA0;29, 2010
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March&amp;#xA0;8, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;55,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;223,334&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April&amp;#xA0;30, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;206,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;10, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;380,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,584&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;15, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.26&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 15, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 15, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;9, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,334&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 9,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 9,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;30, 2010
 Placement Agent Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;30,&amp;#xA0;2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 30,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March&amp;#xA0;28, 2012
 Offering Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,333,061&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 28, 2017&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 7em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total outstanding
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_3E290F6D-9438-44AB-9DAE-211CC45855E8_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive
 Income (Loss).&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Comprehensive income
 (loss) is defined as the change in equity of a business enterprise
 during a period from transactions and other events and
 circumstances from non-owner sources. The Company does not have any
 items of comprehensive income (loss) other than net losses as
 reported.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_1_2">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_99D43832-900B-4B29-BBC3-C162DF6E4AFE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Restricted
 Cash and Security Deposit.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;At
 December&amp;#xA0;31, 2013 and 2012, the Company had a security deposit
 of $6,000 for leased office space. The security deposit was
 included in Prepaid Expenses and Other Current Assets at
 December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_0">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_7001_7">3.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_4">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_BFD19733-4518-425F-A75F-56A91A53FB7A_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company accounts for income
 taxes in accordance with the accounting rules that requires an
 asset and liability approach to accounting for income taxes based
 upon the future expected values of the related assets and
 liabilities. Deferred income tax assets and liabilities are
 determined based on the differences between the financial reporting
 and tax bases of assets and liabilities and for tax loss and credit
 carry forwards, and are measured using the expected tax rates
 estimated to be in effect when such basis differences reverse.
 Valuation allowances are established, if necessary, to reduce the
 deferred tax asset to the amount that will, more likely than not,
 be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1_0">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_8797EDE2-78DB-41F6-8143-5C5E03DCFBD0_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Fair Value of Financial
 Instruments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;A summary of
 changes in the Warrant Liabilities is as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
 Warrant&lt;br /&gt;
 Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
 2010&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;861&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Change in fair value of
 warrant liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;524&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Intrinsic value of liability
 warrants exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,385&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The warrant
 liabilities in the table above were classified as a Level 2
 liability and were valued using the Black-Scholes pricing
 model.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_6">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_1_1">P5Y3M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_3E54125C-1A01-4183-9ABE-4187A630BEB5_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Basis of
 Consolidation.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The consolidated
 financial statements include the accounts of the Company and
 Galectin Therapeutics Security Corp., its wholly-owned subsidiary,
 which was incorporated in Delaware on December&amp;#xA0;23, 2003.
 Galectin Therapeutics Security Corp. holds the cash and cash
 equivalents that are not required to fund current operating needs.
 All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_EB14072D-7406-43CD-ADFF-3945F9665127_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 consist of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Legal and accounting
 fees&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;103&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;109&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued
 compensation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;526&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Severance agreement (Note
 11)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;22&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,651&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,161&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_5">0.366</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_51E3A178-E444-49DF-9A3E-3570975DD011_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Accrued
 Expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 consist of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Legal and accounting
 fees&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;103&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;109&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued
 compensation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;526&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Severance agreement (Note
 11)&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;22&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,651&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,161&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_18">16874000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_E83AE091-CCF2-45BF-A042-2FA8DED9D2D8_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Stockholders&amp;#x2019;
 Deficit&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2013, the Company had 50,000,000 shares of common
 stock and 20,000,000 undesignated shares authorized. As of
 December&amp;#xA0;31, 2012, 5,000,000 shares have been designated for
 Series A 12% Convertible Preferred Stock, 900,000 shares have been
 designated for Series B-1 Convertible Preferred Stock, 2,100,000
 shares have been designated for Series B-2 Convertible Preferred
 Stock, 1,000 shares have been designated for Series C Super
 Dividend Convertible Preferred Stock and 11,999,000 remain
 undesignated.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company has
 raised capital through a number of debt and equity financing
 transactions. The following provides a description of the
 Company&amp;#x2019;s equity financings and certain warrants issued in
 connection with such equity financings.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2001
 Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;During 2001, the
 Company sold a total of 114,884 shares of common stock for proceeds
 of $2,221,000, net of $17,000 of issuance costs through a private
 placement of securities. In connection with this issuance, the
 Company issued 56,534 and 58,350 warrants to purchase common stock
 at $39.00 and $30.00 per share, respectively. The Company valued
 the warrants at $886,000, based on a fair market value of the
 Company&amp;#x2019;s common stock of $13.68 per share. These warrants
 expired unexercised in 2005.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In August 2001,
 the Company offered warrants to holders of its outstanding
 convertible notes as an inducement to convert prior to the maturity
 of the notes. Holders representing $1,126,000 of the outstanding
 principal and accrued interest chose to convert at a conversion
 price of $12.00 per share and received 99,705 common shares and
 93,801 warrants. These warrants have an exercise price of $39.00
 per share and were immediately exercisable. The Company valued the
 warrants at $503,000 based on a fair market value of the
 Company&amp;#x2019;s common stock of $13.68 per share. The value of the
 warrants has been recorded as a debt conversion expense. These
 warrants expired unexercised in 2005.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In 2002, the
 Company issued 18,334 warrants to the agents in connection with the
 2001 offering. The warrants were exercisable immediately at an
 exercise price of $21.00 per share and have a 10 year life. The
 Company valued these warrants at $236,000 based on a deemed fair
 value of the Company&amp;#x2019;s common stock of $21.00 per share and
 recorded such value as interest expense in the statement of
 operations for the year ended December&amp;#xA0;31, 2002. These
 warrants expired unexercised in 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Public
 Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 December&amp;#xA0;13, 2001, the Company commenced a public offering of
 common stock, at a price to the public of $21.00 per share. The
 Company concluded the offering on June&amp;#xA0;30, 2002. During 2002,
 the Company sold 31,000 shares of common stock in this offering for
 proceeds of $602,000, net of $49,000 of issuance costs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2002
 Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In September
 2002, the Company began a private placement (the &amp;#x201C;2002
 Private Placement&amp;#x201D;) of up to 1,666,667 shares of common stock
 at $6.00 per share. As of December&amp;#xA0;31, 2002, the Company had
 sold 537,227 shares for proceeds of $2,861,000, net of issuance
 costs of $212,000 and stock subscription receivable of $150,000,
 which related to shares purchased but for which payment had not
 been received as of December&amp;#xA0;31, 2002. This offering was
 closed on January&amp;#xA0;14, 2003, although subsequent to year end
 the Company sold an additional 181,334 shares for additional
 proceeds of $1,070,000, net of $18,000 of offering
 costs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 compensated a registered investment adviser with respect to shares
 purchased by its clients. As of December&amp;#xA0;31, 2002, the adviser
 was entitled to receive 28,917 shares of common stock. The Company
 also agreed to compensate a finder registered under applicable law,
 and such finder&amp;#x2019;s agents, for identifying qualified
 investors. As of December&amp;#xA0;31, 2002, one of the finder&amp;#x2019;s
 agents was entitled to receive 125 shares of common stock. On
 January&amp;#xA0;14, 2003, the Company closed the 2002 Private
 Placement, at which point the Company agreed to issue the adviser
 an additional 417 shares, and the finder and its other agent an
 aggregate of 1,625 additional shares and $3,000 in cash in
 connection with the shares sold subsequent to December&amp;#xA0;31,
 2002 and through the closing date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Shares placed by
 such registered adviser, finder and finder&amp;#x2019;s agent were
 accounted for as offering costs and valued at $6.00 per share,
 consistent with the price paid for the shares placed in the
 offering. Such offering costs were netted against the proceeds of
 the 2002 Private Placement. Since none of the 29,042 shares had
 been issued as of December&amp;#xA0;31, 2002, the Company recorded the
 obligation to issue such shares as offering costs payable. The
 additional 2,042 shares issued in January 2003 were also valued at
 $6.00 per share and included in the $18,000 offering costs recorded
 at the closing. These shares were subsequently issued in
 2003.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;During 2002, the
 Company also agreed to issue 350 shares of common stock to an
 employee for finding investors in connection with the 2002 Private
 Placement. None of the shares had been issued as of
 December&amp;#xA0;31, 2002. These shares were subsequently issued in
 2003. Accordingly, the Company recorded the obligation to general
 and administrative expenses in the statement of operations in the
 amount of $6,000. On January&amp;#xA0;14, 2003, the Company closed the
 2002 Private Placement, at which point the Company agreed to issue
 such employee an additional 1,167 shares in connection with shares
 sold subsequent to December&amp;#xA0;31, 2002 and through the closing
 date. The Company recorded an additional obligation of $27,000 to
 general and administrative expenses in 2003 representing the fair
 value of the additional 1,167 shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2002
 Related Party Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 agreed to issue 4,226 shares of common stock as payment for 2002
 scientific advisory services. These shares were issued in
 2003.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;May 2003
 Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In May 2003, the
 Company began a private placement of up to 416,667 shares of common
 stock at $12.00 per share. As of the closing on July&amp;#xA0;15, 2003,
 the Company had sold 399,917 shares of common stock for proceeds of
 $4,671,000, net of issuance costs of $128,000. In connection with
 this offering the Company issued 18,269 common stock warrants
 (exercisable at $32.40 per share) to its placement agents. The
 Company valued the warrants at $261,000 using the Black-Scholes
 pricing model and recorded the warrant value as offering costs with
 a corresponding increase to additional paid-in capital. These
 warrants expired unexercised in 2006.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;October
 2003 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 October&amp;#xA0;2, 2003 the Company closed a private offering,
 structured as a Private Investment, Public Equity
 (&amp;#x201C;PIPE&amp;#x201D;), exempt from registration under
 Section&amp;#xA0;4(2) of the Securities Act of 1933, in which it sold
 to institutional investors 219,096 of the 238,096 offered shares of
 common stock at $21.00 per share for proceeds of $4,041,000, net of
 issuance costs of $559,000. In connection with this offering, the
 Company issued 109,549 warrants with an initial exercise price of
 $31.74 per share to the investors and 10,955 warrants with an
 initial exercise price of $41.16 per share to its placement agent.
 The exercise price of the warrants was subject to adjustment
 pursuant to anti-dilution and other provisions. The investor
 warrants and placement agent Warrants were valued at $2,531,000 and
 $191,000, respectively, using the relative fair value, and
 allocated to additional paid-in-capital. The Company used the
 Black-Scholes pricing model to value these warrants. The warrants
 were originally accounted for as freestanding derivative
 instruments. The investor warrants expired unexercised in 2008 and
 the placement agent warrants expired unexercised in
 2007.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;April 2004
 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On April&amp;#xA0;7,
 2004, the Company closed a private equity offering, structured as a
 &amp;#x201C;PIPE&amp;#x201D; in which it sold to certain institutional
 investors 206,019 shares of common stock at $21.60 per share for
 proceeds of $3,983,000, net of cash issuance costs of $466,000. In
 connection with this offering, the Company issued 103,010 warrants
 to investors and 10,301 warrants to a placement agent with an
 initial exercise price of $31.80 per share. The exercise price of
 the warrants was subject to adjustment pursuant to anti-dilution
 and other provisions. The investor warrants and the placement agent
 warrants were valued at $1,931,000 and $154,000, respectively,
 using the relative fair value, and allocated to additional
 paid-in-capital. The Company used the Black-Scholes pricing model
 to value these warrants. The warrants were originally accounted for
 as freestanding derivative instruments. The investor warrants
 expired unexercised in 2009 and the placement agent warrants
 expired unexercised in 2007.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;August
 2004 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;12, 2004, the Company closed a private offering,
 structured as a &amp;#x201C;PIPE&amp;#x201D; in which it sold to certain
 institutional investors 333,334 shares of common stock at $18.00
 per share for proceeds of $5,515,000, net of cash issuance costs of
 $485,000. In connection with this offering the Company issued
 333,334 warrants to the investors and 16,667 warrants to the
 placement agent with an exercise price of $4.20 per share. The
 exercise price of the warrants was subject to adjustment solely as
 a result of stock splits, recapitalizations and similar events. The
 investor warrants and placement agent warrants were valued at
 $4,786,000 and $239,000, respectively, and allocated to additional
 paid-in-capital. The Company used the Black-Scholes pricing model
 to value these warrants. The warrants were originally accounted for
 as freestanding derivative instruments. These warrants expired
 unexercised in 2009.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;February&amp;#xA0;25, 2008 Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;25, 2008, the Company closed an offering in which it
 sold to investors (i)&amp;#xA0;an aggregate of 1,250,000 shares of the
 Company&amp;#x2019;s common stock at $3.00 per share,
 (ii)&amp;#xA0;warrants, which expire on August&amp;#xA0;25, 2013, to
 purchase an aggregate of 1,250,000 share of the Company&amp;#x2019;s
 common stock at an exercise price of $3.50 per share, and
 (iii)&amp;#xA0;warrants, which expired on December&amp;#xA0;26, 2008, to
 purchase an aggregate of 500,000 shares of the Company&amp;#x2019;s
 common stock at an exercise price of $3.78 per share. In addition,
 the Company issued to a placement agent warrants, which expire on
 August&amp;#xA0;25, 2013, to purchase 34,375 shares of the
 Company&amp;#x2019;s common stock at an exercise price of $4.20 per
 share. The warrants are exercisable beginning on August&amp;#xA0;25,
 2008. The warrants provide for cashless exercise if at any time
 during the term of the warrants if there is no effective
 registration statement for the issuance or resale of the underlying
 warrant shares. The exercise price of each warrant is adjustable in
 the event of a stock split or stock combination, capital
 reorganization, merger or similar event.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 received proceeds of $3,381,000, net of cash transaction costs of
 $369,000. In addition the Company incurred $56,000 of costs for
 warrants issued to a placement agent. Proceeds of $1,044,000 were
 allocated to common stock and $2,281,000 were allocated to investor
 warrants using the Black-Scholes method with a fair market value of
 the Company&amp;#x2019;s common stock of $2.40 and the following
 assumptions as of February&amp;#xA0;25, 2008: for the 5 year warrants
 exercisable at $4.20 per share, a risk-free interest rate of 2.94%
 and volatility of 95% and for the 4 month warrants exercisable at
 $3.78 per share, a risk-free interest rate of 2.13% and volatility
 of 95%. The warrants were determined to have the characteristics of
 derivative liabilities and were originally accounted for as
 liabilities prior to the Company increasing the authorized number
 of shares. Changes in fair value were recognized as either a gain
 or loss in the consolidated statement of operations. In the second
 quarter of 2008 the warrants were reclassified to equity. Through
 May&amp;#xA0;21, 2008, these warrants were marked to market resulting
 in a reduction in warrant liabilities in the balance sheet and an
 offsetting credit to change in fair value of warrant liabilities in
 the statement of operations in the amount of $356,000. The
 remaining fair value of $2,160,000 was credited to additional
 paid-in capital in the balance sheet. On December&amp;#xA0;26, 2008 the
 500,000 warrants exercisable at $3.78 expired unexercised. If the
 Company pays a stock dividend or makes a distribution or combines
 shares of its common stock, then the number of shares issuable upon
 exercise of this warrant shall be proportionately adjusted such
 that the aggregate exercise price of this warrant remains
 unchanged.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Cork
 Investments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On July&amp;#xA0;2,
 2008, the Company issued 50,000 warrants to Cork Investments in
 exchange for $20,000. The warrants were exercisable for common
 stock at $6.00 per share for a period of three years and expired
 unexercised in 2011. The $20,000 was credited to additional paid in
 capital.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2012
 Offering of Units&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 March&amp;#xA0;22, 2012, the Company entered into an underwriting
 agreement, relating to the offer and sale of 1,159,445 units (the
 &amp;#x201C;Units&amp;#x201D;) of the Company, each unit consisted of two
 shares of Common Stock and one warrant to purchase one share of
 Common Stock. Pursuant to the underwriting agreement, the Company
 granted the underwriters a 45-day option to purchase up to an
 additional 173,916 Units to cover over-allotments, which they
 exercised on March&amp;#xA0;26, 2012. The public offering price for
 each Unit was $9.00. Each warrant has an initial exercise price of
 $5.63 per share, is exercisable upon separation of the Units and
 expires on March&amp;#xA0;28, 2017.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 March&amp;#xA0;28, 2012, the Company sold and issued 1,333,361 Units
 (2,666,722 shares of common stock and related $5.63 warrants to
 purchase 1,333,361 shares of common stock) for gross proceeds of
 $12.0 million (net cash proceeds of $10,403,000 after the
 underwriting discount and offering costs). The warrants were valued
 at $4,445,000 as of the issuance date of March&amp;#xA0;28, 2012, using
 the closing price of $4.20, a life of 5 years, a volatility of 119%
 and a risk free interest rate of 1.05%. Based upon the
 Company&amp;#x2019;s analysis of the criteria contained in ASC Topic
 815-40, &amp;#x201C;Derivatives and Hedging &amp;#x2014; Contracts in
 Entity&amp;#x2019;s Own Equity&amp;#x201D; the Company has determined that
 warrants issued in connection with this financing transaction were
 not derivative liabilities and therefore, were recorded as
 additional paid-in capital.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 March&amp;#xA0;28, 2012, in connection with the underwritten financing
 as described above, the Company issued a total of 46,378 common
 stock purchase warrants to the underwriters. These warrants expire
 May&amp;#xA0;2, 2016, have an exercise price of $5.63 per share, and
 are exercisable beginning one year from March&amp;#xA0;22, 2012 (the
 date of the underwriting agreement). These warrants were valued at
 $143,000 as of the date of issuance (March 28, 2012), using the
 closing price of $4.20, life of 4.1 years, volatility of 117% and
 risk free interest rate of 0.78%. Based upon the Company&amp;#x2019;s
 analysis of the criteria contained in ASC Topic 815-40,
 &amp;#x201C;Derivatives and Hedging &amp;#x2014; Contracts in Entity&amp;#x2019;s
 Own Equity&amp;#x201D;, the Company has determined that these warrants
 issued in connection with this financing transaction were not
 derivative liabilities and therefore, were recorded as additional
 paid-in capital.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Effective as of
 March&amp;#xA0;23, 2012, and in connection with the pricing of the
 offering of Units, the Company effected a one-for-six reverse split
 of its Common Stock. Per the terms of the reverse split, all
 fractional shares were rounded up. Based on the effective split
 date of March&amp;#xA0;23, 2012, the Company issued 3,324&amp;#xA0;shares
 of common stock to cover fractional shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2013
 Private Placement of Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;16, 2013, the Company issued 500,000 unregistered
 shares of its common stock for proceeds of $3,000,000 to a single
 investor pursuant to a private placement. There were no warrants or
 placement fees associated with this transaction.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2013 At
 Market Issuance of Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 October&amp;#xA0;25, 2013, the Company entered into an At Market
 Issuance Sales Agreement (the &amp;#x201C;At Market Agreement&amp;#x201D;)
 with a sales agent under which the Company may issue and sell
 shares of its common stock having an aggregate offering price of up
 to $30.0 million from time to time through the sales agent. Sales
 of the Company&amp;#x2019;s common stock through the sales agent, if
 any, will be made by any method that is deemed an &amp;#x201C;at the
 market&amp;#x201D; offering as defined by the U.S. Securities and
 Exchange Commission. The Company will pay to the sales agent a
 commission rate equal to 3.0% of the gross proceeds from the sale
 of any shares of common stock sold through the sales agent under
 the At Market Agreement. As of December&amp;#xA0;31, 2013, the Company
 had issued 99,942 shares of its common stock through its At Market
 issuance program at an average price of $9.02 per share resulting
 in gross proceeds of approximately $944,000. The Company incurred
 one time, initial legal and accounting costs of approximately
 $82,000 and commissions of $29,000 resulting in net proceeds of
 $833,000 as of December&amp;#xA0;31, 2013. In January and February
 2014, the Company issued 2,663,647 shares of common stock for net
 proceeds of approximately $28,178,000 which completed the At Market
 Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series A
 12% Convertible Preferred Stock &amp;#x2014; February&amp;#xA0;4, 2008
 Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;4, 2008, the Company&amp;#xA0;closed&amp;#xA0;a private
 placement begun in October 2007&amp;#xA0;of its Series A 12%
 Convertible Preferred Stock (&amp;#x201C;Series A&amp;#x201D;) and related
 warrants. In this transaction, the Company sold units of securities
 at $6.00 per unit, each unit comprised of (i)&amp;#xA0;one share of
 Series A Preferred, (ii)&amp;#xA0;a warrant to purchase one share of
 common stock for $9.00, and (iii)&amp;#xA0;a warrant to purchase one
 share of common stock for $12.00. Each share of the Series A is
 entitled to dividends at the rate of 12%&amp;#xA0;per annum payable at
 the Company&amp;#x2019;s option in cash or shares of common stock valued
 at the higher of $6.00 per share or 100% of the value weighted
 average price of the Company&amp;#x2019;s share price for the 20
 consecutive trading days prior to the applicable dividend payment
 date. Dividends are payable semi-annually on March&amp;#xA0;30 and
 September&amp;#xA0;30. The dividend paid on the initial dividend
 payment date is calculated from the date the Company deposited each
 subscription advance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The shares of
 Series A are entitled to vote as a class with the Company&amp;#x2019;s
 common stock and each share of Series A is convertible at any time
 to one-sixth of a share of common stock, subject to adjustment in
 the event of a stock dividend, stock split or combination,
 reclassification or similar event. The Company has the right to
 require conversion if the closing price of the common stock exceeds
 $18.00 for 15 consecutive trading days and a registration statement
 covering the resale of the shares of common stock issuable upon
 conversion of the Series A is then in effect. Each warrant is
 exercisable solely for cash beginning August&amp;#xA0;3, 2008 and
 expired on February&amp;#xA0;4, 2012. The exercise price of each
 warrant is adjustable in the event of a stock split or stock
 combination, capital reorganization, merger or similar
 event.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2007, the Company had received subscription
 advances of $1,667,500 for Series A.&amp;#xA0;In 2008, the Company
 received additional subscription advances of $75,000 resulting in
 total gross proceeds of $1,742,500. On February&amp;#xA0;4, 2008 the
 Company closed the private placement. The Company incurred $52,000
 of cash transaction costs resulting in net cash proceeds of
 $1,691,000. In addition, the Company incurred $3,000 of costs for
 1,400 warrants exercisable at $9.00 issued to placement agents.
 Proceeds of $984,000 were allocated to investor warrants using the
 Black-Scholes method with the following assumptions as of
 February&amp;#xA0;4, 2008: risk free interest rate 2.51%, volatility
 95%, fair market value of the company&amp;#x2019;s common stock on
 February&amp;#xA0;4, 2008, and the share price on the closing date of
 the transaction of $3.54. The warrants were originally accounted
 for as freestanding derivative instruments in the consolidated
 balance sheet formerly under the caption &amp;#x201C;Warrant
 Liabilities&amp;#x201D;. These warrants were originally classified as a
 liability because the February 2006 warrants contain an
 anti-dilution provision in the event of a subsequent dilutive
 issuance and the potential number of shares issuable exceeded the
 Company&amp;#x2019;s authorized shares. Changes in fair value were
 recognized as either a gain or loss in the consolidated statement
 of operations under the caption &amp;#x201C;Change in fair value of
 warrant liabilities&amp;#x201D;. In the second quarter of 2008, the
 warrants were reclassified to equity as a result of an amendment to
 the Company&amp;#x2019;s articles of incorporation approved at the
 May&amp;#xA0;21, 2008 annual meeting of shareholders increasing the
 Company&amp;#x2019;s authorized common. Through May&amp;#xA0;21, 2008, these
 warrants were marked to market resulting in a reduction in warrant
 liabilities in the balance sheet and an offsetting credit to change
 in fair value of warrant liabilities in the statement of operations
 in the amount of $100,000. The remaining fair value of $502,000 was
 credited to additional paid-in capital in the balance
 sheet.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In 2013, 110,000
 shares of Series A were converted into 18,387 shares of common
 stock. Prior to 2013, a total of 180,000 shares of Series A had
 been converted into 30,000 shares of common stock.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series B
 Redeemable Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;12, 2009, the Company entered into a securities
 purchase agreement (the &amp;#x201C;10X Agreement&amp;#x201D;) pursuant to
 which it agreed to issue and sell to 10X Fund LP, at two or more
 closings, up to: (i)&amp;#xA0;3,000,000 shares its Series B convertible
 preferred stock (&amp;#x201C;Series B redeemable convertible preferred
 stock&amp;#x201D; or &amp;#x201C;Series&amp;#xA0;B&amp;#x201D;) with an aggregate
 stated value of $6.0 million and convertible into 2,000,000 shares
 of common stock at December&amp;#xA0;31, 2011 and (ii)&amp;#xA0;warrants to
 purchase 6,000,000 shares of common stock.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Through a series
 of closings from February 2009 through May 2010, the Company issued
 and sold, pursuant to the 10X Agreement, a total of
 (i)&amp;#xA0;900,000 shares of Series B-1 convertible preferred stock
 (&amp;#x201C;Series B-1 redeemable convertible preferred stock&amp;#x201D; or
 &amp;#x201C;Series B-1&amp;#x201D;) and related common stock warrants for
 1,800,000 shares of common stock and (ii)&amp;#xA0;2,100,000 shares of
 Series B-2 convertible preferred stock (&amp;#x201C;Series B-2
 redeemable convertible preferred stock&amp;#x201D; or &amp;#x201C;Series
 B-2&amp;#x201D;) and related warrants for 4,200,000 shares of common
 stock. During 2010, the Company received total net cash proceeds of
 $1,463,000 from the issuance of 770,000 shares of Series B-2 and
 related warrants. During 2009, the Company received total net cash
 proceeds of $1,548,000 from the issuance of 900,000 shares of
 Series B-1 and related warrants and $2,472,000 from the issuance of
 1,330,000 shares of Series B-2 and related warrants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Series B
 closings were as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;12, 2009, the Company issued and sold, pursuant to
 the 10X Agreement: (i)&amp;#xA0;900,000 shares of Series B-1
 convertible preferred stock (&amp;#x201C;Series B-1 redeemable
 convertible preferred stock&amp;#x201D; or &amp;#x201C;Series B-1&amp;#x201D;)
 convertible into 600,000 shares of common stock;
 (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase 300,000
 shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
 exercisable to purchase 300,000 shares of common stock; and
 (iv)&amp;#xA0;Class B warrants exercisable to purchase 1,200,000 shares
 of common stock. Net proceeds from the closing were
 $1,548,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On May&amp;#xA0;13,
 2009, the Company issued and sold, pursuant to the 10X Agreement:
 (i)&amp;#xA0;450,000 shares of Series B-2 convertible preferred stock
 (&amp;#x201C;Series B-2 redeemable convertible preferred stock&amp;#x201D; or
 &amp;#x201C;Series B-2&amp;#x201D;) convertible into 300,000 shares of common
 stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase
 150,000 shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
 exercisable to purchase 150,000 shares of common stock; and
 (iv)&amp;#xA0;Class B warrants exercisable to purchase 600,000 shares
 of common stock. Net proceeds from the closing were
 $801,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On June&amp;#xA0;30,
 2009, the Company issued and sold, pursuant to the 10X Agreement:
 (i)&amp;#xA0;250,000 shares of Series B-2 convertible into 166,666
 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants
 exercisable to purchase 83,333 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 83,333
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 333,333 shares of common stock. Net proceeds from the
 closing were $473,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;12, 2009, the Company issued and sold, pursuant to the
 10X Agreement: (i)&amp;#xA0;150,000 shares of Series B-2 convertible
 into 100,000 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
 warrants exercisable to purchase 50,000 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 50,000
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 200,000 shares of common stock. Net proceeds from the
 closing were $287,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 September&amp;#xA0;30, 2009, the Company issued and sold, pursuant to
 the 10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2
 convertible into 108,333 shares of common stock;
 (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase 54,166
 shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
 exercisable to purchase 54,166 shares of common stock; and
 (iv)&amp;#xA0;Class B warrants exercisable to purchase 216,666 shares
 of common stock. Net proceeds from the closing were
 $305,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 November&amp;#xA0;4, 2009, the Company issued and sold, pursuant to the
 10X Agreement: (i)&amp;#xA0;155,000 shares of Series B-2 convertible
 into 103,333 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
 warrants exercisable to purchase 51,666 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 51,666
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 206,666 shares of common stock. Net proceeds from the
 closing were $296,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 December&amp;#xA0;8, 2009, the Company issued and sold, pursuant to the
 10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2 convertible
 into 108,333 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
 warrants exercisable to purchase 54,167 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 54,167
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 216,667 shares of common stock. Net proceeds from the
 closing were $310,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 January&amp;#xA0;29, 2010, the Company issued and sold, pursuant to the
 10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2 convertible
 into 108,334 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
 warrants exercisable to purchase 54,167 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 54,167
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 216,667 shares of common stock. Net proceeds from the
 closing were $308,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On March&amp;#xA0;8,
 2010, the Company issued and sold, pursuant to the 10X Agreement:
 (i)&amp;#xA0;167,500 shares of Series B-2 convertible into 111,667
 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants
 exercisable to purchase 55,834 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 55,834
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 223,334 shares of common stock. Net proceeds from the
 closing were $322,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 April&amp;#xA0;30, 2010, the Company issued and sold, pursuant to the
 10X Agreement: (i)&amp;#xA0;155,000 shares of Series B-2 convertible
 into 103,334 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
 warrants exercisable to purchase 51,667 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 51,667
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 206,667 shares of common stock. Net proceeds from the
 closing were $297,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On May&amp;#xA0;10,
 2010, the Company issued and sold, pursuant to the 10X Agreement:
 (i)&amp;#xA0;285,000 shares of Series B-2 convertible into 190,000
 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants
 exercisable to purchase 95,000 shares of common stock;
 (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 95,000
 shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
 to purchase 380,000 shares of common stock. Net proceeds from the
 closing were $536,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The terms of the
 Series B are as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Dividends&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Holders of the Series
 B will be entitled to receive cumulative dividends at the rate of
 12%&amp;#xA0;per share per annum (compounding monthly) payable
 quarterly which may, at the Company&amp;#x2019;s option, be paid in cash
 or common stock. Pursuant to an agreement with the holder of all
 shares of Series B, on January&amp;#xA0;26, 2011, the Company amended
 and restated the Certificate of Designation of Preferences, Rights
 and Limitations for the Series B-1 and Series B-2, to provide that
 dividends are payable in cash or shares of Common Stock valued at
 100% of the volume weighted average price of the Common Stock for
 the 20 consecutive trading days prior to the dividend payment date
 on and after September&amp;#xA0;30, 2011. If the Company does not pay
 any dividend on the Series B, dividends will accrue at the rate of
 15%&amp;#xA0;per annum (compounding monthly).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Conversion
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each share of Series B is
 convertible into two-thirds (approximately 0.667) shares of common
 stock at the conversion price of $3.00 per share at the option of
 (i)&amp;#xA0;the holder, at any time and (ii)&amp;#xA0;the Company, at any
 time after February&amp;#xA0;12, 2010 (and upon 10 days notice) if the
 common stock is quoted at or above $9.00 for 15 consecutive trading
 days and an effective registration statement regarding the
 underlying shares of common stock is in effect (subject to certain
 monthly volume limits). Pursuant to an agreement with the holder of
 all shares of Series B, on January&amp;#xA0;26, 2011, the Company
 amended and restated the Certificate of Designation of Preferences,
 Rights and Limitations for the Series B-1 and Series B-2, to remove
 the Company&amp;#x2019;s right to compel conversion of the Series B
 Preferred Stock to shares of its Common Stock&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Redemption
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Pursuant to an agreement with
 the holder of all shares of Series B, on January&amp;#xA0;26, 2011, the
 Company amended and restated the Certificate of Designation of
 Preferences, Rights and Limitations for the Series B-1 and Series
 B-2, to provide that, upon notice of not less than 30 trading days,
 a holder of Series B may require the Company to redeem, in whole or
 in part at any time on or after the earlier of
 (a)&amp;#xA0;February&amp;#xA0;12, 2019 or (b)&amp;#xA0;the date of issuance of
 a promissory note to David Platt (see Note 11) in connection with
 the achievement of certain milestones under his separation
 agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The redemption
 price will be equal to the sum of the stated value of the Series B,
 plus all accrued but unpaid dividends thereon, as of the redemption
 date. If the Company fails to pay the redemption price in cash on
 the redemption date, then the holders of the Series B requesting
 redemption may, at their sole option, automatically convert their
 shares of Series B into a promissory note bearing interest at the
 rate of 15%&amp;#xA0;per year and secured by a lien on all of the
 Company&amp;#x2019;s assets. So long as any shares of the Series B
 remain outstanding, the Company is also subject to restrictions
 limiting, among other things, amendments to the Company&amp;#x2019;s
 organizational documents; the purchase or redemption of the
 Company&amp;#x2019;s capital stock; mergers, consolidations,
 liquidations and dissolutions; sales of assets; dividends and other
 restricted payments; investments and acquisitions; joint ventures,
 licensing agreements, exclusive marketing and other distribution
 agreements; issuances of securities; incurrence of indebtedness;
 incurrence of liens and other encumbrances and issuances of any
 common stock equivalents.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Liquidation
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In the event of any liquidation,
 dissolution or winding up of the Company, either voluntarily or
 involuntarily, the holders of Series B will receive $2 per share
 plus accrued and unpaid dividends, payable prior and in preference
 to any distributions to the holders of Common Stock but &lt;i&gt;pari
 passu&lt;/i&gt; with the holders of the Series A 12% Convertible
 Preferred Stock.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Voting
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Except as noted below, the
 holder of each share of Series B shall be entitled to the number of
 votes equal to the number of shares of Common Stock into which such
 share of Series B would be convertible, and shall otherwise have
 voting rights and powers equal to the voting rights and powers of
 the Common Stock. With respect to the election of directors, the
 holders of the Series B shall vote together as a separate class to
 elect two (2)&amp;#xA0;members of the Board of Directors (the
 &amp;#x201C;Series B Directors&amp;#x201D;), and the Company shall take all
 reasonably necessary or desirable actions within its control
 (including, without limitation, calling special meetings of the
 Board of Directors, nominating such persons designated by the
 holders of the Series B as directors on the applicable proxy
 statements and recommending their election) to permit the holders
 of the Series B to appoint two additional (2)&amp;#xA0;members of the
 Board of Directors (the &amp;#x201C;Series B Nominees&amp;#x201D;), who shall
 be subject to election by all shares of voting stock of the Company
 voting together as a single group, until such time as all
 authorized shares of Series B have has been issued and sold, after
 which the number of Series B Nominees shall be three (3), and shall
 remain three (3)&amp;#xA0;until there are no longer any shares of
 Series B outstanding. The holders of Series B shall vote together
 with the holders of Common Stock and other voting capital stock of
 the Company to elect all other members of the Board of
 Directors.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Other
 Restrictions&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;So long as any shares of
 the Series B remain outstanding, the Company may not, without the
 approval of the holders of a majority of the shares of Series B
 outstanding, among other things, (i)&amp;#xA0;change the size of the
 Company&amp;#x2019;s Board of Directors; (ii)&amp;#xA0;amend or repeal the
 Company&amp;#x2019;s Articles of Incorporation or Bylaws or file any
 articles of amendment designating the preferences, limitations and
 relative rights of any series of preferred stock; (iii)&amp;#xA0;create
 or increase the authorized amount of any additional class or series
 of shares of stock that is equal to or senior to Series B;
 (iv)&amp;#xA0;increase or decrease the authorized number of shares of
 the Series B; (v)&amp;#xA0;purchase, redeem or otherwise acquire for
 value any shares of any class of capital stock; (vi)&amp;#xA0;merge or
 consolidate the Company into or with any other corporation or sell,
 assign, lease, pledge, encumber or otherwise dispose of all or
 substantially all of the Company&amp;#x2019;s assets or those of any
 subsidiary; (vii)&amp;#xA0;voluntarily or involuntarily liquidate,
 dissolve or wind up the Company or the Company&amp;#x2019;s business;
 (viii)&amp;#xA0;pay or declare dividends on any capital stock other
 than the Preferred Stock, unless the Series B share ratably in such
 dividend and all accrued dividends payable with respect to the
 Series B have been paid prior to the payment or declaration of such
 dividend; (ix)&amp;#xA0;acquire an equitable interest in, or the assets
 or business of any other entity in any form of transaction;
 (x)&amp;#xA0;create or commit us to enter into a joint venture,
 licensing agreement or exclusive marketing or other distribution
 agreement with respect to the Company&amp;#x2019;s products, other than
 in the ordinary course of business; (xi)&amp;#xA0;permit the Company or
 any subsidiary to sell or issue any security of such subsidiary to
 any person or entity other than the Company; (xii)&amp;#xA0;enter into,
 create, incur, assume or guarantee any indebtedness for borrowed
 money of any kind (other than indebtedness existing on the initial
 closing date and approved by Series B shareholders);
 (xiii)&amp;#xA0;enter into, create, incur or assume any liens of any
 kind (other than certain permitted liens); (xiv)&amp;#xA0;issue any
 common stock equivalents; (xv)&amp;#xA0;increase the number of shares
 of the Company&amp;#x2019;s common stock that may be issued pursuant to
 options, warrants or rights to employees, directors, officers,
 consultants or advisors above 250,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each Class&amp;#xA0;A-1
 warrant, Class&amp;#xA0;A-2 warrant and Class B warrant is exercisable
 at $3.00 per share of common stock at any time on or after the date
 of issuance until the fifth anniversary of the respective issue
 date. The Company may, upon 30 days notice and so long as an
 effective registration statement regarding the underlying shares of
 common stock is in effect, issue a termination notice with respect
 to (i)&amp;#xA0;each Class&amp;#xA0;A-1 warrant on any trading day on which
 the market value of the common stock for each of the 15 previous
 trading days exceeded $7.50 per share and (ii)&amp;#xA0;each
 Class&amp;#xA0;A-2 warrant on any trading day on which the market value
 of the common stock for each of the 15 previous trading days
 exceeded $10.50 per share. All Class&amp;#xA0;A-1 warrants were
 exercised for cash proceeds of $3,000,000 in 2011 and 500,000 of
 the Class&amp;#xA0;A-2 warrants were exercised for cash proceeds of
 $1,500,000 in 2013. Subsequently, in January 2014, the remaining
 500,000 Class&amp;#xA0;A-2 warrants were exercised for cash proceeds of
 $1,500,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The fair value
 of the warrants issued in connection with the Series B-1 was
 $1,296,000 at the date of issuance based on the following
 assumptions: an expected life of 5 years, volatility of 118%, risk
 free interest rate of 1.79% and zero dividends. The Company
 allocated the gross proceeds based on the relative fair value of
 the Series B-1 and the related warrants, resulting in $1,105,000 of
 the proceeds being allocated to additional paid-in capital. The
 Company analyzed the Series B-1, post-allocation of the gross
 proceeds, and determined that there was no beneficial conversion
 feature at the date of issuance. The issuance costs of the Series
 B-1 and the amounts allocated to warrants were recorded as a
 reduction to the carrying value of the Series B-1 when issued, and
 are accreted to the redemption value of the Series B-1 through the
 earliest redemption date. Due to the redemption feature, the
 Company has presented the Series B-1 outside of permanent equity,
 in the mezzanine of the consolidated balance sheet at
 December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The fair value
 of the warrants issued during the year ended December&amp;#xA0;31, 2010
 in connection with the Series B-2 was $4,148,000 at the dates of
 issuance based on the following assumptions: an expected life of 5
 years, volatility of 126% to 129%, risk free interest rates of
 2.27% to 2.43% and zero dividends. The fair value of the warrants
 issued during the year ended December&amp;#xA0;31, 2009 in connection
 with the Series B-2 was $5,333,000 at the dates of issuance based
 on the following assumptions: an expected life of 5 years,
 volatility of 124% to 127%, risk free interest rates of 1.98% to
 2.70% and zero dividends. The Company allocated the gross proceeds
 based on the relative fair value of the Series B-2 and the related
 warrants, resulting in $1,028,000 and $1,732,000 of the proceeds
 being allocated to additional paid-in capital for the years ended
 December&amp;#xA0;31, 2010 and 2009, respectively. The issuance costs
 of the Series B-2 and the amounts allocated to warrants were
 recorded as a reduction to the carrying value of the Series B-2
 when issued, and are accreted to the redemption value of the Series
 B-2 through the earliest redemption dates. Due to the redemption
 feature, the Company has presented the Series B-2 outside of
 permanent equity, in the mezzanine of the consolidated balance
 sheet at December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 analyzed the Series B-2, post-allocation of the gross proceeds, and
 determined that there was a beneficial conversion feature at the
 dates of issuance. Because the closing price of the common stock on
 the closing date was greater than the effective conversion price,
 $388,000 and $628,000 of the proceeds (limited to the allocation of
 the proceeds) during the years ended December&amp;#xA0;31, 2010 and
 2009, respectively, were allocated to an embedded beneficial
 conversion feature of the Series&amp;#xA0;B-2. The amount allocated to
 the beneficial conversion feature was recorded as a discount to the
 Series B-2 is being accreted, with such accretion being charged
 through the earliest redemption dates.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:1px;margin-top:18px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series C
 6% Super Dividend Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 December&amp;#xA0;29, 2010, the Company designated and authorized the
 sale and issuance of up to 1,000 shares of Series C Super Dividend
 Convertible Preferred Stock (&amp;#x201C;Series C&amp;#x201D;) with a par
 value of $0.01 and a stated value equal to $10,000 (the
 &amp;#x201C;Stated Value&amp;#x201D;).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 December&amp;#xA0;30, 2010, the Company sold and issued 212 shares of
 Series C at a price of $10,000 per share for gross proceeds of
 $2,120,000. The Company incurred $47,000 of cash transaction costs
 resulting in net cash proceeds of $2,073,000. In addition, the
 Company issued 500 warrants exercisable at $7.20 to a placement
 agent which had a de minimis value. Additionally, in January 2011,
 the Company sold and issued 13 shares of Series C at a price of
 $10,000 per share for gross proceeds of $130,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The terms of the
 Series C are as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Conversion
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each holder of Series C may
 convert all, but not less than all, of his Series C shares plus
 accrued and unpaid dividends into Common Stock at the price of
 $6.00 per share of Common Stock (&amp;#x201C;Conversion Price&amp;#x201D;),
 such that approximately 1,667 shares of Common Stock will be issued
 per each converted share of Series C (accrued and unpaid dividends
 will be issued as additional shares). At December&amp;#xA0;31, 2013,
 the 196 outstanding shares of Series C were convertible into a
 total of approximately 326,667 shares of Common Stock.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Subject to the
 continuing obligation to pay post conversion dividends, the Company
 may convert all, but not less than all, of the Series C (plus all
 accrued and unpaid dividends) into Common Stock, at the Conversion
 Price, upon such time that the closing price of the Common Stock is
 no less than $18.00 per share for 15 consecutive trading
 days.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%;padding-bottom:0px;"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Dividends&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Holders of Series C
 shall be entitled to receive cumulative non-compounding dividends
 at the rate per share of Series C equal to the greater of
 (i)&amp;#xA0;6%&amp;#xA0;per annum of the Stated Value (also defined as the
 &amp;#x201C;Floor&amp;#x201D;) or (ii)&amp;#xA0;2.5% of net sales until the total
 dividends paid is equal to the initial investment and 1.25% of net
 sales thereafter. The maximum amount each Series C shareholder will
 receive in dividend payments is equal to $100,000 (the
 &amp;#x201C;Maximum Payout&amp;#x201D;).&amp;#xA0;For purposes of this dividend
 calculation, net sales shall mean gross revenues actually received
 by the Company, from the sale or licensing of the product
 DAVANAT&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;sup style="vertical-align:baseline; position:relative; bottom:.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;
 (GM-CT-01), less chargebacks, returns, expenses attributable to
 product recalls, duties, customs, sales tax, freight, insurance,
 shipping expenses, allowances and other customary
 deductions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The dividend
 shall be payable in arrears semiannually on March&amp;#xA0;31 and
 September&amp;#xA0;30, beginning with the first such date after the
 original issue date; provided, however, that all dividends and all
 other distributions shall cease, and no further dividends or other
 distributions shall be paid, in respect of each share of Series C
 from and after such time that the Maximum Payout has been paid in
 respect of such share of Series C. Such dividends shall be payable
 at the Company&amp;#x2019;s option either in cash or in duly authorized,
 fully paid and non-assessable shares of Common Stock valued at the
 higher of (i)&amp;#xA0;$3.00 per share or (ii)&amp;#xA0;the average of the
 Common Stock trading price for the ten (10)&amp;#xA0;consecutive
 trading days ending on the trading day that is immediately prior to
 the dividend payment date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Series C Post
 Conversion Dividend Right&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In the event
 that any share of Series C is converted into Common Stock before
 the Maximum Payout is paid in respect of such converted share of
 Series C, then the holder shall have the right to continue to
 receive dividends in respect of such converted share of Series C
 equal to the remaining payout (the &amp;#x201C;Series C Preferred Stock
 Post Conversion Dividend Right&amp;#x201D;) which shall be equal to the
 Maximum Payout less the cumulative dividends received through the
 conversion date. One share of Series C Preferred Stock Post
 Conversion Dividend Right shall be issued for each such converted
 share of Series C. The holder of each Series C Preferred Stock Post
 Conversion Dividend Right shall receive the remaining payout on an
 equal basis and in conjunction with the then outstanding shares of
 Series C and all the other then outstanding Series C Post
 Conversion Dividend Rights, in the same manner and subject to the
 same terms and conditions as applicable to the payment of dividends
 on each share of Series C, except that for purposes of calculating
 the dividend the Floor shall not apply. The Series C Preferred
 Stock Post Conversion Dividend Right shall have no stated value,
 liquidation preference or right to any dividends or distributions
 other than the remaining payout. The Series C Preferred Stock Post
 Conversion Right is subject to redemption in the same manner as
 outstanding Series C shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;At the date of
 issuance, the Series C have an embedded dividend right to continue
 to receive dividend payments after conversion to common stock (the
 Series C Post Conversion Dividend Right) which requires
 bifurcation. The value of this post conversion dividend right on
 the date of issuance was determined to be de minimis due to the
 fact that the payment of a dividend stream other than the 6%
 dividend and conversion of Series C prior to the Company achieving
 sales of GM-CT-01 was deemed improbable at that time. Upon a
 conversion of the Series C, the Company will be required to record
 a liability and the related expense during the period of
 conversion.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In July 2011, 5
 shares of Series C were converted into 8,334 shares of common stock
 and 5 Series C Post Conversion Dividend Rights (Dividend Rights)
 were issued. In 2013, 24 shares of Series C were converted into
 40,193 shares of common stock and 24 Dividend Rights were issued.
 Per the terms of the Series C, these Dividend Rights shall continue
 to participate in dividends, however the Floor shall not apply. At
 December&amp;#xA0;31, 2013 and 2012, these Dividend Rights were
 determined to have a de minimis value, as the payment of a dividend
 is considered improbable at this time. The Company will continue to
 evaluate and assess the Series C Post Conversion Dividend Right for
 each reporting period.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Liquidation
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In the event of any liquidation,
 dissolution or winding up of the Company, either voluntarily or
 involuntarily, the holders of Series C will receive $10,000 per
 share plus accrued and unpaid dividends, payable prior and in
 preference to any distributions to the holders of Common Stock but
 after and subordinate to the Series A 12% Convertible Preferred
 Stock (&amp;#x201C;Series A&amp;#x201D;), Series B-1 and Series B-2, subject
 to the Maximum Payout.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Redemption&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Upon a sale of the
 Company, the Company shall redeem all of the then outstanding
 shares of Series C and Series C Preferred Stock Post Conversion
 Rights within thirty (30)&amp;#xA0;days after the transaction
 constituting the sale of the Company is closed and such closing is
 fully funded. The price to redeem a share of Series C and each
 redeemed Series C Preferred Stock Post Conversion Redemption Right
 shall be equal to (i)&amp;#xA0;(A)&amp;#xA0;the applicable return on
 investment (&amp;#x201C;ROI&amp;#x201D;) percentage, multiplied by
 (B)&amp;#xA0;$10,000, minus (ii)&amp;#xA0;the cumulative dividends received
 through the redemption date. The redemption price shall be payable
 at the Company&amp;#x2019;s option either in cash or in shares of common
 stock valued at the higher of (i)&amp;#xA0;$3.00 per share or
 (ii)&amp;#xA0;the average market price for the ten consecutive trading
 days ending immediately prior to the date of redemption. The ROI
 Percentage shall mean the percentage that applies as of the
 redemption date, as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="15%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;u&gt;ROI&amp;#xA0;Percentage&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="2"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;200%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;before the second anniversary of the date of
 issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;250%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the second anniversary of the date of issuance, but
 before the third anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;300%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the third anniversary of the date of issuance, but
 before the fourth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;350%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the fourth anniversary of the date of issuance, but
 before the fifth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;400%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the fifth anniversary of the date of issuance, but
 before the sixth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;450%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the sixth anniversary of the date of issuance, but
 before the seventh anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;500%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the seventh anniversary of the date of issuance,
 but before the eighth anniversary of the date of issuance;
 and&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;550%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the eighth anniversary of the date of issuance, but
 before the ninth anniversary of the date of issuance.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Due to the
 redemption feature, the Company has presented the Series C outside
 of permanent equity, in the mezzanine of the consolidated balance
 sheets at December&amp;#xA0;31, 2013 and 2012. At December&amp;#xA0;31,
 2013, the Series C redemption value was $5,547,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Voting
 Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Series C shares have no
 voting rights.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_1_0">3.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_A745F4CA-6763-42F9-8F9B-09A477D16B71_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Property and equipment,
 including leasehold improvements, are stated at cost, net of
 accumulated depreciation and amortization, and are depreciated or
 amortized using the straight-line method over the estimated useful
 lives of the related assets of generally three years for computers
 and office equipment, five years for furniture and fixtures and the
 shorter of the useful life or life of the lease for leasehold
 improvements.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_4142217_070E5F90-1FA1-4B44-B891-BB440C65E82A_1_2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_B1ADFF76-7AA4-4EE6-A2F7-AC63D0F7EFAD_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Cash and Cash
 Equivalents.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company considers all
 highly-liquid investments with original maturities of 90 days or
 less at the time of acquisition to be cash equivalents.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_14">-7484000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_89B54505-4B89-467F-A9A1-93F1F1BE4ABB_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Intangible
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Intangible assets include patent
 costs, consisting primarily of related capitalized legal fees,
 which are amortized over an estimated useful life of five years
 from issuance. Amortization expense in 2013 and 2012 was $7,000 and
 $6,000, respectively. Gross intangible assets at December&amp;#xA0;31,
 2013 and 2012 totaled $78,000 each year, and accumulated
 amortization at December&amp;#xA0;31, 2013 and 2012 totaled $55,000 and
 $48,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_9EA818DD-AFF4-4130-905F-28517905C8F4_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Loss Per
 Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic net loss
 per common share is computed by dividing the net loss available to
 common stockholders by the weighted average number of common shares
 outstanding during the period. Diluted net loss per common share is
 computed by dividing the net loss available to common stockholders
 by the weighted average number of common shares and other potential
 common shares then outstanding. Potential common shares consist of
 common shares issuable upon the assumed exercise of in-the-money
 stock options and warrants and potential common shares related to
 the conversion of the preferred stock. The computation of diluted
 net loss per share does not assume the issuance of common shares
 that have an anti-dilutive effect on net loss per share.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands,&amp;#xA0;except&amp;#xA0;share&lt;br /&gt;
 and per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2013&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;br /&gt;
 
 &amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2012&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,088&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(9,675&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
 dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(867&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(976&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
 accretion&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrant
 modification&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(8,763&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(21,947&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,881&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
 per share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.72&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares used in computing
 basic and diluted net loss per share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,874&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dilutive shares
 which could exist pursuant to the exercise of outstanding stock
 instruments and which were not included in the calculation because
 their affect would have been anti-dilutive are as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="74%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year
 Ended&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants to purchase shares
 of common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Options to purchase shares
 of common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares of common stock
 issuable upon conversion preferred stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,568,771&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,952,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,591,312&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1_0">213008</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_1131AE2A-0D23-4183-85E5-D6F5C0CE63EF_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Concentration
 of Credit Risk.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Financial instruments
 that subject the Company to credit risk consist of cash and cash
 equivalents and certificates of deposit. The Company maintains cash
 and cash equivalents and certificates of deposit with
 well-capitalized financial institutions. At times, those amounts
 may exceed federally insured limits. The Company has no significant
 concentrations of credit risk.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_3251CDF0-951B-4AE3-B066-3363FF56AFB0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The primary
 factors affecting the Company&amp;#x2019;s income tax rates were as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax benefit at U.S.
 statutory rates&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax
 benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Credit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent
 differences&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expiring state
 NOL&amp;#x2019;s&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Changes in valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_E40ECC5C-AE70-46AD-9A07-3A49945B9D4F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Stock-based compensation
 cost is measured at the grant date based on the fair value of the
 award and is recognized as expense over the service period, which
 generally represents the vesting period. For awards that have
 performance based vesting conditions the Company recognizes the
 expense over the estimated period that the awards are expected to
 be earned. The Company generally uses the Black-Scholes
 option-pricing model to calculate the grant date fair value of
 stock options. For options that only vest upon the achievement of
 market conditions, the Company values the options using a Monte
 Carlo model to calculate the grant date fair value of the stock
 options. The expense related to options that vest based on market
 conditions is not reversed should those options not ultimately
 vest. The expense recognized over the service period is required to
 include an estimate of the awards that will be forfeited. Stock
 options issued to non-employees are accounted for in accordance
 with the provisions of ASC Subtopic 505-50, &lt;i&gt;Equity-Based
 Payments to Non-employees&lt;/i&gt;, which requires valuing the stock
 options using an option pricing model (the Company uses
 Black-Scholes) and measuring such stock options to their current
 fair value when they vest.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_1">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_AA8BF5F3-BF7D-437E-9DCE-5A1DBBB96C7C_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Summary of Significant
 Accounting Policies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 accompanying consolidated financial statements have been prepared
 in conformity with accounting principles generally accepted in the
 United States (&amp;#x201C;GAAP&amp;#x201D;).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
 Consolidation.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The consolidated
 financial statements include the accounts of the Company and
 Galectin Therapeutics Security Corp., its wholly-owned subsidiary,
 which was incorporated in Delaware on December&amp;#xA0;23, 2003.
 Galectin Therapeutics Security Corp. holds the cash and cash
 equivalents that are not required to fund current operating needs.
 All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Use of
 Estimates.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America requires management to
 make estimates and judgments that may affect the reported amounts
 of assets, liabilities, equity, revenue, expenses and related
 disclosure of contingent assets and liabilities. Management&amp;#x2019;s
 estimates and judgments include assumptions used in stock option
 and warrant liability valuations, useful lives of property and
 equipment and intangible assets, accrued liabilities, deferred
 income taxes and various other assumptions that are believed to be
 reasonable under the circumstances. Actual results may differ from
 those estimates under different assumptions or
 conditions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 Measurements&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has certain
 financial assets and liabilities recorded at fair value. Fair
 values determined by Level 1 inputs utilize observable data such as
 quoted prices in active markets. Fair values determined by Level 2
 inputs utilize data points other than quoted prices in active
 markets that are observable either directly or indirectly. Fair
 values determined by Level 3 inputs utilize unobservable data
 points in which there is little or no market data, which require
 the reporting entity to develop its own assumptions. The estimated
 value of accounts payable and accrued expenses approximates their
 carrying value due to their short-term nature using level 3 inputs
 as defined above. Included in cash and cash equivalents, as of
 December&amp;#xA0;31, 2013 and 2012, the Company had $0 and $583,000,
 respectively, invested in money market funds which had calculated
 net asset values and were therefore classified as
 Level&amp;#xA0;2.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company considers
 all highly-liquid investments with original maturities of 90 days
 or less at the time of acquisition to be cash
 equivalents.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
 Expenses and Other Current
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Prepaid expenses and other
 assets consist principally of prepaid insurance and prepaid rent on
 the Company&amp;#x2019;s leased executive office space.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Property and equipment,
 including leasehold improvements, are stated at cost, net of
 accumulated depreciation and amortization, and are depreciated or
 amortized using the straight-line method over the estimated useful
 lives of the related assets of generally three years for computers
 and office equipment, five years for furniture and fixtures and the
 shorter of the useful life or life of the lease for leasehold
 improvements.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Restricted
 Cash and Security Deposit.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;At
 December&amp;#xA0;31, 2013 and 2012, the Company had a security deposit
 of $6,000 for leased office space. The security deposit was
 included in Prepaid Expenses and Other Current Assets at
 December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Intangible
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Intangible assets include patent
 costs, consisting primarily of related capitalized legal fees,
 which are amortized over an estimated useful life of five years
 from issuance. Amortization expense in 2013 and 2012 was $7,000 and
 $6,000, respectively. Gross intangible assets at December&amp;#xA0;31,
 2013 and 2012 totaled $78,000 each year, and accumulated
 amortization at December&amp;#xA0;31, 2013 and 2012 totaled $55,000 and
 $48,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Long-Lived
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company reviews all
 long-lived assets for impairment whenever events or circumstances
 indicate the carrying amount of such assets may not be recoverable.
 Recoverability of assets to be held or used is measured by
 comparison of the carrying value of the asset to the future
 undiscounted net cash flows expected to be generated by the asset.
 If such asset is considered to be impaired, the impairment
 recognized is measured by the amount by which the carrying value of
 the asset exceeds the discounted future cash flows expected to be
 generated by the asset.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Accrued
 Expenses&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;As part of the process of
 preparing our consolidated financial statements, we are required to
 estimate accrued expenses. This process involves identifying
 services that third parties have performed on our behalf and
 estimating the level of service performed and the associated cost
 incurred on these services as of each balance sheet date in our
 consolidated financial statements. Examples of estimated accrued
 expenses include contract service fees in conjunction with
 pre-clinical and clinical trials, professional service fees, such
 as those arising from the services of attorneys and accountants and
 accrued payroll expenses. In connection with these service fees,
 our estimates are most affected by our understanding of the status
 and timing of services provided relative to the actual services
 incurred by the service providers. In the event that we do not
 identify certain costs that have been incurred or we under- or
 over-estimate the level of services or costs of such services, our
 reported expenses for a reporting period could be understated or
 overstated. The date on which certain services commence, the level
 of services performed on or before a given date, and the cost of
 services are often subject to our judgment. We make these judgments
 based upon the facts and circumstances known to us in accordance
 with accounting principles generally accepted in the
 U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has issued
 common stock warrants in connection with the execution of certain
 equity and debt financings. Certain warrants were accounted for as
 derivative liabilities at fair value. Such warrants did not meet
 the accounting criteria that a contract should not be considered a
 derivative instrument if it is (1)&amp;#xA0;indexed to its own stock
 and (2)&amp;#xA0;classified in stockholders&amp;#x2019; equity. Changes in
 fair value of derivative liabilities are recorded in the
 consolidated statement of operations under the caption
 &amp;#x201C;Change in fair value of warrant liabilities.&amp;#x201D; Warrants
 that are not considered derivative liabilities are accounted for at
 fair value at the date of issuance in additional paid-in capital.
 The fair value of warrants was determined using the Black-Scholes
 option-pricing model using assumptions regarding volatility of our
 common share price, remaining life of the warrant, and risk-free
 interest rates at each period end. There were no warrant
 liabilities as of December&amp;#xA0;31, 2013 or 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Revenue
 Recognition&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company records revenue
 provided that there is persuasive evidence that an arrangement
 exists, the price is fixed and determinable, services were rendered
 and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Research and
 Development Expenses.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Costs associated
 with research and development are expensed as incurred. Research
 and development expenses include, among other costs, salaries and
 other personnel-related costs, and costs incurred by outside
 laboratories and other accredited facilities in connection with
 clinical trials and preclinical studies.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company accounts for income
 taxes in accordance with the accounting rules that requires an
 asset and liability approach to accounting for income taxes based
 upon the future expected values of the related assets and
 liabilities. Deferred income tax assets and liabilities are
 determined based on the differences between the financial reporting
 and tax bases of assets and liabilities and for tax loss and credit
 carry forwards, and are measured using the expected tax rates
 estimated to be in effect when such basis differences reverse.
 Valuation allowances are established, if necessary, to reduce the
 deferred tax asset to the amount that will, more likely than not,
 be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Income
 (Loss).&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Comprehensive income (loss) is
 defined as the change in equity of a business enterprise during a
 period from transactions and other events and circumstances from
 non-owner sources. The Company does not have any items of
 comprehensive income (loss) other than net losses as
 reported.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit
 Risk.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Financial instruments that subject
 the Company to credit risk consist of cash and cash equivalents and
 certificates of deposit. The Company maintains cash and cash
 equivalents and certificates of deposit with well-capitalized
 financial institutions. At times, those amounts may exceed
 federally insured limits. The Company has no significant
 concentrations of credit risk.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Stock-based compensation
 cost is measured at the grant date based on the fair value of the
 award and is recognized as expense over the service period, which
 generally represents the vesting period. For awards that have
 performance based vesting conditions the Company recognizes the
 expense over the estimated period that the awards are expected to
 be earned. The Company generally uses the Black-Scholes
 option-pricing model to calculate the grant date fair value of
 stock options. For options that only vest upon the achievement of
 market conditions, the Company values the options using a Monte
 Carlo model to calculate the grant date fair value of the stock
 options. The expense related to options that vest based on market
 conditions is not reversed should those options not ultimately
 vest. The expense recognized over the service period is required to
 include an estimate of the awards that will be forfeited. Stock
 options issued to non-employees are accounted for in accordance
 with the provisions of ASC Subtopic 505-50, &lt;i&gt;Equity-Based
 Payments to Non-employees&lt;/i&gt;, which requires valuing the stock
 options using an option pricing model (the Company uses
 Black-Scholes) and measuring such stock options to their current
 fair value when they vest.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_EE68DAD1-D43D-4AC6-B970-228F59292755_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The components
 of the net deferred tax assets are as follows at
 December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,881&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,753&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax credit
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;400&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other temporary
 differences&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,302&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,921&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(24,991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:DerivativesPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_1C8A8BBA-3F59-41C3-B470-A5FBECADFDC5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has issued
 common stock warrants in connection with the execution of certain
 equity and debt financings. Certain warrants were accounted for as
 derivative liabilities at fair value. Such warrants did not meet
 the accounting criteria that a contract should not be considered a
 derivative instrument if it is (1)&amp;#xA0;indexed to its own stock
 and (2)&amp;#xA0;classified in stockholders&amp;#x2019; equity. Changes in
 fair value of derivative liabilities are recorded in the
 consolidated statement of operations under the caption
 &amp;#x201C;Change in fair value of warrant liabilities.&amp;#x201D; Warrants
 that are not considered derivative liabilities are accounted for at
 fair value at the date of issuance in additional paid-in capital.
 The fair value of warrants was determined using the Black-Scholes
 option-pricing model using assumptions regarding volatility of our
 common share price, remaining life of the warrant, and risk-free
 interest rates at each period end. There were no warrant
 liabilities as of December&amp;#xA0;31, 2013 or 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_7001_8">403674</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_1_3">11952705</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_4A0CE978-58D9-4DAB-82F5-90CA92A27B26_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Long-Lived
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company reviews all
 long-lived assets for impairment whenever events or circumstances
 indicate the carrying amount of such assets may not be recoverable.
 Recoverability of assets to be held or used is measured by
 comparison of the carrying value of the asset to the future
 undiscounted net cash flows expected to be generated by the asset.
 If such asset is considered to be impaired, the impairment
 recognized is measured by the amount by which the carrying value of
 the asset exceeds the discounted future cash flows expected to be
 generated by the asset.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_A514B9DB-8019-4DD0-866C-7801941D2C43_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Following is
 the stock-based compensation expense related to common stock
 options, restricted common stock and common stock
 warrants:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;922&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,798&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,870&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total stock-based
 compensation expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,789&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,792&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_754BCB20-201A-4D08-907F-95ABD7089D8E_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Use of
 Estimates.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America requires management to
 make estimates and judgments that may affect the reported amounts
 of assets, liabilities, equity, revenue, expenses and related
 disclosure of contingent assets and liabilities. Management&amp;#x2019;s
 estimates and judgments include assumptions used in stock option
 and warrant liability valuations, useful lives of property and
 equipment and intangible assets, accrued liabilities, deferred
 income taxes and various other assumptions that are believed to be
 reasonable under the circumstances. Actual results may differ from
 those estimates under different assumptions or
 conditions.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_CE74CC31-C748-4366-8206-908865E3CFA8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
 of the options granted is determined using the Black-Scholes
 option-pricing model. The following weighted average assumptions
 were used:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="57%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Cumulative&lt;br /&gt;
 Period&amp;#xA0;from&lt;br /&gt;
 Inception&lt;br /&gt;
 (July&amp;#xA0;10,&amp;#xA0;2000)&amp;#xA0;to&lt;br /&gt;
 December&amp;#xA0; 31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.68&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected life of the
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.29&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.81&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.19&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of the
 underlying stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;115&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;116&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;119&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected dividend
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_17">-1.30</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_7001_9">2.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_7001_7">425426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_663E22B2-D1CB-45F3-9D6E-8A6952DAF725_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr&gt;
 &lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Subsequent
 Events&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 evaluated all events and transactions occurring after December 31,
 2013 through the date of which the financial statements were issued
 for recognition or disclosure and noted the following:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In January 2014,
 we created Galectin Sciences, LLC, a collaborative joint venture
 co-owned by SBH Sciences, to research and develop small organic
 molecule inhibitors of galectin-3 for oral administration. Galectin
 Sciences, LLC was initially capitalized with a $400,000 cash
 investment to fund future research and development activities,
 which was provided by the Company, and specific in-process research
 and development provided by SBH Sciences.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1_4">81591</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_1_3">P4Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_2">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_87FB0292-BCA2-4F84-9F20-87A02215C617_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Income
 Taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The components
 of the net deferred tax assets are as follows at
 December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,881&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,753&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax credit
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;400&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other temporary
 differences&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,302&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,921&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;30,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30,583&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(24,991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 asset&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The primary
 factors affecting the Company&amp;#x2019;s income tax rates were as
 follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax benefit at U.S.
 statutory rates&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax
 benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Credit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.2&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent
 differences&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expiring state
 NOL&amp;#x2019;s&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Changes in valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2013, the Company has federal and state net
 operating loss carryforwards totaling $69,888,000 and $29,881,000
 respectively, which expire through 2032. The net operating losses
 include Federal and State excess benefits related to stock options
 of $707,000 that will be charged to additional paid-in capital when
 utilized. In addition, the Company has federal and state research
 and development credits of $284,000 and $176,000, respectively,
 which expire through 2032. Ownership changes, as defined by
 Section&amp;#xA0;382 of the Internal Revenue Code, may have limited the
 amount of net operating loss carryforwards that can be utilized
 annually to offset future taxable income. Subsequent ownership
 changes could further affect the limitation in future years.
 Because of the Company&amp;#x2019;s limited operating history and its
 recorded losses, management has provided, in each of the last two
 years, a 100% valuation allowance against the Company&amp;#x2019;s net
 deferred tax assets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company is
 subject to taxation in the U.S. and various states. Based on the
 history of net operating losses all jurisdictions and tax years are
 open for examination until the operating losses are utilized or the
 statute of limitations expires. As of December&amp;#xA0;31, 2013 and
 2012, the Company does not have any significant uncertain tax
 positions.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_D1478B30-3AE0-4448-ABF1-FBFE51B14B47_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Research and
 Development Expenses.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Costs associated
 with research and development are expensed as incurred. Research
 and development expenses include, among other costs, salaries and
 other personnel-related costs, and costs incurred by outside
 laboratories and other accredited facilities in connection with
 clinical trials and preclinical studies.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_BB33C8D0-8EB3-43BB-A768-AEB298B16D6D_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
 payments under this lease as of December&amp;#xA0;31, 2013 are as
 follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="93%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 88pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6753D256-702D-4DC9-B282-DF5C59969D9B_2001_3">P6Y2M5D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_66AED34F-FB15-47B4-9B89-9768A5155C9E_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stock-Based
 Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Summary
 of Stock-Based Compensation Plans&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2013, the Company had three stock-based
 compensation plans where the Company&amp;#x2019;s common stock has been
 made available for equity-based incentive grants as part of the
 Company&amp;#x2019;s compensation programs (the &amp;#x201C;Incentive
 Plans&amp;#x201D;) as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2001 Stock
 Incentive Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In October 2001, the
 Company&amp;#x2019;s Board of Directors adopted the Pro-Pharmaceuticals,
 Inc. 2001 Stock Incentive Plan (the &amp;#x201C;Incentive Plan&amp;#x201D;),
 which permits awards of incentive and nonqualified stock options
 and other forms of incentive compensation to employees and
 non-employees such as directors and consultants. Originally, there
 were 833,334 shares of common stock for issuance upon exercise of
 grants made under the Incentive Plan. Options granted under the
 Incentive Plan vest either immediately or over a period of up to
 three years, and expire 3 years to 10 years from the grant date. At
 December&amp;#xA0;31, 2013, there were no shares were available for
 future grant under the Incentive Plan as the terms of the Incentive
 Plan did not allow for grants to be made after 10 years; however,
 there were 194,167 options outstanding under the Incentive
 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2003
 Non-Employee Director Stock Option
 Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In 2003, the stockholders approved
 the Pro-Pharmaceuticals, Inc. 2003 Non-Employee Director Stock
 Option Plan (the &amp;#x201C;Director Plan&amp;#x201D;), which permits awards
 of stock options to non-employee directors. The stockholders
 originally reserved 166,667 shares of common stock for issuance
 upon exercise of grants made under the Director Plan. At
 December&amp;#xA0;31, 2013, there were no shares were available for
 future grant under the Director Plan as the terms of the Director
 Plan did not allow for grants to be made after 10 years; however,
 there were 5,168 options outstanding under the Director
 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2009
 Incentive Compensation Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In February
 2009, the Company adopted the 2009 Incentive Compensation Plan (the
 &amp;#x201C;2009 Plan&amp;#x201D;) which provides for the issuance of up to
 3,333,334 shares of the Company&amp;#x2019;s common stock in the form of
 options, stock appreciation rights, restricted stock and other
 stock-based awards to employees, officers, directors, consultants
 and other eligible persons. At December&amp;#xA0;31, 2013, 709,638
 shares were available for future grant under the 2009
 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In addition,
 the Company has awarded 1,477,379 non-plan stock option grants to
 employees and non-employees. These non-plan grants have vesting
 periods and expiration dates similar to those options granted under
 the Incentive Plans. At December&amp;#xA0;31, 2012, 1,416,669 non-plan
 grants were outstanding.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Following is
 the stock-based compensation expense related to common stock
 options, restricted common stock and common stock
 warrants:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;991&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;922&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,798&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,870&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total stock-based
 compensation expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,789&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,792&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
 of the options granted is determined using the Black-Scholes
 option-pricing model. The following weighted average assumptions
 were used:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="57%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Cumulative&lt;br /&gt;
 Period&amp;#xA0;from&lt;br /&gt;
 Inception&lt;br /&gt;
 (July&amp;#xA0;10,&amp;#xA0;2000)&amp;#xA0;to&lt;br /&gt;
 December&amp;#xA0; 31,&lt;br /&gt;
 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.68&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected life of the
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.29&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.81&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.19&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of the
 underlying stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;115&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;116&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;119&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected dividend
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As noted above,
 the fair value of stock options is determined by using the
 Black-Scholes option pricing model. For all options granted since
 January&amp;#xA0;1, 2006 the Company has generally used option terms of
 between 5 to 10 years, with 5 years representing the estimated life
 of options granted to employees. The volatility of the common stock
 is estimated using historical volatility over a period equal to the
 expected life at the date of grant. The risk-free interest rate
 used in the Black-Scholes option pricing model is determined by
 reference to historical U.S. Treasury constant maturity rates with
 terms equal to the expected terms of the awards. An expected
 dividend yield of zero is used in the option valuation model,
 because the Company does not expect to pay any cash dividends in
 the foreseeable future. At December&amp;#xA0;31, 2013, the Company does
 not anticipate any option awards will be forfeited in the
 calculation of compensation expense due to the limited number of
 employees that receive stock option grants and the Company&amp;#x2019;s
 historical employee turnover.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Of the options
 granted during 2011, 166,668 vest only upon the achievement of
 certain market conditions (83,334 and 83,334 upon the Company
 achieving a market capitalization of $5 billion and $10 billion,
 respectively). These market condition stock option awards were
 valued at $1,006,000 using a Monte Carlo model and will be
 recognized over a weighted average period of 5.5 years. Assumptions
 used to value these options included the following: annualized
 volatility of 110%, annualized drift/risk-free interest rate of
 3.5% and a forecast horizon/life of 10 years.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes the stock option activity in the stock based
 compensation plans:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Remaining&lt;br /&gt;
 Contractual&lt;br /&gt;
 Life&lt;br /&gt;
 (in years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&amp;#xA0;Value&lt;br /&gt;
 (in thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.83&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;800,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.13&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(299,683&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,830&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.31&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;425,426&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.89&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(403,674&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(213,008&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,420&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable,
 December&amp;#xA0;31, 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,084,463&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.43&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,721&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The aggregate
 intrinsic value in the table above represents the total pre-tax
 amount, net of exercise price, which would have been received by
 option holders if all option holders had exercised all options with
 an exercise price lower than the market price on December&amp;#xA0;31,
 2013, based on the closing price of the Company&amp;#x2019;s common
 stock of $8.08 on that date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 weighted-average grant-date fair values of options granted during
 2013 and 2012 were $3.17 and $1.77, respectively. As of
 December&amp;#xA0;31, 2013 and December&amp;#xA0;31, 2012, there were
 unvested options to purchase 1,256,735 and 1,472,051 shares of
 common stock, respectively. Total expected unrecognized
 compensation cost related to such unvested options is $4,522,000 at
 December&amp;#xA0;31, 2013, which is expected to be recognized over a
 weighted-average period of 4.5 years.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
 years ended December&amp;#xA0;31 2013 and 2012, the Company issued
 shares totaling 213,008 and 51,830, respectively, upon the exercise
 of options valued at $378,000 and $96,000, respectively. During the
 years ended December&amp;#xA0;31, 2013 and 2012, the Company received
 $271,000 and $0, respectively, for the exercise of stock options.
 During 2013 and 2012, 173,669 and 90,253 options were exercised on
 a cashless basis resulting in the issuance of 81,591 and 51,830
 shares, respectively. The intrinsic value of options exercised
 during the years ended December&amp;#xA0;31, 2013 and 2012 and from the
 period from inception to December&amp;#xA0;31, 2013 was $1,498,000,
 $162,000 and $3,222,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
 years ended December&amp;#xA0;31, 2013 and 2012, 614,041 and 595,420
 options became vested, respectively. The total grant date fair
 value of options vested during the years ended December&amp;#xA0;31,
 2013, 2012 and the cumulative period from inception to
 December&amp;#xA0;31, 2013 was $2,406,000 $2,447,000 and $15,473,000
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes additional information regarding outstanding and
 exercisable options under our stock based compensation plans at
 December&amp;#xA0;31, 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="45%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Options
 Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Options&amp;#xA0;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1px; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px; WIDTH: 46pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price
 (Range)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number
 of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number
 of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
 years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.72 &amp;#x2013;
 1.83&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;531,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.33&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.60&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;531,839&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.60&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$2.08 &amp;#x2013;
 2.88&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;835,001&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.18&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;496,001&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.38&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$3.59 &amp;#x2013;
 4.41&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;358,294&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.07&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;99,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$5.82 &amp;#x2013;
 7.56&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,551,626&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.11&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;884,958&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$8.10 &amp;#x2013;
 11.40&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;71,945&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.96&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;71,945&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9.36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,348,705&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,084,463&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.43&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Other
 Stock Based Compensation Transactions&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During 2001,
 the Company entered into a consulting agreement with a
 non-employee, who was also a Board member and former member of the
 Audit Committee, pursuant to which the Company granted 33,334
 options to purchase common stock at an exercise price of $21.00 in
 consideration for services to be performed. At the time of
 issuance, these options were valued at $239,000 based on a deemed
 fair market value of the Company&amp;#x2019;s common stock of $13.68 per
 share. Total expense for the years ended December&amp;#xA0;31, 2003,
 2002 and 2001 related to these options was $71,000, $64,000 and
 $147,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2002,
 the Company entered into a second agreement with the same
 non-employee, by which the Company granted 334 options a month to
 purchase common stock at an exercise price of $21.00 in
 consideration for monthly consulting services. On November&amp;#xA0;11,
 2002 such agreement was superseded by an amendment, which was
 effective retroactively to the date of the original agreement,
 March&amp;#xA0;1, 2002. Under the amended agreement, the Company
 granted 4,000 options on March&amp;#xA0;1, 2002, which vest at a rate
 of 334 options per month, as services are performed. These options
 were valued at $11,000 using the Black-Scholes option-pricing
 model, based on a grant date fair value of the Company&amp;#x2019;s
 common stock of $12.96 per share. During 2002, the Company recorded
 a $41,000 charge to stock compensation expense related to the 3,334
 options that vested during the year. As of December&amp;#xA0;31, 2002,
 the Company had deferred compensation of $11,000 that related to
 the remaining unvested options, which was recognized in
 2003.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2003,
 the Company entered into a third agreement with the same
 non-employee, by which the Company granted 4,000 options effective
 retroactively to March&amp;#xA0;1, 2003, which vest at a rate of 334
 options per month as services are performed. These options were
 valued at $33,000 using the Black-Scholes option-pricing model,
 based on a fair market value of the Company&amp;#x2019;s common stock of
 $21.00 per share. The consulting arrangement was concluded on
 March&amp;#xA0;1, 2004. The Company recorded fair value adjustments of
 ($2,000) and $21,000 related to the unvested consultant options
 during 2004 and 2003, respectively. Total expense for the years
 ended December&amp;#xA0;31, 2004 and 2003 related to these options was
 $17,000 and $40,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In January
 2003, the Company granted 16,667 options at an exercise price of
 $21.00 to a Board member for consulting services unrelated to
 services performed as a director. One-third of the options vested
 immediately and the balance vests in equal amounts on the first and
 second anniversaries of the award. The options were valued at
 $156,000 using the Black-Scholes option-pricing model, based on a
 fair market value of the Company&amp;#x2019;s common stock of $16.80 per
 share. The consulting services were completed and the consulting
 arrangement was concluded as of March&amp;#xA0;31, 2004. The Company
 recorded fair value adjustments of $4,000 and $82,000 related to
 the unvested consultant options during 2004 and 2003, respectively.
 Total expense for the years ended December&amp;#xA0;31, 2004 and 2003
 related to these options was $51,000 and $193,000,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2003,
 the Company granted 1,667 options at an exercise price of $21.00 to
 a new member of the Scientific Advisory Board. One-half of the
 options vested immediately and the balance vests on the second
 anniversary. These options were valued at $16,000 using the
 Black-Scholes option-pricing model based on a fair market value of
 the Company&amp;#x2019;s common stock of $16.80 per share. The Company
 recorded fair value adjustments of $2,000 and $6,000 related to the
 unvested consultant options during 2004 and 2003, respectively.
 Total expense for the years ended December&amp;#xA0;31, 2004 and 2003
 related to these options was $5,000 and $13,000,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
 2003, the Company granted 4,167 options each to a Board member and
 to a member of the Scientific Advisory Board for consulting
 services. The options were exercisable immediately at $24.30 per
 share. These options were valued using the Black-Scholes
 option-pricing model based on a grant date fair value of the
 Company&amp;#x2019;s common stock of $14.64 per share. The Company
 recorded a $122,000 charge to stock compensation expense in 2003
 related to these awards.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
 2003, in connection with the resignation of its former Chief
 Financial Officer, the Company accelerated the vesting on 16,667
 options granted to such officer in September 2003 at an exercise
 price of $24.30, which was equal to the fair market value of the
 common stock on the date of grant. As the fair market value of the
 common stock was $26.70 per share at the time the vesting was
 accelerated, the Company recorded a $40,000 charge to stock
 compensation expense. Also, in October 2003, such officer exercised
 on a cashless basis 8,334 options at an exercise price of $17.82
 per share resulting in the issuance of 2,772 shares. As the fair
 market value of the Company&amp;#x2019;s common stock on the date of
 exercise was $26.70 per share, the Company recorded a charge of
 $74,000 to stock compensation expense in 2003 related to the
 exercise of these options.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2004,
 the Company issued 4,167 options in fulfillment of a September 2003
 agreement with an investor relations firm. The agreement obligated
 the Company to pay a monthly retainer and issue options at a rate
 of 834 options per month, up to a maximum of 16,667 options,
 exercisable at $34.80 per share as services are performed. The
 Company concluded the engagement in February 2004. The options were
 exercisable immediately and expired on March&amp;#xA0;26, 2007.
 Accordingly, the Company recorded $29,000 as stock compensation
 expense in 2003 on the 2,500 options that vested as of
 December&amp;#xA0;31, 2003 and an additional stock compensation expense
 of $23,000 in 2004 on the 10,000 options that vested in January and
 February 2004. The stock compensation expense was determined based
 on a fair market value of the options when the options were earned.
 These options expired unexercised in 2007.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2004,
 the Company entered into an agreement with an investor relations
 firm. The agreement obligated the Company to pay a monthly retainer
 and issue options at a rate of 834&amp;#xA0;per month up to a maximum
 of 10,000 options exercisable at $30.96 per share as services are
 performed. During 2004, 7,500 options were earned but not issued.
 During 2005, 2,500 options were earned and the full 10,000 options
 were issued. The Company recorded $67,000 in 2004 and $14,000 in
 2005 as stock compensation expense related to this agreement. The
 stock compensation expense was determined based on the fair market
 value of the options when the options were earned. The options were
 exercisable immediately and expired three years from the agreement
 date. These options expired unexercised in 2007.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In November
 2005, the Company issued 834 options to a member of the Scientific
 Advisory Board for consulting services. The options were
 exercisable immediately at $15.66 per share. These options were
 valued using the Black-Scholes option-pricing model based on a
 grant date fair value of the Company&amp;#x2019;s common stock of $8.10
 per share which was the fair market value at the date of the grant.
 The Company recorded a $7,000 charge to stock compensation expense
 in 2005 related to this award. These options expired unexercised in
 2010.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2006
 the Company issued 2,500 options to a consultant for consulting
 services, of which 834 of the options were exercisable immediately,
 833 options vested in March 2008 and 833 options vested in March
 2009. The options are exercisable at $22.50 per share. These
 options were valued using the Black-Scholes option-pricing model
 based on a grant date fair value of the Company&amp;#x2019;s common
 stock of $13.20 per share which was the fair market value at the
 date of the grant. The Company recorded a $33,000 charge to stock
 compensation expense over the vesting period of the
 options.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In December
 2007, the Company issued 834 options to a consultant for consulting
 services. The options were exercisable immediately at $3.78 per
 share. These options were valued using the Black-Scholes
 option-pricing model based on a grant date fair value of the
 Company&amp;#x2019;s common stock of $2.76 per share which was the fair
 market value at the date of the grant. The Company recorded a
 $2,000 charge to stock compensation expense in 2007 related to this
 award.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2008,
 the Company issued 8,000 options to a consultant for consulting
 services. The options were exercisable immediately at $2.64 per
 share. These options were valued using the Black-Scholes
 option-pricing model based on a grant date fair value of the
 Company&amp;#x2019;s common stock of $2.34 per share which was the fair
 market value at the date of the grant. The Company recorded a
 $15,000 charge to stock compensation expense in 2008 related to
 this award.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In February
 2009, the Company issued 33,334 options to a consultant for
 consulting services. The options were exercisable immediately at $0
 per share. These options were valued using the Black-Scholes
 option-pricing model based on a grant date fair value of the
 Company&amp;#x2019;s common stock of $0.72 per share which was the fair
 market value at the date of the grant. The Company recorded a
 $24,000 charge to stock compensation expense in 2009 related to
 this award.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
 ended December&amp;#xA0;31, 2012, the Company modified the terms of
 certain option grants for four employees to extend the exercisable
 period from ninety days post-employment to the remaining legal life
 of the option grant. During the year ended December&amp;#xA0;31, 2012,
 the Company modified certain cashless exercise terms for one
 employee. The modification of these option terms resulted in
 additional stock-based compensation expense of $271,000 during the
 year ended December&amp;#xA0;31, 2012. During the year ended
 December&amp;#xA0;31, 2011, the Company modified the options of one
 employee to extend the exercisable period post-employment from
 ninety days to the remaining legal life of the option, resulting in
 additional stock-based compensation expense of $63,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2012,
 the Company granted 7,000 shares of common stock to a consultant
 for payment of past services. These shares of common stock were
 valued at $16,000, based on the market value of the shares at the
 date of grant and are included in stock based compensation expense
 for the year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2012,
 the Company granted 4,348 shares of common stock to a consultant
 for payment of services. These shares of common stock were valued
 at $10,000, based on the market value of the shares at the date of
 grant and are included in stock based compensation expense for the
 year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In
 September&amp;#xA0;2013, the Company modified certain vested stock
 options held by a former member of the Company&amp;#x2019;s board of
 directors. The individual left the board on May&amp;#xA0;23, 2013. The
 modification extended the contractual period of exercise of 103,158
 stock options until the end of their original terms instead of such
 options expiring 3 months after service on the board ended. As a
 result, the Company recorded a one-time, non-cash charge of
 $930,000 in general and administrative expenses related to the
 modification in for the year ended December&amp;#xA0;31,
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2013
 the Company issued 25,000 options to a consultant for consulting
 services, which vested in August 2013. The options are exercisable
 at $3.97 per share. These options were valued using the
 Black-Scholes option-pricing model based on a grant date fair value
 of the Company&amp;#x2019;s common stock ranging from $3.97 per share
 upon grant to $7.25 per share at completion of vesting. The Company
 recorded a $173,000 charge to stock compensation expense over the
 vesting period of the options.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Restricted Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
 ended December&amp;#xA0;31, 2009, the Company granted 416,670 shares of
 restricted common stock to members of its Board of Directors. These
 shares were restricted and any unvested shares were subject to
 forfeiture upon termination and would revert back to the Company.
 Of the 416,670 shares, 390,628 were vested as of December&amp;#xA0;31,
 2010, and the final 26,042 vested in 2011. The restricted shares
 were valued at $450,000 ($1.08 per share) at the date of grant and
 were recognized over the vesting period. During 2011, the Company
 recognized stock-based compensation of $18,000 related to these
 restricted stock grants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In 2011, the
 Company issued 20,834 shares of restricted common stock to a
 consultant. These shares were restricted until November&amp;#xA0;15,
 2011 and any unvested shares were subject to forfeiture upon
 termination and would revert back to the Company. At
 December&amp;#xA0;31, 2011 there no restricted shares remaining. The
 restricted shares were valued at $113,000 ($5.40 per share) at
 November&amp;#xA0;15, 2011, and the Company recognized expense of
 $110,000 during 2011 related to these shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Price&amp;#xA0;on&amp;#xA0;Grant&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
 outstanding, December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;26,042&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
 issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;20,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.04&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
 vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
 outstanding, December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_7001_400008">1344012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_D37CD625-A6F9-4201-9C29-2068FCA0961A_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Price&amp;#xA0;on&amp;#xA0;Grant&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
 outstanding, December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;26,042&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
 issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;20,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.04&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
 vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
 outstanding, December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_7001_400007">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_77ECF289-4460-454C-81E6-45BD173658D9_1_0">614041</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_6753D256-702D-4DC9-B282-DF5C59969D9B_2001_2">P6Y10M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_8363DEDB-7FAE-4482-89D7-15148DA9CCF0_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Commitments and
 Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Lease
 Commitments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
 2012, the Company entered into an operating lease for office space
 in Norcross, GA for a term of twenty-six months, beginning on
 October&amp;#xA0;1, 2012 and ending November&amp;#xA0;30, 2014 at a rate of
 approximately $3,000 per month. The lease provides for free rent
 for the first two months of the lease and required a security
 deposit of $6,000. In addition to base rental payments included in
 the contractual obligations table above, we are responsible for our
 pro-rata share of the operating expenses for the
 building.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
 2012, the Company entered into an operating lease for office space
 collocated with lab space for research and development activities.
 The lease is for a period of one year, beginning on October&amp;#xA0;1,
 2012, for a rate of $15,000 for the term, payable in equal monthly
 increments. This lease was continued on a month to month basis from
 October&amp;#xA0;1, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2011,
 the Company entered into an agreement to amend its lease for
 offices in Newton, MA to extend the term for a period of one year,
 which expired on September&amp;#xA0;30, 2012, at a base rent of
 $235,000 for the period. In addition to base rental payments, the
 Company was responsible for its pro-rata share of increases in the
 operating expenses for the building. In connection with this lease,
 a commercial bank issued a letter of credit collateralized by cash,
 which the Company had on deposit with the bank of $59,000 at
 December&amp;#xA0;31, 2011 and which was released during 2012 after the
 lease term ended. In July 2011, the Company entered into an
 operating lease for an apartment for Company executive use for a
 one-year term, which ended in August 2012, at a rate of $44,000 for
 the term.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Rent expense
 under the above operating leases was $36,000 and $216,000 for the
 years ended December&amp;#xA0;31, 2013 and 2012,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
 payments under this lease as of December&amp;#xA0;31, 2013 are as
 follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="93%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 88pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Separation Agreement&amp;#xA0;&amp;#x2014;&amp;#xA0;Former Chief
 Executive Officer and Chairman of the Board of
 Directors&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In February
 2009, the Company entered into a Separation Agreement in connection
 with the resignation of David Platt, Ph.D., the Company&amp;#x2019;s
 former Chief Executive Officer and Chairman of the Board of
 Directors. The Separation Agreement provides for the deferral of a
 $1.0 million separation payment due to Dr.&amp;#xA0;Platt upon the
 earlier occurrence of any of the following milestone events:
 (i)&amp;#xA0;the approval by the Food and Drug Administration for a new
 drug application (&amp;#x201C;NDA&amp;#x201D;) for any drug candidate or drug
 delivery candidate based on the Company&amp;#x2019;s GM-CT-01 technology
 (whether or not such technology is patented), in which case
 Dr.&amp;#xA0;Platt is also entitled to a fully vested 10-year
 cashless-exercise stock option to purchase at least 83,334 shares
 of common stock at an exercise price not less than the fair market
 value of the common stock determined as of the date of grant;
 (ii)&amp;#xA0;consummation of a transaction with a pharmaceutical
 company expected to result in at least $10.0 million of equity
 investment or $50 million of royalty revenue to the Company, in
 which case Dr.&amp;#xA0;Platt is also entitled to stock options on the
 same terms to purchase at least 50,000 shares of common stock; or
 (iii)&amp;#xA0;the renewed listing of the Company&amp;#x2019;s securities on
 a national securities exchange and the achievement of a market
 capitalization of $100 million. Payment upon the events
 (i)&amp;#xA0;and (iii)&amp;#xA0;may be deferred up to six months, and if
 the Company has insufficient cash at the time of any of such
 events, it may issue Dr.&amp;#xA0;Platt a secured promissory note for
 such amount. If the Company files a voluntary or involuntary
 petition for bankruptcy, whether or not a milestone event has
 occurred, such event shall trigger the obligation to pay the $1.0
 million with the result that Dr.&amp;#xA0;Platt may assert a claim for
 such obligation against the bankruptcy estate. During 2011, when it
 became probable that the Company could be relisted on a national
 securities exchange and eventually reach a market capitalization of
 $100 million, the Company recognized the $1.0 million severance
 payment due to Dr.&amp;#xA0;Platt and it is included in accrued
 expenses at December&amp;#xA0;31, 2013 and 2012.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;2,
 2012, Dr.&amp;#xA0;Platt instituted an arbitration with the American
 Arbitration Association seeking the $1 million payment based on a
 claim that the milestone event in the Separation Agreement
 described in clause (iii)&amp;#xA0;above had occurred. Although the
 Company had listed its common stock on the Nasdaq Capital Markets
 as of March&amp;#xA0;22, 2012, the market capitalization since the
 listing had not reached $100 million when the arbitration was heard
 in October 2012. On November&amp;#xA0;1, 2012, the arbitrator denied
 Dr.&amp;#xA0;Platt&amp;#x2019;s demand in all respects.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 October&amp;#xA0;12, 2012, Dr.&amp;#xA0;Platt commenced a lawsuit under the
 Massachusetts Wage Act against Dr.&amp;#xA0;Traber and
 Mr.&amp;#xA0;McGauley who in their capacities as the Company&amp;#x2019;s
 Chief Executive Officer and the Company&amp;#x2019;s former Chief
 Financial Officer, respectively, can be held individually liable
 under the Wage Act for non-payment of wages. The lawsuit is based
 on the facts and issues raised in the arbitration regarding the
 payment of the $1.0 million separation payment under the Separation
 Agreement, and other unspecified &amp;#x201C;wages&amp;#x201D;. The statute
 provides that a successful claimant may be entitled to multiple
 damages, interest and attorney&amp;#x2019;s fees. Although the Company
 is not a party to the lawsuit, it plans to indemnify
 Dr.&amp;#xA0;Traber and Mr.&amp;#xA0;McGauley consistent with its
 obligations under the by-laws and applicable law, and intends a
 vigorous defense on their behalf. On April&amp;#xA0;29, 2013, the Court
 allowed Dr.&amp;#xA0;Traber&amp;#x2019;s and Mr.&amp;#xA0;McGauley&amp;#x2019;s
 motion to dismiss. On May&amp;#xA0;28, 2013, Dr.&amp;#xA0;Platt filed a
 Notice of Appeal to appeal the Court&amp;#x2019;s order allowing the
 defendants&amp;#x2019; motion to dismiss.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 March&amp;#xA0;29, 2013, the Company instituted arbitration before the
 American Arbitration Association, seeking to rescind or reform the
 Separation Agreement discussed above. The Company claims that
 Dr.&amp;#xA0;Platt fraudulently induced the Company to enter into the
 Separation Agreement, breached his fiduciary duty to the Company,
 and was unduly enriched from his conduct. Along with removal of the
 $1.0 million milestone payment under the Separation Agreement, the
 Company is seeking repayment of all separation benefits paid to
 Dr.&amp;#xA0;Platt to date. Depending on the outcome of the
 arbitration, the previously accrued $1.0 million could be reversed.
 This arbitration has been scheduled for May 2014; however, the
 ultimate outcome is uncertain and there is no guarantee that the
 Company will be successful in this demand.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;1, 2013, the market capitalization of the
 Company&amp;#x2019;s common stock exceeded $100 million and the Company
 received a letter dated October&amp;#xA0;1, 2013, demanding payment of
 the $1 million. As described in the preceding paragraph, the
 Company had previously instituted an arbitration proceeding against
 Dr.&amp;#xA0;Platt seeking to rescind the Separation Agreement,
 including the milestone payment provision, and the Company is
 currently delaying payment pending the outcome of this
 arbitration.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Other
 Legal Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 records accruals for such contingencies to the extent that the
 Company concludes that their occurrence is probable and the related
 damages are estimable. There are no other pending legal proceedings
 except as noted above.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_1A2C75EA-9DC7-4D4B-AE01-E4120DD0C16E_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 Measurements&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has certain
 financial assets and liabilities recorded at fair value. Fair
 values determined by Level 1 inputs utilize observable data such as
 quoted prices in active markets. Fair values determined by Level 2
 inputs utilize data points other than quoted prices in active
 markets that are observable either directly or indirectly. Fair
 values determined by Level 3 inputs utilize unobservable data
 points in which there is little or no market data, which require
 the reporting entity to develop its own assumptions. The estimated
 value of accounts payable and accrued expenses approximates their
 carrying value due to their short-term nature using level 3 inputs
 as defined above. Included in cash and cash equivalents, as of
 December&amp;#xA0;31, 2013 and 2012, the Company had $0 and $583,000,
 respectively, invested in money market funds which had calculated
 net asset values and were therefore classified as
 Level&amp;#xA0;2.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600033">3833000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_CEDAAFF8-3201-46E1-A85E-16503C1012DB_1_3">-8763000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600032">271000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_6">16000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_77ECF289-4460-454C-81E6-45BD173658D9_1_1">2406000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_10" />
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_16">-21947000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_11">39000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_4">-12104000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_11">16000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_12">-12088000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600038">3789000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_2">6416000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_30">8609000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:DeferredTaxExpenseFromStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_1_4">707000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600022">54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_4">3789000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_3BC2D04A-3E33-4733-B6E8-80D109033FD0_1_0">5000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_31">1125000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_3">12104000</us-gaap:OperatingExpenses>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_13">867000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_4142217_ED0EAAEC-A670-48D9-A09A-9459588569CC_2_2">1500000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1_5">1498000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_21">3833000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_13">-6000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1_2">271000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_3">12000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_1_1">7000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_9C515651-FA8B-477F-997C-C70F214A8F83_1_0">36000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_1">5688000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_12">848000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_14">229000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <galt:StockWarrantsTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_84DA8977-AEE7-4054-96BA-412F337E3CC6_1_0">&lt;div&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Warrants and Warrant
 Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrant
 activity is summarized as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,379,739&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(616,726&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,177&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2012&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,344,012&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(50,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2013&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information with regard to outstanding warrants
 issued in connection with equity and debt financings and
 consultants as of December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 90pt"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Issued in
 Connection With&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 Issued&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Exercisable&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Expiration&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February&amp;#xA0;12, 2009
 Series B-1 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,200,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;February 12,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;13, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;600,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,333&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;333,333&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;1, 2009 Consultant
 Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,250&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 1, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 1, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;40,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August&amp;#xA0;12, 2009 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;50,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;200,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,166&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September 30,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;September 30,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November&amp;#xA0;4, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;206,666&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;November 4,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;8, 2009
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2009&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 8,
 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January&amp;#xA0;29, 2010
 Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;January 29,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March&amp;#xA0;8, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;55,834&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;223,334&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April&amp;#xA0;30, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;206,667&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;10, 2010 Series
 B-2 Transaction&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$0.50 Investor
 Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;380,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;14,584&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15.00&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June&amp;#xA0;15, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.26&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 15, 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;June 15, 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;9, 2010
 Consultant Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,334&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 9,
 2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 9,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;30, 2010
 Placement Agent Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;500&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December&amp;#xA0;30,&amp;#xA0;2010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;December 30,
 2015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March&amp;#xA0;28, 2012
 Offering Warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,333,061&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;March 28, 2017&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 7em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total outstanding
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,035,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In January
 2014, the remaining 500,000 Class&amp;#xA0;A-2 warrants were exercised
 for cash proceeds of $1,500,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Consultant Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2008 the
 Company entered into an agreement with Investor Relations Group
 (&amp;#x201C;IRG&amp;#x201D;) for IRG to provide investor relations services
 to the Company in exchange for cash and warrants on a monthly
 basis. On September&amp;#xA0;30, 2008 the Company terminated the
 agreement under the provisions of the agreement. During the
 effective contract period IRG earned 6,500 warrants valued at
 $3,000. The expense associated with these warrants was calculated
 using the Black-Scholes option-pricing model and charged to stock
 compensation expense. The warrants were exercisable at $3.00 per
 share for a period of three years and expired in 2011.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2009,
 the Company entered into agreements with consultants that provided
 for the grant of warrants for the purchase of 55,000 shares of
 common stock at an exercise price of $3.00 per share. Of the 55,000
 warrants, 13,334 vested immediately and 41,666 will vest upon the
 achievement of certain milestones. The initial 13,334 warrants were
 valued at $32,000 on issuance based on the following assumptions:
 an expected life of 4 years, volatility of 134%, risk free interest
 rate of 1.76% and zero dividends and the expense recognized upon
 issuance. During the year ended December&amp;#xA0;31, 2010, 8,334
 warrants vested (valued at $16,000 on the vesting date using the
 following assumptions: expected life of 3.06 years, volatility of
 140%, risk free interest rates of 1.69% and zero dividends). In
 2010, when it appeared probable that the remaining 33,332 warrants
 would vest, the Company valued the warrants at $124,000 as of
 December&amp;#xA0;31, 2010 using the following assumptions: expected
 life of 2.29 years, volatility of 141%, risk free interest rates of
 0.61% and zero dividends. The Company valued the warrants at
 $104,000 as of December&amp;#xA0;31, 2011 using the following
 assumptions: expected life of 1.29 years, volatility of 70%, risk
 free interest rates of 0.12% and zero dividends. The Company
 recognized expense related to the 33,332 warrants of $111,000 for
 the year ended December&amp;#xA0;31, 2010 and a reversal of expense of
 $13,000 for the year ended December&amp;#xA0;31, 2011. During the year
 ended December&amp;#xA0;31, 2012, these warrants were no longer
 expected to vest and the Company recognized a reversal of
 previously recognized expense related to these warrants of $100,000
 for the year ended December&amp;#xA0;31, 2012. The 33,333 warrants that
 had vested from the April 2009 issuance expired in April
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2009,
 the Company entered into agreements with consultants that provided
 for the grant of warrants to purchase 95,834 shares of common stock
 at an exercise price of $3.00 per share of which 74,000 vested and
 21,834 were forfeited. The warrants were valued at $232,000 on
 issuance based on the following assumptions: an expected life of 5
 years, volatility of 124%, risk free interest rate of 2.16% and
 zero dividends. The Company recognized expense related to these
 warrants of $53,000 during the year ended December&amp;#xA0;31, 2010.
 As of December&amp;#xA0;31, 2010, 74,000 of these warrants were vested
 and 21,834 shares were forfeited. In 2013, 67,750 of these warrants
 were exercised leaving 6,250 outstanding at December&amp;#xA0;31,
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2010,
 the Company granted warrants to consultants for the purchase of
 35,001 shares of common stock at an exercise price of $4.50 per
 share. The warrants were valued at $134,000 on issuance based on
 the following assumptions: an expected life of 4 years, volatility
 of 143%, risk free interest rate of 1.610% and zero dividends. The
 warrants vested immediately and the company recognized an expense
 of $134,000 related to these warrants during the year ended
 December&amp;#xA0;31, 2010. As of December&amp;#xA0;31, 2013, 14,584 of
 these warrants were outstanding as 13,750 and 6,667 warrants were
 exercised during the years ended December&amp;#xA0;31, 2013 and 2012,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2010,
 the Company entered into an agreement with a consultant that
 provided for the grant of warrants for the purchase of 12,000
 shares of common stock at an exercise price of $15.00 per share.
 The warrants were initially valued at $40,000 on issuance based on
 the following assumptions: an expected life of 4 years, volatility
 of 143%, risk free interest rate of 1.610% and zero dividends. The
 warrants vest at a rate of 500&amp;#xA0;per month and the unvested
 warrants will be revalued as they vest. At December&amp;#xA0;31, 2011,
 7,500 warrants were vested and 4,500 were forfeited upon
 cancellation of the agreement. The following assumptions were used
 to value the warrants for the year ended December&amp;#xA0;31, 2011: an
 expected life of 2.99 to 3.32 years, volatility of 128% to 130%,
 risk free interest rate of 0.79% to 1.29% and zero dividends. The
 following assumptions were used to value the warrants for the year
 ended December&amp;#xA0;31, 2010: an expected life of 3.40 to 3.99
 years, volatility of 130% to 144%, risk free interest rate of 0.51%
 to 1.68% and zero dividends. The company recognized an expense of
 $12,000 and $15,000 related to these warrants during the years
 ended December&amp;#xA0;31, 2011 and 2010, respectively. At
 December&amp;#xA0;31, 2013, these 7,500 warrants are
 outstanding.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2010,
 the Company entered into an agreement with a consultant, who was
 also a board member, which provided for the grant of warrants for
 100,000 shares of common stock at an exercise price of $4.26 per
 share. Of the 100,000 warrants, 25,000 vested immediately on
 signing of the agreement, 25,000 were to vest at the end of one
 year and the remaining 50,000 warrants were to vest based on the
 achievement of certain milestones. The following assumptions were
 used to value the remaining unvested warrants on March&amp;#xA0;7, 2011
 at the date the consultant effectively became an employee of the
 Company: an expected life of 4.28 years, volatility of 135%, risk
 free interest rate of 1.705% and zero dividends. Pursuant to an
 employment agreement entered into in May 2011, all remaining
 unvested warrants were immediately vested and the 100,000 warrants
 remain outstanding at December&amp;#xA0;31, 2013. The Company
 recognized expense of $340,000 and $219,000 related to these
 warrants during the years ended December&amp;#xA0;31, 2011 and 2010,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In December
 2010, the Company granted warrants to a consultant for the purchase
 of 33,334 shares of common stock at an exercise price of $3.90 per
 share. The warrants were valued at $112,000 on issuance based on
 the following assumptions: an expected life of 5 years, volatility
 of 130%, risk free interest rate of 1.9% and zero dividends. The
 warrants vested immediately and the company recognized an expense
 of $112,000 related to these warrants during the year ended
 December&amp;#xA0;31, 2010. These warrants are outstanding at
 December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In December
 2010, the Company issued warrants to a placement agent for the
 purchase of 500 shares of common stock at an exercise price of
 $7.20 per share. These warrants were valued at $2,000 using the
 following assumptions: an expected life of 5 years, volatility of
 130%, risk free interest rate of 2.06% and zero dividends. These
 warrants are outstanding at December&amp;#xA0;31, 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In January
 2013, the Company entered into an agreement with a consultant that
 provided for the grant of warrants for the purchase of 5,000 shares
 of common stock at an exercise price of $2.65 per share. The
 following assumptions were used to value the warrants: an expected
 life of 3 years, volatility of 87%, risk free interest rate of
 0.42% and zero dividends. The Company recognized an expense of
 $7,000 related to these warrants at the time of the grant as they
 were vested at issuance. The warrants were exercised in September
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Warrants
 Modification&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;6,
 2013, the Company modified the terms of the Class&amp;#xA0;A-2 and
 Class B warrants that were originally issued to the 10X Fund with
 the Series B Preferred Stock offering. The Class B warrants were
 modified to allow for the cashless exercise of all 4,000,000
 outstanding Class B warrants. Previously, only half of the Class B
 warrants allowed for cashless exercise. The Class&amp;#xA0;A-2 warrants
 for the purchase of 1,000,000 shares of common and all of the Class
 B warrants had their exercisable life extended by an additional
 five years. In exchange for these modifications, the 10X Fund
 agreed to a future amendment of the Company&amp;#x2019;s Series B
 certificate of designation to remove the redemption provision such
 that the Series B Preferred Stock will no longer be redeemable, if
 and when the Company will no longer be required to issue
 Dr.&amp;#xA0;Platt a promissory note as may currently be required under
 the separation agreement (see Note 11).&amp;#xA0;Should the Company
 amend their Series B certificate of designation in the future as
 described above, the Company will be required at that time to
 evaluate whether such amendment is to be accounted for as a
 modification or an extinguishment of the Company&amp;#x2019;s Series B
 Preferred Stock.&amp;#xA0;The Company has accounted for the modified
 terms of the Class&amp;#xA0;A-2 and Class B warrants pursuant to ASC
 718, Stock Compensation, whereby the Company has recognized a
 charge for the change in fair value of the warrants immediately
 before and immediately after the modification.&amp;#xA0;In the second
 quarter of 2013, the Company recognized a one-time charge of
 $8,763,000 related to the extension of the 5,000,000 warrants. The
 following assumptions were used to value the extension of the
 warrants immediately before and immediately after the modification:
 a) immediately before the modification &amp;#x2014; an expected life
 range of 0.77 to 2.01 years, volatility range of 77% to 96%, risk
 free interest rate range of 0.11% to 0.22% and zero dividends and;
 b) immediately following the modification &amp;#x2014; an expected life
 range of 5.78 to 7.02 years, volatility range of 113% to 122%, risk
 free interest rate range of 0.74% to 1.19% and zero
 dividends.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Impact of
 Adopting Provisions Regarding Warrant
 Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2008,
 the Financial Accounting Standards Board (&amp;#x201C;FASB&amp;#x201D;)
 ratified standards related to determining whether an instrument (or
 an embedded feature) is indexed to an entity&amp;#x2019;s own stock. The
 standards provide that an entity should use a two step approach to
 evaluate whether an equity-linked financial instrument (or embedded
 feature) is indexed to its own stock, including evaluating the
 instrument&amp;#x2019;s contingent exercise and settlement provisions.
 The standard is effective for fiscal years beginning after
 December&amp;#xA0;15, 2008. The Company adopted the standard on
 January&amp;#xA0;1, 2009 and determined that the 1,164,929 warrants
 issued in connection with the February 2006 Transaction that had
 been classified as equity and included in additional paid-in
 capital at December&amp;#xA0;31, 2008, should be classified as
 liabilities due to repricing and anti-dilution provisions contained
 in the warrant agreements. The impact of adopting new accounting
 provisions on January&amp;#xA0;1, 2009, which required the treatment of
 warrants with certain features as liabilities rather than equity,
 was a decrease in additional paid-in-capital by $458,000, which was
 the fair value recorded at the time the warrants were transferred
 from a liability to equity during the year ended December&amp;#xA0;31,
 2008, an increase of warrant liabilities by $204,000, the fair
 value of the warrants as of January&amp;#xA0;1, 2009 and a credit to
 accumulated deficit for the difference.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
 ended December&amp;#xA0;31, 2011, the Company recognized a loss of
 $524,000 in its consolidated statements of operations related to
 the change in fair value of warrant liabilities.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</galt:StockWarrantsTextBlock>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_7001_400009">50000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod>
  <galt:ScheduleOfEquityAndOtherInvestmentsTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_9C8DDA8D-0151-4623-AD80-21C0A7EA8B9B_1_0">&lt;div&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="15%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td width="82%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;u&gt;ROI&amp;#xA0;Percentage&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="2"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;200%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;before the second anniversary of the date of
 issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;250%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the second anniversary of the date of issuance, but
 before the third anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;300%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the third anniversary of the date of issuance, but
 before the fourth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;350%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the fourth anniversary of the date of issuance, but
 before the fifth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;400%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the fifth anniversary of the date of issuance, but
 before the sixth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;450%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the sixth anniversary of the date of issuance, but
 before the seventh anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;500%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the seventh anniversary of the date of issuance,
 but before the eighth anniversary of the date of issuance;
 and&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top" nowrap="nowrap" align="center"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em" align="center"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;550%&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;on or after the eighth anniversary of the date of issuance, but
 before the ninth anniversary of the date of issuance.&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</galt:ScheduleOfEquityAndOtherInvestmentsTableTextBlock>
  <galt:ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_74701199-834D-46FB-8214-B842F270658C_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;A summary of
 changes in the Warrant Liabilities is as follows:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
 Warrant&lt;br /&gt;
 Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
 2010&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;861&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Change in fair value of
 warrant liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;524&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Intrinsic value of liability
 warrants exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,385&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
 2011&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</galt:ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600034">111000</galt:StockIssuanceCosts>
  <galt:PrepaidExpensesAndOtherPolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_315EB3F7-5BD7-4EF6-85FF-FC9190B14CBE_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
 Expenses and Other Current
 Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Prepaid expenses and other
 assets consist principally of prepaid insurance and prepaid rent on
 the Company&amp;#x2019;s leased executive office space.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</galt:PrepaidExpensesAndOtherPolicyTextBlock>
  <galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1_1">378000</galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount>
  <galt:AccruedExpensePolicyTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_F3F61DF9-CD0B-4017-A3E9-08AACDD2DD4B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Accrued
 Expenses&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;As part of the process of
 preparing our consolidated financial statements, we are required to
 estimate accrued expenses. This process involves identifying
 services that third parties have performed on our behalf and
 estimating the level of service performed and the associated cost
 incurred on these services as of each balance sheet date in our
 consolidated financial statements. Examples of estimated accrued
 expenses include contract service fees in conjunction with
 pre-clinical and clinical trials, professional service fees, such
 as those arising from the services of attorneys and accountants and
 accrued payroll expenses. In connection with these service fees,
 our estimates are most affected by our understanding of the status
 and timing of services provided relative to the actual services
 incurred by the service providers. In the event that we do not
 identify certain costs that have been incurred or we under- or
 over-estimate the level of services or costs of such services, our
 reported expenses for a reporting period could be understated or
 overstated. The date on which certain services commence, the level
 of services performed on or before a given date, and the cost of
 services are often subject to our judgment. We make these judgments
 based upon the facts and circumstances known to us in accordance
 with accounting principles generally accepted in the
 U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</galt:AccruedExpensePolicyTextBlock>
  <galt:ScheduleOfComputationOfBasicAndDilutedEarningsPerShareTableTextBlock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" id="id_4142217_85D9E6CE-241E-4FCA-A652-CE57245C7F25_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The computation
 of diluted net loss per share does not assume the issuance of
 common shares that have an anti-dilutive effect on net loss per
 share.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands,&amp;#xA0;except&amp;#xA0;share&lt;br /&gt;
 and per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2013&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;br /&gt;
 
 &amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2012&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,088&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(9,675&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
 dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(867&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(976&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
 accretion&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrant
 modification&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(8,763&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
 common stockholders&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(21,947&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,881&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
 per share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.30&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.72&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares used in computing
 basic and diluted net loss per share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,874&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</galt:ScheduleOfComputationOfBasicAndDilutedEarningsPerShareTableTextBlock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600021">175000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_1_3">0.009</galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13013_1600031">4505000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_40">867000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:ProceedsFromStockOptionAndWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1_28">4776000</galt:ProceedsFromStockOptionAndWarrantExercises>
  <galt:AdjustmentForModificationOfWarrants contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_1_15">8763000</galt:AdjustmentForModificationOfWarrants>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_708873x796972" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1001_3">173669</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x747231" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2004_2">7.56</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x747231" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2004_1">5.82</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x747231" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2004_4">P7Y1M10D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x753422" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2005_2">11.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x753422" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2005_1">8.10</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x753422" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2005_4">P4Y11M16D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x760806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2002_2">2.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x760806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2002_1">2.08</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x760806" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2002_4">P7Y2M5D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x765708" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2003_2">4.41</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x765708" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2003_1">3.59</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x765708" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2003_4">P9Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x803399" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2001_2">1.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x803399" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2001_1">0.72</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x803399" id="id_4142217_378589C2-F795-414C-9D20-086E3BC9CD69_2001_4">P4Y3M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13012_1500039">-12088000</us-gaap:NetIncomeLoss>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13012_1500022">54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13012_1500037">-8763000</galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13012_1500021">175000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14012_1500030">123000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_15012_1500024">148000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_16012_1500026">178000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17012_1500028">418000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13011_1400033">3832000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13011_1400032">271000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13011_1400038">3789000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13011_1400037">8763000</galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13011_1400031">4504000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14011_1400030">-123000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14011_1400036">235000</galt:IssuanceOfRedeemablePreferredStockValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_15011_1400024">-148000</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x827065" unitRef="iso4217_USD" decimals="0" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_1001_5">1105000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_16011_1400026">-178000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17011_1400028">-418000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17011_1400035">45000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713470_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14005_900036">-235000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713470_711196x742327" unitRef="shares" decimals="0" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14005_800036">-24</galt:IssuanceOfRedeemablePreferredStockShares>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713505_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17007_1100035">-45000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713505_711196x884051" unitRef="shares" decimals="0" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17007_1000035">-110000</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13009_1200033">599942</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13009_1200032">213008</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13009_1300033">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13009_1300031">1000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x742327" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14009_1200029">23848</us-gaap:PreferredStockDividendsShares>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x742327" unitRef="shares" decimals="0" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14009_1200036">40193</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x746545" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_15009_1200023">25062</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x883035" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_16009_1200025">36106</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x884051" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17009_1200027">84553</us-gaap:PreferredStockDividendsShares>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x884051" unitRef="shares" decimals="0" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_17009_1200035">18387</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13003_700022">-54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13003_700021">-158000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_13001_500021">-17000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x707398" unitRef="iso4217_USD" decimals="0" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_1001_5">284000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <galt:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x707398" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_1001_2">2032</galt:OperatingLossCarryforwardsExpirationYear>
  <galt:ResearchAndDevelopmentCreditsExpirationYear contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x707398" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_1001_7">2032</galt:ResearchAndDevelopmentCreditsExpirationYear>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x711886" unitRef="iso4217_USD" decimals="0" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_2001_6">176000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <galt:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x711886" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_2001_3">2032</galt:OperatingLossCarryforwardsExpirationYear>
  <galt:ResearchAndDevelopmentCreditsExpirationYear contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x711886" id="id_4142217_6E8F1665-8E01-4AB2-A3C0-0B06BF50D65C_2001_8">2032</galt:ResearchAndDevelopmentCreditsExpirationYear>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x710990" unitRef="pure" decimals="2" id="id_4142217_8AF0633B-76B2-4837-9AD6-37BD2DE7F3F4_1001_0">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x710990" unitRef="pure" decimals="2" id="id_4142217_8AF0633B-76B2-4837-9AD6-37BD2DE7F3F4_1001_1">1.00</galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate>
  <galt:DividendAccrualRateOnInvestmentsInAffiliates contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x710990" unitRef="pure" decimals="2" id="id_4142217_8AF0633B-76B2-4837-9AD6-37BD2DE7F3F4_1001_3">0.15</galt:DividendAccrualRateOnInvestmentsInAffiliates>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_216F82CE-78FD-4B8A-A110-005D6C0F8415_1002_2">196</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713470" unitRef="shares" decimals="INF" id="id_4142217_216F82CE-78FD-4B8A-A110-005D6C0F8415_1002_3">326667</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713505" unitRef="shares" decimals="INF" id="id_4142217_3CEB3530-76A5-462A-9942-2D99B9E26AFA_1001_0">110000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713713" unitRef="shares" decimals="INF" id="id_4142217_3CEB3530-76A5-462A-9942-2D99B9E26AFA_2001_1">18387</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_14013_1600036">235000</galt:IssuanceOfRedeemablePreferredStockValue>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x827065" unitRef="pure" decimals="2" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_2001_2">1.18</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x827065" unitRef="pure" decimals="2" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_2001_4">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x827065" unitRef="pure" decimals="4" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_2001_3">0.0179</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x827065" id="id_4142217_5C13E0FB-B612-4860-84FD-4E79FF0B4017_2001_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711502x711169" id="id_4142217_070E5F90-1FA1-4B44-B891-BB440C65E82A_1001_0">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711502x716112" id="id_4142217_070E5F90-1FA1-4B44-B891-BB440C65E82A_2001_1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2008_3">2009-08-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_1001_12">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2007_3">2009-08-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_2001_11">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x730156" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2026_3">2010-12-09</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x735983" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2001_3">2009-02-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x735983_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_3001_2">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2022_3">2010-05-10</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_4001_33">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2021_3">2010-05-10</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_5001_32">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2014_3">2009-12-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_6001_21">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2013_3">2009-12-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_7001_20">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2016_3">2010-01-29</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_8001_24">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2015_3">2010-01-29</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_9001_23">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x773941" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2002_3">2009-05-13</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x773941_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_10001_4">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x786055" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2025_3">2010-06-15</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x796706" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2006_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x803310" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2028_3">2012-03-28</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2018_3">2010-03-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_11001_27">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2017_3">2010-03-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_12001_26">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2012_3">2009-11-04</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_13001_18">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2011_3">2009-11-04</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_14001_17">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x811277" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2027_3">2010-12-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2020_3">2010-04-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_15001_30">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2019_3">2010-04-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_16001_29">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x818860_741278x756917" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2024_3">2010-05-25</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x818860_741278x804137" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2023_3">2010-05-25</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2010_3">2009-09-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_17001_15">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2009_3">2009-09-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_18001_14">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x834904" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2005_3">2009-05-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x805643" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2004_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x805643" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_19001_7">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x813918" id="id_4142217_E85EC861-4DCC-4388-B896-EF114DC4DD0A_2003_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x813918" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_3C81A948-A2B5-4D89-A9DF-2F30C81AE5C7_20001_6">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712080x707836" unitRef="iso4217_USD" decimals="-3" id="id_4142217_250071DC-E11C-4EB8-9F29-1DB9AFB109C7_1001_1">2798000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712080x713040" unitRef="iso4217_USD" decimals="-3" id="id_4142217_250071DC-E11C-4EB8-9F29-1DB9AFB109C7_2001_0">991000</us-gaap:ShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626" unitRef="shares" decimals="INF" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1002_2">99942</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsForCommissions contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626" unitRef="iso4217_USD" decimals="0" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1002_6">29000</us-gaap:PaymentsForCommissions>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626" unitRef="iso4217_USD" decimals="0" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1002_7">833000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <galt:GrossProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626" unitRef="iso4217_USD" decimals="0" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1002_4">944000</galt:GrossProceedsFromIssuanceOfCommonStock>
  <galt:LegalAccountingUnderwritingFee contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626" unitRef="iso4217_USD" decimals="0" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1002_5">82000</galt:LegalAccountingUnderwritingFee>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x708980" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_1001_1">3348705</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x710313" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_2001_2">2568771</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x715581" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_3001_0">6035229</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_713879x778478" id="id_4142217_2997156D-A968-4465-A15B-B0FC10F52DAE_1003_2">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_713879x842739" id="id_4142217_829BCE0D-4FBC-4B68-B1EE-4440C51B3D0D_3004_5">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_715832x710442" id="id_4142217_60295B6B-10E9-407C-8F36-4A77EBEFB71F_1001_1">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_715832x725975" id="id_4142217_60295B6B-10E9-407C-8F36-4A77EBEFB71F_2001_0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_716763x749992" unitRef="shares" decimals="0" id="id_4142217_3951E15C-CC10-44B2-940E-CB815C6BA9ED_1003_12">67750</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_716763x819924" unitRef="shares" decimals="INF" id="id_4142217_2FDB975C-7CBC-4EFD-9A62-2D199DE60890_3001_3">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_365_20131231_0_716763x819924" unitRef="iso4217_USD" decimals="INF" id="id_4142217_2FDB975C-7CBC-4EFD-9A62-2D199DE60890_3001_1">1500000</us-gaap:ProceedsFromWarrantExercises>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x735475" unitRef="iso4217_USD" decimals="0" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_1001_5">4000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x735475_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_41227525-F5E4-4D78-9872-4AA0B78DE2DA_2001_6">51000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x743063_708873x775931" unitRef="iso4217_USD" decimals="0" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_1001_4">-2000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x743063_708873x775931_713115x708980" unitRef="iso4217_USD" decimals="0" id="id_4142217_AC037D0E-3C4B-46DF-9135-4E12896F8FAE_2001_5">17000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x745885" unitRef="shares" decimals="INF" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1002_3">7500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x745885" unitRef="iso4217_USD" decimals="0" id="id_4142217_87109E91-811A-40B1-AFED-F4860055EF59_1002_5">67000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x745885_708873x807711_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_3001_5">23000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x764378" unitRef="iso4217_USD" decimals="0" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_1001_5">2000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x764378_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_966DEFFA-AB2C-4D37-8B01-A4A742343487_2001_6">5000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20081231_0_707179x753998_713115x711585" unitRef="iso4217_USD" decimals="0" id="id_4142217_840382EA-3EFC-406F-8656-2B9A27E967F0_2002_3">15000</us-gaap:ShareBasedCompensation>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1310-K0015_STD_366_20081231_0_708873x735492_711196x713505" unitRef="iso4217_USD" decimals="INF" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_1002_1">75000</galt:ProceedsFromSubscriptionAdvances>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1310-K0015_STD_366_20081231_0_711196x713505" unitRef="iso4217_USD" decimals="INF" id="id_4142217_7FA1E4D1-510B-4156-9D9C-CEAE52051886_3002_2">1742500</galt:ProceedsFromSubscriptionAdvances>
  <galt:IncreaseDecreaseInWarrants contextRef="eol_PE87402---1310-K0015_STD_366_20081231_0_716389x770436" unitRef="iso4217_USD" decimals="0" id="id_4142217_7441BB64-933C-4231-A4DB-60237D99B681_1002_2">204000</galt:IncreaseDecreaseInWarrants>
  <galt:DecreaseInAdditionalPaidInCapital contextRef="eol_PE87402---1310-K0015_STD_366_20081231_0_716389x770436" unitRef="iso4217_USD" decimals="0" id="id_4142217_7441BB64-933C-4231-A4DB-60237D99B681_1002_1">458000</galt:DecreaseInAdditionalPaidInCapital>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_4001_4">8.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_2_0">0.0090</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_2_2">1.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_0">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_4001_3">2.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_4">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_6">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_2_1">P5Y9M22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_5">0.348</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_18">15131000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_BDF2AF34-C70F-4CD1-A8EC-C311B193317C_2_0">1.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_2_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_14">-7500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_2_0">51830</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_1">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_4001_4">299683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_2_3">13591312</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_17">-0.72</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_4142217_D17896CF-79FA-49E4-A67B-107AF0FF9FBA_4001_5">2.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_A5B265AB-1402-4777-8053-8A8608143594_4001_3">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_2_4">51830</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_2">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_4001_400004">616726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_4001_400003">1379739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_77ECF289-4460-454C-81E6-45BD173658D9_2_0">595420</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_16">5000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_17">-69000</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_10">200000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_6">24000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_77ECF289-4460-454C-81E6-45BD173658D9_2_1">2447000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_10" />
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_16">-10881000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_11">55000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_4">-9899000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_11">224000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_12">-9675000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4013_1600018">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_2">5372000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_30">10403000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4013_1600003">56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_4">2792000</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_3BC2D04A-3E33-4733-B6E8-80D109033FD0_2_0">3000</us-gaap:DepreciationAndAmortization>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_31">2967000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_3">9899000</us-gaap:OperatingExpenses>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_13">976000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_2_5">162000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_21">10403000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_13">6000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_2_2">0</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_3">9000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_CA5F75E4-200C-4DBD-9401-3FDEE6C5BE18_2_1">6000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_9C515651-FA8B-477F-997C-C70F214A8F83_2_0">216000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_19">64000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_1">4527000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_12">-577000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_2_14">230000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_A69517FE-82EF-42F5-ACBB-D498BE82A28B_1_1">271000</galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4013_1600004">10403000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_4142217_E5B3AFEB-1079-484C-86FE-2B7532967B4E_4001_400005">12177</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4013_1600005">1597000</galt:StockIssuanceCosts>
  <galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_2_1">96000</galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount>
  <galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_4142217_E8B4E859-2F9C-4630-8694-7087E6246687_2_3">0.014</galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <galt:ConversionOfAccruedLiabilitiesToCommonStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_37">26000</galt:ConversionOfAccruedLiabilitiesToCommonStock>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_36">4445000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2_40">976000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:ReversalOfSharebasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_4_28">100000</galt:ReversalOfSharebasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_708873x796972" unitRef="shares" decimals="INF" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_1002_3">90253</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4012_1500019">-9675000</us-gaap:NetIncomeLoss>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4012_1500003">56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x710990" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_5012_1500002">174000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_6012_1500014">127000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_7012_1500008">103000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_9012_1500010">224000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_10012_1500012">522000</us-gaap:DividendsPreferredStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4011_1400018">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4011_1400004">10400000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_6011_1400014">-127000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_7011_1400008">-103000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x753998" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_8011_1400015">26000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_9011_1400010">-224000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_10011_1400012">-522000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4009_1200006">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4009_1200017">51830</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <galt:IssuanceOfCommonStockAndWarrantsShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4009_1200004">2666722</galt:IssuanceOfCommonStockAndWarrantsShares>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4009_1300004">3000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4009_1200016">12177</galt:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x742327" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_6009_1200013">46053</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x746545" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_7009_1200007">31250</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x753998" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_8009_1200015">11348</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x883035" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_9009_1200009">95584</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x884051" unitRef="shares" decimals="INF" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_10009_1200011">223027</us-gaap:PreferredStockDividendsShares>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_4003_700003">-56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x810388_711196x710990" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_5003_700002">-157000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x827065_711196x710990" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_5001_500002">-17000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x710990" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_5013_1600002">174000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x713505" unitRef="shares" decimals="INF" id="id_4142217_3CEB3530-76A5-462A-9942-2D99B9E26AFA_1002_0">180000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x713713" unitRef="shares" decimals="INF" id="id_4142217_3CEB3530-76A5-462A-9942-2D99B9E26AFA_2002_1">30000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x753998" unitRef="iso4217_USD" decimals="-3" id="id_4142217_7E9D2D7F-8F5A-4698-BA18-0350594B605E_8013_1600015">26000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_712080x707836" unitRef="iso4217_USD" decimals="-3" id="id_4142217_250071DC-E11C-4EB8-9F29-1DB9AFB109C7_1002_1">1870000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_712080x713040" unitRef="iso4217_USD" decimals="-3" id="id_4142217_250071DC-E11C-4EB8-9F29-1DB9AFB109C7_2002_0">922000</us-gaap:ShareBasedCompensation>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x708980" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_1002_1">3539961</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x710313" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_2002_2">2627110</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x715581" unitRef="shares" decimals="INF" id="id_4142217_6D475802-5809-4562-8963-A3BA8237FDF2_3002_0">7424241</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <galt:ExtensionOfExercisePeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_713115x711585" id="id_4142217_A69517FE-82EF-42F5-ACBB-D498BE82A28B_1001_0">P90D</galt:ExtensionOfExercisePeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_713879x820386" unitRef="shares" decimals="0" id="id_4142217_5936315B-3124-45A2-9177-AE40E9213E6C_1001_0">1477379</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1310-K0015_STD_366_20121231_0_716763x740658" unitRef="shares" decimals="INF" id="id_4142217_E1B5EFC9-8225-4C89-A18E-0AF82FC51AB2_3004_29">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1001_2">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x810388" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_1001_3">4200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_2001_0">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x827065" unitRef="shares" decimals="INF" id="id_4142217_233CE93D-DB78-4BE1-BDF1-EF7514E3027A_2001_1">1800000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="pure" decimals="4" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_3_0">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="pure" decimals="2" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_3_2">1.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_3_1">P5Y2M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="pure" decimals="2" id="id_4142217_D9681132-5272-4E62-89AF-F6D9F04D83BA_3_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_14">-66037000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:RepaymentsOfConvertibleDebt contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_27">1641000</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_4142217_BDF23E9C-61E3-4AA1-B617-033BF9F705A2_1_1">77400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_16">431000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_38">12243000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:PaymentsToAcquireProductiveAssets contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_18">404000</us-gaap:PaymentsToAcquireProductiveAssets>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_10">691000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_6">834000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:StockIssued1 contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_42">107000</us-gaap:StockIssued1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_77ECF289-4460-454C-81E6-45BD173658D9_3_1">15473000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_10" />
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_16">-102221000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:InterestPaid contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_34">114000</us-gaap:InterestPaid>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600047">53000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_11">195000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_4">-86750000</us-gaap:OperatingIncomeLoss>
  <us-gaap:SubscriptionRevenue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600019">150000</us-gaap:SubscriptionRevenue>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_11">2670000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_12">-84080000</us-gaap:NetIncomeLoss>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_39">171000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600046">15424000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_29">9000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_2">53452000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_30">77361000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:PaidInKindInterest contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_5">4279000</us-gaap:PaidInKindInterest>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_4">16163000</us-gaap:ShareBasedCompensation>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_31">10489000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_3">86750000</us-gaap:OperatingExpenses>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_13">5104000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:ProceedsFromConvertibleDebt contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_26">10621000</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_8">351000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B6D7E4FA-48F2-47F9-A846-BEB59D9869F3_3_5">3222000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:InterestExpense contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_7">4451000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_21">42926000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_3">567000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_19">-835000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_1">33298000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_12">2474000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:FairValueAdjustmentOfWarrants contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_9">-9022000</us-gaap:FairValueAdjustmentOfWarrants>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_14">4274000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600048">-204000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:StockBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600045">157000</galt:StockBasedCompensation>
  <galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600044">-455000</galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600008">2221000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:ReclassificationOfWarrantsToLiability contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600043">3193000</galt:ReclassificationOfWarrantsToLiability>
  <galt:StockIssuedDuringPeriodValueMerger contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600005">107000</galt:StockIssuedDuringPeriodValueMerger>
  <galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600003">1036000</galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600009">17000</galt:StockIssuanceCosts>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600001">9000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600002">222000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3013_1600067">18812000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:ConversionOfAccruedLiabilitiesToCommonStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_37">329000</galt:ConversionOfAccruedLiabilitiesToCommonStock>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_36">9482000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_40">5022000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:ProceedsFromStockOptionAndWarrantExercises contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_28">16069000</galt:ProceedsFromStockOptionAndWarrantExercises>
  <galt:IssuanceOfWarrantsToInduceConversionOfNotesPayable contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3_41">503000</galt:IssuanceOfWarrantsToInduceConversionOfNotesPayable>
  <galt:UnrealizedGainLossInDebtInstrumentFairValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_8">-3426000</galt:UnrealizedGainLossInDebtInstrumentFairValue>
  <galt:AdjustmentForModificationOfWarrants contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_1EA935E1-15D4-4EFC-B72C-4FB7F35337E0_3_15">8763000</galt:AdjustmentForModificationOfWarrants>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_709650x710802_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_4011_1400007">503000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_709650x710802_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_5011_1400015">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_4013_1600007">503000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_5013_1600015">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_709650x710802_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_6011_1400026">74000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_709650x713713_741278x736639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_6009_1200026">2772</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_6013_1600026">74000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x750826" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_8011_1400029">489000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_9011_1400023">261000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x776355" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_10011_1400016">1070000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x785453" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_11011_1400024">1319000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_12011_1400012">2860000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x823795" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_13011_1400027">1898000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x834701" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_14011_1400021">4409000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713505_711196x746545_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_7007_1100034">704000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713505_711196x746545_741278x736639" unitRef="shares" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_7007_1000034">1742500</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x750826" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_8009_1200029">333334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x750826" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_8009_1300029">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x776355" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_10009_1200016">181334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x785453" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_11009_1200024">219096</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x796434" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_12009_1200012">537227</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_12009_1300012">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x823795" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_13009_1200027">206019</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x834701" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_14009_1200021">399917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x834701" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_14009_1300021">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:EquityIssuanceDates contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_711196x746545_741278x736639" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_7013_1600035">2008-02-04</us-gaap:EquityIssuanceDates>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_711196x746545_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_7013_1600034">704000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_711196x746545_741278x736639" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_7013_1600036">52000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x750826" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_8013_1600029">490000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x750826" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_8013_1600030">485000</galt:StockIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_9013_1600023">261000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x776355" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_10013_1600016">1070000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x776355" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_10013_1600017">18000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x785453" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_11013_1600024">1319000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x785453" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_11013_1600025">559000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_12013_1600012">2861000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x796434" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_12013_1600013">212000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x823795" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_13013_1600027">1898000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x823795" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_13013_1600028">466000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x834701" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_14013_1600021">4410000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x834701" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_14013_1600022">128000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x710802_741278x740448" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15011_1400037">1043000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x710802_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_16011_1400010">602000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x713713_741278x740448" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15009_1200037">1250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x713713_741278x740448" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15009_1300037">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x713713_741278x755589" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_16009_1200010">31000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuanceDates contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x740448" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15013_1600038">2008-02-25</us-gaap:EquityIssuanceDates>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x740448" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15013_1600037">1044000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x740448" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_15013_1600039">369000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_16013_1600010">602000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x755589" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_16013_1600011">49000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_709650x710802_741278x780633" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_17011_1400020">302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_709650x713713_741278x780633" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_17009_1200020">33618</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_741278x780633" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_17013_1600020">302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_709650x710425_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_18012_1500058">2215000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_709650x810388_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_18003_700058">-2215000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_18013_1600058">2215000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_709650x710802_741278x830241" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_19011_1400018">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_709650x713713_741278x830241" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_19009_1200018">2042</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_741278x830241" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_19013_1600018">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_709650x710425_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_20012_1500065">685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_709650x810388_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_20003_700065">-685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_20013_1600065">685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_709650x710425_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_21012_1500051">1320000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_709650x827065_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_21001_500051">-1320000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_21013_1600051">1320000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x710802_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_22011_1400006">1126000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x710802_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_23011_1400014">290000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x713713_741278x736639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_22009_1200006">99705</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x713713_741278x779639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_23009_1200014">17647</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_22013_1600006">1126000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_23013_1600014">290000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3012_1500074">-84080000</us-gaap:NetIncomeLoss>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3012_1500048">254000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3012_1500073">-8763000</galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_24012_1500064">380000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26012_1500041">1070000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_27012_1500060">1212000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_29012_1500062">2440000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400047">53000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:SubscriptionRevenue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400019">150000</us-gaap:SubscriptionRevenue>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400066">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400046">15424000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400048">-458000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:StockBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400045">157000</galt:StockBasedCompensation>
  <galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400044">-455000</galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400008">2221000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:ReclassificationOfWarrantsToLiability contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400043">3193000</galt:ReclassificationOfWarrantsToLiability>
  <galt:StockIssuedDuringPeriodValueMerger contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400005">107000</galt:StockIssuedDuringPeriodValueMerger>
  <galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400003">1036000</galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400001">7000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400002">222000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400073">8763000</galt:AdjustmentsToAdditionalPaidInCapitalWarrantModification>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3011_1400067">18808000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_24011_1400064">-347000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x742327_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25011_1400057">284000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26011_1400069">117000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26011_1400041">-1023000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x883035" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_27011_1400060">-1212000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x883035_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_28011_1400049">1105000</galt:IssuanceOfRedeemablePreferredStockValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_29011_1400062">-2440000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_30011_1400052">2761000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051_741278x829211" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_31011_1400054">1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_32011_1400031">1745000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33011_1400068">632000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33011_1400032">3947000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x795852" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_34011_1400071">3832000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35011_1400042">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35011_1400033">5329000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x809450" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_36011_1400070">10400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713470_711196x742327_741278x779639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25005_800057">-29</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713470_711196x742327_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25005_900057">-284000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713470_711196x742327_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25005_900055">2203000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713470_711196x742327_741278x779639" unitRef="shares" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25005_800055">225</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713505_711196x746545" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26007_1000069">-290000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713505_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26007_1100069">-117000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200072">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200066">454167</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200047">12515</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1300066">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <galt:StockIssuedDuringPeriodSharesFounders contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200001">2059112</galt:StockIssuedDuringPeriodSharesFounders>
  <galt:IssuanceOfCommonStockAndWarrantsShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200008">114884</galt:IssuanceOfCommonStockAndWarrantsShares>
  <galt:StockIssuedDuringPeriodSharesConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200003">110054</galt:StockIssuedDuringPeriodSharesConversionOrExchangeOfConvertibleSecurities>
  <galt:StockIssuedDuringPeriodSharesMerger contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200004">203649</galt:StockIssuedDuringPeriodSharesMerger>
  <galt:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1200067">4704518</galt:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1300001">2000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_3009_1300067">4000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x742327" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_24009_1200063">86967</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x742327_741278x779639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25009_1200057">48527</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x746545" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26009_1200040">185392</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x746545" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26009_1200069">48387</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x883035" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_27009_1200059">334913</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x884051" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_29009_1200061">653274</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x736639" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_32009_1200031">79367</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x755589" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33009_1200032">1227972</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x755589" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33009_1200068">611945</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33009_1300068">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33009_1300032">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x795852" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_34009_1200071">599942</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x795852" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_34009_1300071">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x796434" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35009_1200033">867558</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35009_1300033">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x809450" unitRef="shares" decimals="INF" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_36009_1200070">2666722</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x809450" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_36009_1300070">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x810388_711196x884051_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_30003_700052">1174000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x810388_711196x884051_741278x796434" unitRef="shares" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_30003_600052">2100000</galt:IssuanceOfRedeemablePreferredStockShares>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x810388_711196x884051_741278x829211" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_31003_700054">-1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x827065_711196x883035_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_28001_500049">395000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x827065_711196x883035_741278x755589" unitRef="shares" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_28001_400049">900000</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x713470" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_1003_25">2203000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x713505" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_2003_22">1691000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x742327" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_24013_1600064">33000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x742327_741278x779639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25013_1600057">284000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x742327_741278x779639" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_25013_1600056">47000</galt:StockIssuanceCosts>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x746545" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_26013_1600041">47000</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x810388" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_3003_24">3935000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
  <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x827065" unitRef="iso4217_USD" decimals="-3" id="id_4142217_59944782-C95F-445A-A717-73F2641F2F8D_4003_23">1548000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x883035_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_28013_1600049">1105000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x883035_741278x755589" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_28013_1600050">300000</galt:StockIssuanceCosts>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x884051_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_30013_1600052">2761000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x884051_741278x796434" unitRef="iso4217_USD" decimals="0" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_30013_1600053">188000</galt:StockIssuanceCosts>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x884051_741278x829211" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_31013_1600054">1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x736639" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_32013_1600031">1745000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33013_1600068">632000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x755589" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_33013_1600032">3948000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x795852" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_34013_1600071">3833000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35013_1600042">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x796434" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_35013_1600033">5330000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x809450" unitRef="iso4217_USD" decimals="-3" id="id_4142217_AFED9A34-B130-484F-ABAE-266D395E4991_36013_1600070">10403000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1310-K0015_STD_59_20140228_0_710720x714667_712375x743626" unitRef="shares" decimals="INF" id="id_4142217_4D70FADD-FBED-46E6-B7A4-D4BDE99AC094_1003_8">2663647</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1310-K0015_STD_59_20140228_0_710720x714667_712375x743626" unitRef="iso4217_USD" decimals="0" id="id_4142217_ED0EAAEC-A670-48D9-A09A-9459588569CC_1003_1">28178000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="eol_PE87402---1310-K0015_STD_60_20040229_0_713115x711585" unitRef="shares" decimals="INF" id="id_4142217_0FE3B332-74F5-4F71-851A-05AB981F22BA_6004_6">10000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1310-K0015_STD_91_20080630_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_2_15">2160000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:FairValueAdjustmentOfWarrants contextRef="eol_PE87402---1310-K0015_STD_91_20080630_0" unitRef="iso4217_USD" decimals="-3" id="id_4142217_CC59913B-5467-40E4-825F-1DA0F43A87E1_2_14">356000</us-gaap:FairValueAdjustmentOfWarrants>
  <galt:WarrantExpense contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_3_4">8763000</galt:WarrantExpense>
  <galt:NumberOfWarrantsExercise contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0" unitRef="Warrants" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_3_5">5000000</galt:NumberOfWarrantsExercise>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1003_15">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1003_18">0.0119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1003_17">0.0074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1003_16">1.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_1003_19">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867_711502x711169" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_2003_13">P5Y9M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867_711502x716112" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_3003_14">P7Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4003_8">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4003_11">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072" unitRef="pure" decimals="4" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4003_10">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072" unitRef="pure" decimals="2" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4003_9">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072" unitRef="iso4217_USD" decimals="0" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_4003_12">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072_711502x711169" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_5003_6">P9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072_711502x716112" id="id_4142217_B67715C8-EFBF-4D08-934A-AD7C26D71EC5_6003_7">P2Y4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x841072">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0_708873x748867">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_93_20130630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2013-03-30</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_91_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_60_20040229_0_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_59_20140228_0_710720x714667_712375x743626">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">galt:MarketSaleAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x809450">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x795852">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x884051_741278x829211">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x884051_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x883035_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x742327_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x827065_711196x883035_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x810388_711196x884051_741278x829211">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x810388_711196x884051_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x809450">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x795852">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x742327_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713505_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x713470_711196x742327_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x809450">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x795852">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051_741278x829211">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x883035_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x742327_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x713713_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x713713_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x710802_741278x779639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x812794_709650x710802_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_709650x827065_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x810389_709650x710425_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_709650x810388_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x752948_709650x710425_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_741278x830241">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_709650x713713_741278x830241">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x750561_709650x710802_741278x830241">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_709650x810388_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x745453_709650x710425_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_741278x780633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_709650x713713_741278x780633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711498_709650x710802_741278x780633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_741278x740448">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x713713_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x713713_741278x740448">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x710802_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x711289_709650x710802_741278x740448">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x834701">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x823795">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x785453">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x776355">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_741278x750826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_711196x746545_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x834701">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x823795">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x785453">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x776355">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713713_741278x750826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x713505_711196x746545_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x834701">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x823795">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x796434">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x785453">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x776355">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x709629_709650x710802_741278x750826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_709650x713713_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708980_709650x710802_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_709650x710802_741278x755589">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0_708873x708807_709650x710802_741278x736639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_4922_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_485_20100531_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_713879x820386">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonQualifiedOptionsPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x710313">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_712382x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_712080x713040">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_712080x707836">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x827065_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x810388_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0_708873x796972">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20081231_0_716389x770436">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProspectiveAdoptionOfNewAccountingPronouncementsAxis">galt:AdoptionOfNewAccountingPronouncementEffectMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20081231_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20081231_0_708873x735492_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:PeriodTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20081231_0_707179x753998_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x764378_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x764378">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x745885_708873x807711_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:OptionsVestedOnJanuaryAndFebruaryTwentyZeroFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x745885">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x743063_708873x775931_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x743063_708873x775931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x735475_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_366_20041231_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_716763x819924">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesATwoWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_716763x749992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_715832x725975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_715832x710442">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_713879x778478">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonEmployeeDirectorStockOptionsPlanTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x710313">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712382x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712375x743626">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">galt:MarketSaleAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712080x713040">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_712080x707836">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x843449_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x834904">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayOneTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x825930_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x818860_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x818860_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x815309_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x811277">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberThirtyTwentyTenPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x809525_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x804453_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x803310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchTwentyEightTwentyTwelveOfferingWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x796706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x786055">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneFifteenTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x773941_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x773941">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x754040_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x742459_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x738944_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x735983_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x735983">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x730156">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberNineTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711952x726894_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x711886">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_710844x707398">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713505_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x713470_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x884051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x883035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x746545">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesAOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425_711196x742327">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x803399">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x765708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x760806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x753422">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_709283x747231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0_708873x796972">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_842646x773308">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationPlansAxis">galt:MonteCarloOptionPricingModelMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x810377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_716763x736056">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesAOneWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x716112_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711502x711169_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x829211">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x828584">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x824056">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x814598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x796385">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x770088">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x735492">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_755443x730903">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x840823_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:FirstPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x840719_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:DividendPaymentTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x825279">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x784846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x770326_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:DividendPaymentOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_708873x744092_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x753998_708873x825279_713115x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x735475_713115x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x810377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x789620_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x781749_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x749992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x716112_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_711502x711169_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_709650x806044_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:BeneficialConversionFeatureMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_709650x710802_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x835592_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_708873x768454_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_709650x806044_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:BeneficialConversionFeatureMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_709650x710802_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x753998_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20091231_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20071231_0_708873x829211_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:PeriodOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20071231_0_707179x753998_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x764378_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20051231_0_707179x745885">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_715329x770884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:ScientificAdvisoryServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_715329x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x830547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x789346_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardMemberAndMemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x764378_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x764378">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x745885_708873x756332_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:OptionsVestedOnDecemberThirtyOneTwentyZeroThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_713115x711585_809041x757891">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_708873x775931_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x743063_708873x775931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x735475_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20031231_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20021231_0_714777x827982">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">galt:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_713115x711585_809041x757891">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_708873x733612_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20021231_0_707179x743063_708873x733612">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20011231_0_716763x815051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20011231_0_716763x797754">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_809041x757891">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20011231_0_707179x743063_713115x711585_809041x757891">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_365_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_35_20080331_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-26</startDate>
      <endDate>2008-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20131231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-12-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20101231_0_716763x789620_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20071231_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-12-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20120831_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547_708873x796972">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20031031_0_707179x830547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20011031_0_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20011031_0_711502x716112_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20011031_0_711502x711169_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20010831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2001-08-01</startDate>
      <endDate>2001-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20110731_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20110731_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20100531_0_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20090531_0_716763x749992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-05-01</startDate>
      <endDate>2009-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20080531_0_705999x767774">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">galt:InvestorRelationsGroupIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-05-01</startDate>
      <endDate>2008-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20030531_0_707179x764378">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2003-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20030531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2003-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20090331_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-03-01</startDate>
      <endDate>2009-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-03-01</startDate>
      <endDate>2006-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20060331_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-03-01</startDate>
      <endDate>2006-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20040331_0_707179x745885">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20020331_0_707179x743063_708873x733612">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-03-01</startDate>
      <endDate>2002-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20140131_0_710720x714667_711196x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20140131_0_710256x714598_710720x714667">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20130131_0_713115x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20110131_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20030131_0_707179x735475">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_31_20030131_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20101230_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20101230_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20130930_0_711528x781739_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">galt:AmendmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-09-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20130630_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-06-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20120930_0_790000x792996">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:LocationAxis">galt:NorcrossMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-09-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x830547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20030930_0_707179x789346">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:BoardMemberAndMemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20020930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2002-09-01</startDate>
      <endDate>2002-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20100630_0_716763x810377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-06-01</startDate>
      <endDate>2010-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20030630_0_707179x743063_708873x775931">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-06-01</startDate>
      <endDate>2003-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090430_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-01</startDate>
      <endDate>2009-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20080430_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20040430_0_707179x745885_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-01</startDate>
      <endDate>2004-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20040430_0_707179x745885">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-01</startDate>
      <endDate>2004-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090513_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20090513_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_30_20051130_0_707179x764378">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-11-01</startDate>
      <endDate>2005-11-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_29_20120531_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-05-03</startDate>
      <endDate>2012-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_28_20111115_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-19</startDate>
      <endDate>2011-11-15</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_28_20090228_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_28_20090228_0_707179x753998">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_28_20090228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_22_20120323_0_707046x785450">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="invest:InvestmentAxis">galt:ReverseSplitMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-23</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_22_20120323_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-23</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20110126_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-25</startDate>
      <endDate>2011-01-26</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-28</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-28</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-28</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100129_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-28</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100129_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-01-28</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-12-07</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-12-07</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-12-07</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091208_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-12-07</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-12-07</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20030114_0_715329x781829">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-13</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20030114_0_715329x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-13</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20030114_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2003-01-13</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20121012_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-10-11</startDate>
      <endDate>2012-10-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-29</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-29</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-29</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090930_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-29</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-09-29</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20031002_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-29</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-29</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-29</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090630_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-29</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-06-29</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-07-01</startDate>
      <endDate>2008-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20130329_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2013-03-28</startDate>
      <endDate>2013-03-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120502_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-05-01</startDate>
      <endDate>2012-05-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120328_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-27</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120328_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-27</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120322_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-21</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120322_0_714750x796043">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">galt:UnderwritingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-21</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20120322_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-21</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-29</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-29</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-29</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100430_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-29</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100430_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-04-29</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-03-07</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-03-07</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-03-07</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100308_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-03-07</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100308_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-03-07</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-06</startDate>
      <endDate>2004-04-07</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20040407_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-06</startDate>
      <endDate>2004-04-07</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20140131_0_710720x714667_716763x819924">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesATwoWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-30</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20130816_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2013-08-15</startDate>
      <endDate>2013-08-16</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20130506_0_711196x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-05-05</startDate>
      <endDate>2013-05-06</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20130506_0_711196x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-05-05</startDate>
      <endDate>2013-05-06</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-09</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-09</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-09</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100510_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-09</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20100510_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-05-09</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-03</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-03</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-03</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091104_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-03</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20091104_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-11-03</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-11</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-11</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-11</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090812_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-08-11</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090812_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-08-11</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x807713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065_716763x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20090212_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-02-11</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080521_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-05-20</startDate>
      <endDate>2008-05-21</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x821234">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0_716763x725855">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0_711952x731237_716763x821234">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080225_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-02-24</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_716763x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x840823_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:FirstPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x825279_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x784846_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0_708873x744092_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20080204_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-02-03</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-08-11</startDate>
      <endDate>2004-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_2_20040812_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-08-11</startDate>
      <endDate>2004-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x841072">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:BeforeModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0_708873x748867">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:AfterModificationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_181_20130630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x810377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x781749">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_716763x749992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x725975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x716297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_715832x710442">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x781654">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:IncentiveCompensationPlanTwentyZeroNineMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_713879x778478">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonEmployeeDirectorStockOptionsPlanTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_712375x743626">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">galt:MarketSaleAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_712021x710575_715757x707855">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x843449">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x834904">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayOneTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x825930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_716763x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x818860_716763x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x815309">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x811277">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberThirtyTwentyTenPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x809525">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x804453">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x803310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchTwentyEightTwentyTwelveOfferingWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x796706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x786055">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneFifteenTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x773941">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x754040">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x742459">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x738944">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x735983">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x730156">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberNineTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711952x726894">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_710844x711886">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_710844x707398">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x803399">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x765708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x760806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x753422">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0_709283x747231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">galt:ExercisePriceRangeFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_716763x781749">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x725975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x716297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_715832x710442">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_713879x820386">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonQualifiedOptionsPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_712021x710575_715757x707855">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x842935">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_842646x773308">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationPlansAxis">galt:MonteCarloOptionPricingModelMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x819924">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesATwoWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x805518">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesAAndBWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x736056">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesAOneWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_716763x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_715329x760081">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_715329x726338">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBNomineesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x716112_715329x726338">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBNomineesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x716112">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x710802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_709650x710425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_708873x825279">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0_708873x784846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20110126_0_711196x710990_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-01-26</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0_716763x789620_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0_713115x716908">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0_708873x835592_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101230_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2010-12-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20101229_0_711196x713470">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-29</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100129_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-01-29</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20091231_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20091208_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-08</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20081231_0_716389x770436">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProspectiveAdoptionOfNewAccountingPronouncementsAxis">galt:AdoptionOfNewAccountingPronouncementEffectMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20081226_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-12-26</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20031231_0_713879x778478">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonEmployeeDirectorStockOptionsPlanTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x781829">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x771670">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:AdvisorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20030114_0_715329x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x781829">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x771670">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:AdvisorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x770884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:ScientificAdvisoryServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0_715329x768389">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0_707179x743063_713115x711585">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20011231_0_716763x815051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20011231_0_716763x797754">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20011213_0_714777x827982">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">galt:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-13</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20131025_0_712375x743626">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">galt:MarketSaleAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130930_0_713115x708980">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2013-06-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-10-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20120930_0_790000x792996">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:LocationAxis">galt:NorcrossMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090930_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-10-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20031002_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-10-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20020930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20011031_0_713879x842739">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-10-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20010831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2001-08-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130801_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2013-08-01</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20110731_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2011-07-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100630_0_716763x810377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-06-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x804137">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100531_0_716763x781749_741278x756917">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090630_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-06-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090531_0_716763x749992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-07-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080531_0_705999x767774">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">galt:InvestorRelationsGroupIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20030531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2003-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20140319_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2014-03-19</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20120328_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20120328_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20120322_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-22</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20120322_0_714750x796043">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">galt:UnderwritingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-22</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100430_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-04-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100308_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-03-08</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090430_0_716763x740658">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-04-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-04-07</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20040407_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-04-07</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20140131_0_710720x714667_711196x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-01-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130506_0_711196x752557">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-05-06</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130506_0_711196x742455">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-05-06</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20130131_0_713115x715581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-01-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20100510_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-10</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20091104_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-11-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090812_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090513_0_711196x810388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-05-13</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090228_0_713879x781654">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:IncentiveCompensationPlanTwentyZeroNineMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090228_0_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090212_0_711196x827065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20090212_0_711196x710990">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x821234">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x813918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x805643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0_716763x725855">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0_711952x731237_716763x821234">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080225_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080204_0_711196x713505_711502x711169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080204_0_711196x713505">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20080204_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x780010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20040812_0_711952x731237">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1310-K0015_STD_0_20030131_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2003-01-31</instant>
    </period>
  </context>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_Warrants">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>galt:Warrants</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>galt:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Person">
    <measure>galt:Person</measure>
  </unit>
  <unit id="CompensationPlan">
    <measure>galt:CompensationPlan</measure>
  </unit>
  <unit id="Warrants">
    <measure>galt:Warrants</measure>
  </unit>
</xbrl>




